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                                                                        Abstract    
Tsetse flies (Diptera: Glossinidae) are the vectors of African trypanosomiasis, a 
parasitic disease of humans and other animals that can be fatal if untreated. 
Trypanosomes undergo a complex life cycle in the fly involving a series of 
morphological and biochemical changes that culminate in the development of 
mammalian infective metacyclics in the salivary glands (Trypanosoma brucei) or 
the mouthparts (T. congolense). Once in the fly‟s midgut, the stumpy forms, 
which are thought to be pre-adapted for life in the tsetse midgut, differentiate into 
the procyclic form. However, the majority of flies can effectively get rid of 
parasites before they develop or establish an infection in the midgut. One would 
expect that as a result of the high disease burden in Africa, there would be a 
corresponding large number of flies that are also infected, yet paradoxically, just 
very few number of flies (<5%) can actually transmit the parasites to susceptible 
mammalian hosts. This means that tsetse flies are generally resistant to 
trypanosome infection, but the molecular mechanisms underlying this 
phenomenon are yet to be elucidated. The reasons for this natural refractoriness 
to a trypanosome infection are considered to be multifactorial and include the 
age of the fly, maturation of the fly immune system and peritrophic matrix among 
others, but so far few tsetse genes have been associated with this intr insic 
phenotype.  
In this thesis, I have identified and partially characterised several midgut genes 
from the tsetse vector, Glossina morsitans, that have been identified as 
differentially expressed (DE) in flies refractory to a trypanosome infection. A 
bioinformatics analysis of the 454 transcriptome data shows a total of 55 genes 
were DE in flies that were challenged with trypanosome. Four differentially 
regulated midgut genes (i.e. Chitinase (CHIT; GMOY000153), O-GlcNAc 
transferase (OGT; GMOY002400), secreted Phospholipase A2 (sPLA2; 
GMOY009713) and serine proteinase inhibitor (SPI; GMOY006016)) were 
further analysed in silico as representative of different metabolic pathways.  
RNAi knockdown of midgut-expressed CHIT, OGT, sPLA2 and SPI genes 
significantly increased susceptibility to T. brucei infection in young files, 
suggesting that these genes are involved in the immune response to 
trypanosome infection in G. m. morsitans. However, reversion of the infection 
phenotype after RNAi silencing was not higher than ~40%, indicating that several 
proteins/pathways may be implicated in preventing establishment of a 
trypanosome infection in the tsetse midgut.  
The potential role of the midgut-expressed sPLA2 activity as a trypanocidal 
molecule was also studied. Over a period of two weeks, it was found that 
expression of midgut sPLA2, in flies receiving blood meals infected with 
bloodstream forms (BSF), is suppressed at the early stage of trypanosome 
infection, but its rises sharply after 14 days post-infection (dpi). The level of 
sPLA2 expression in response to infection with procyclic forms (PCF) did not 
differ from the expression seen when flies were challenged with BSFs, ruling out 
the possibility of sPLA2 expression being in response to the presence of mature 
PCFs. However, expression of sPLA2 was augmented at 14 dpi in flies 
challenged with a higher parasite load, but not with either dead parasites or 
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bacteria, suggesting that its expression is somewhat dependent on the density of 
live parasite density. Surprisingly, when flies are fed with live Staphylococcus 
aureus, but not Escherichia coli there was a strong induction of sPLA2 as early 
as 5 dpi, suggesting that its expression may be linked or modulated by the Toll 
pathway in response to certain pathogens. Furthermore, in vitro killing assays 
using recombinant sPLA2 showed that procyclic trypanosomes were lysed after 
24 hours when co-cultured with at least 50 g/ml of active enzyme. Thus, it is 
hypothesised that at 14 dpi, when the trypanosome infection is well established 
in both the midgut and proventriculus of the fly, a release of PLA2 may help 
control parasite infection, but is unable to clear it.  
The data obtained from this thesis will offer new insights on the molecular 
dialogue that ensues between trypanosomes and tsetse following the ingestion 
of trypanosomes by tsetse in a blood meal.  
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                                                         Chapter 1.   
                                       Literature Review     
 
      
      1.1     General Introduction  
African trypanosomiasis is a debilitating parasitic disease that affects both 
humans and animals. It is transmitted by the bite of a tsetse fly infected with 
trypanosomes (genus Trypanosoma, order Kinetoplastida) when taking a blood 
meal. The disease afflicts populations in rural sub-Saharan Africa, consisting 
mainly of the poor and less privileged that depend on fishing, hunting, agriculture 
or animal husbandry for their livelihood (Barrett et al., 2003). The human form of 
the disease, human African trypanosomiasis (HAT) also known as sleeping 
sickness is caused by Trypanosoma brucei gambiense and Trypanosoma brucei 
rhodesiense, two subspecies of Trypanosoma brucei. While T. b. gambiense 
which causes over 98% of reported cases occurs in central and west Africa and 
causes a more chronic infection that lasts for years with a latent period that takes 
months and sometimes years before symptoms become manifest, T. b. 
rhodesiense occurs in southern and east Africa and causes a more virulent and 
acute infection, which progresses more rapidly to the late stage involving the 
central nervous system (CNS) accounts for the remainder of cases (WHO, 
2013a, WHO, 2014b).  
Animal African trypanosomiasis, which is known locally as Nagana disease is 
caused by different trypanosome species with T. vivax and T. congolense being 
the major pathogens for livestock, especially cattle and other ruminants (Eyford 
et al., 2011, Rotureau and Van Den Abbeele, 2013). Other species that infect 
livestock include T. simiae, T. godfreyi, T. b. brucei, T. uniforme, and T. suis 
(Rotureau and Van Den Abbeele, 2013). African trypanosomiases have 
catastrophic socio-economic impact on the African continent. More than 8 million 
square kilometres of the Sub-Saharan African continent otherwise known as the 
“the tsetse belt”, an area of fertile land, are inhabited by tsetse flies, the vectors 
of African trypanosomiasis turning the area into a “green desert” because it is 
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deserted by humans and cattle resulting in huge economic loss (FAO, 2002).  
About 70 million people in 36 countries are at risk of contracting HAT because 
they live in the so called “tsetse belt” and are therefore exposed to tsetse bites 
(Simarro et al., 2012a). Sleeping sickness is usually fatal if left untreated and 
occurs in two stages – the haemolymphatic stage and the neurologic stage 
(Barrett et al., 2003). N‟gana is responsible for high mortality rate in cattle 
leading to huge economic loss. Currently there is no vaccine and the drugs used 
for treatment of HAT cause serious side effects and sometimes toxic in addition 
to the fact that administration of the drugs involves a complicated posology and 
requires hospitalization of patients and trained personnel (Fevre et al., 2006, 
Brun et al., 2010). Also there is widespread increase in the incidence of drug 
resistance in the treatment of AAT (Delespaux et al., 2008b, Delespaux et al., 
2008a). 
Both male and female tsetse flies feed only on blood and as a result both can 
transmit trypanosomes to mammals during a blood meal. For a successful 
transmission of trypanosomes to a mammalian host, the parasites must undergo 
a complex cycle of development and maturation in the tsetse fly. Since tsetse 
flies are the exclusive cyclical vectors of trypanosomiasis, although mechanical 
transmission by other haematophagous insects such as tabanids and Stomoxys 
can occur in the case of T. vivax (Rotureau and Van Den Abbeele, 2013), and in 
light of the fact that all efforts to develop a vaccine for the disease have so far 
proved unsuccessful, vector-oriented control measures form the bedrock of the 
fight against African trypanosomiases. In light of the above, an in-depth 
knowledge of the molecular mechanisms of the crosstalk between trypanosomes 
and tsetse flies is of paramount importance and one that could lead to the 
unravelling of the transmission dynamics of these medically and economically 
important parasites. 
 
1.2    Epidemiology of African trypanosomiasis 
The geographical distribution of African trypanosomiasis is restricted to discrete 
areas or foci in sub-Saharan Africa where there are suitable habitats for the 
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tsetse fly vector, and there are areas where tsetse flies are found with no 
incidence of sleeping sickness (WHO, 2010). There are many species and 
subspecies of Glossina with varied environmental requirements leading to the 
focal nature of the distribution of the vector across the tsetse belt of Africa. 
Although both T. b. gambiense and T. b. rhodesiense cause HAT or sleeping 
sickness, the presentation, manifestation, duration and treatment regimens as 
well as the epidemiological patterns of the diseases caused by these subspecies 
are quite distinct and understanding these differences plays a major role in the 
formulation of control strategies for HAT (Welburn et al., 2001, Fevre et al., 
2006). The Palpalis group of tsetse flies, especially G. fuscipes and G. palpalis 
are the principal vectors of T. b. gambiense while the Morsitans group are the 
vectors of T. b. rhodesiense (Welburn et al., 2001). The clinical presentation for 
both diseases consists of an early haemolymphatic stage and a late encephalitic 
stage involving the CNS. The clinical presentation is characterized by a variety of 
symptoms ranging from non-specific such as fever, headache, weakness and 
general malaise to a more specific organ dysfunction involving the heart, skin, 
liver, spleen, eye and the endocrine system (Atouguia JLM, 2000, Duggan and 
Hutchinson, 1966). The late stage occurs when the parasites invade the CNS 
and is insidious in onset and chronic in nature in gambiense disease but in 
rhodesiense disease it is acute with a duration of weeks or a few months 
(Kennedy, 2006).  Progression from early to late stage of the disease is not a 
clear cut process with symptoms of both stages overlapping thereby making 
distinction between the two stages based on clinical presentation ambiguous 
(Atouguia JLM, 2000, Franco et al., 2014a). Because of the non-specific nature 
of the symptoms, HAT can be confused with other diseases with similar 
symptoms and may require continued re-evaluation of patients before a correct 
diagnosis can be made (Sahlas et al., 2002, Simarro et al., 2012b)). 
 
1.2.1    Transmission cycle 
For both forms of HAT, infection prevalence requires the involvement of the 
three factors that constitute the “epidemiological triangle” namely, human host, 
reservoir and tsetse fly, all co-existing in an environment that is a suitable habitat 
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for tsetse flies (Figure 1.1) (WHO, 2013a). The reservoirs of infection, be it 
human or animal can also be the host suffering from the disease depending on 
their behavioural interactions with the environment. The vectors (tsetse flies) are 
wholly dependent on a conducive environment for survival while the parasite is 
transmitted between hosts by the vector (Franco et al., 2014a). Human beings 
act as both host and reservoir for Gambiense HAT while for Rhodesiense HAT 
which is a zoonotic disease, the main reservoirs are animals. The role of animals 
as reservoirs of infection in Gambiense HAT is not clear although T. b. 
gambiense has been discovered in a variety of animals and are therefore 
regarded as potential reservoir hosts for this trypanosome species (Simo et al., 
2006, Njiokou et al., 2006, Wastling et al., 2011, Nkinin et al., 2002, Njiokou et 
al., 2010, Cordon-Obras et al., 2009)). It has also been established that animals 
are susceptible to infection with T. b. gambiense when they are experimentally 
infected (Duke, 1931, Penchenier et al., 2005).  
However it has been suggested that how often humans are exposed to the 
tsetse fly vector could be an important factor in the distribution of T. b. 
gambiense (Davis et al., 2011). Although the vectors for Rhodesiense HAT may 
be present but with the unavailability of infected reservoir, transmission cannot 
always occur (WHO, 2013a). Also the acute nature of the disease means that 
infected individuals are less likely to be present in the same environment 
harbouring tsetse flies as a result the transmission cycle of T. b. rhodesiense 
mainly involves the circulation of the parasites between non-human reservoirs 
and the vector with occasional transmission of the disease to humans (WHO, 
2013a). In the case of Gambiense HAT, because an infected individual can still 
maintain normal activities during the long period of infection, the flies can 
transmit the disease between humans even though very few flies are infected 
with the parasites and this may be the reason why gambiense HAT accounts for 
most of the HAT cases (Baker, 1974).  
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Figure 1.1 Epidemiological triangle for the transmission cycle of human 
African trypanosomiasis (adapted from WHO, 2013). 
 
1.2.2   Risk factors 
Combinations of various factors influence the rate of transmission of HAT. These 
include: increases in the likelihood of humans encountering tsetse flies, the site 
of contact between humans and tsetse flies, the intensity and frequency of 
contact and, in the case of rhodesiense HAT the existence of nonhuman 
reservoirs (Franco et al., 2014a).  
 
Gambiense human African trypanosomiasis 
The risk factors for Gambiense HAT is influenced by factors such as the type of 
environment harbouring the flies, the characteristics of the flies such as vector 
competence, behaviour, how often they come in contact with humans, life span 
and fly distribution and human activities within the different environments 
occupied by tsetse flies that are likely to bring humans in close proximity to 
tsetse flies (WHO, 2013a, Franco et al., 2014a). The risk for disease 
transmission increases when tsetse natural habitats are impinged upon by 
natural causes such as drought or human activities that destroy their habitats, for 
example, logging and farming (WHO, 2013a). About 31 species and subspecies 
of tsetse are known to inhabit various habitats ranging from forest for the fusca 
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group to savannah for the morsitans group and riverine and forest for the 
Palpalis group (Jordan, 1993). 
The wide distribution of tsetse flies in humid forest habitats comes with an 
extensive range of hosts and human-fly contact does not occur on a regular 
basis because it is dependent on human activities that bring them in contact with 
tsetse flies such as hunting, fetching firewood, timber cutting for business, and 
clearing of forest for farming activities (Grebaut et al., 2001). Tsetse flies prefer 
to stay close to rivers and streams in the woodland savannah and riverine forest 
galleries. Humans who go to these water bodies to fetch water or carry out other 
domestic activities such as washing clothing or food, together with those 
engaged in mining and fishing are the ones mostly at risk of being bitten by 
infected tsetse flies (Robays et al., 2004, Kohagne et al., 2011, Moore et al., 
1999). In-between forest and woodland savannah, the so called transitional 
vegetation where there are islands of vegetation which are frequently used for 
agricultural purposes also serve as suitable habitats for tsetse affording them the 
opportunity to sight hosts and this makes farming a risk factor for HAT in these 
areas (Moore et al., 1999).  
Tsetse flies are also found in large populations in the mangrove areas where 
fishing and crustacean collection are associated with a high risk of transmission 
as well as cleared mangrove swamps used for rice cultivation. Pirogue jetties 
and encampments used for fishing provide an ideal environment for human-fly 
contact (Solano et al., 2009, Henry et al., 1982, Courtin et al., 2010). Areas 
where the original forest has been destroyed to plant cash crops such as cocoa, 
coffee, mango and banana form a suitable habitat for tsetse flies and people who 
work in these plantations are often exposed to tsetse bite and these areas 
therefore constitute transmission sites for plantation workers (Meda et al., 1993). 
In as much as Gambiense HAT is regarded as a rural disease, there have been 
occasional incidences of the disease in urban areas where transmission has 
been associated with seasonal travels to neighbouring villages for cultivating 
fields and agricultural activities or in suburban outskirts of cities closer to 
transitional vegetation areas and therefore serve as a suitable habitat for tsetse, 
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but with a small number of alternative hosts (Fournet et al., 1999, Courtin et al., 
2005, Robays et al., 2004). Also the disease is known to affect mainly young 
adults because they are the ones engaged in productive activities that 
predispose them to tsetse bite (Pepin and Meda, 2001, Paquet et al., 1995, 
Moore et al., 1999). Because children are less exposed to flies during the day, 
the rate of infection in children is low compared to adults except in some areas 
where children are engaged in at-risk activities such as fishing and leisure 
activities in water areas (Vanhecke et al., 2010, Abel et al., 2004).  
Infection prevalence is not gender-specific but the behaviours and activities in 
certain areas determine which sex group is most at risk of contracting the 
disease. For instance, in areas where mining, hunting, or fishing constitute at-
risk activities, infection prevalence is higher in males than in females, whereas in 
areas where the risk of infection is associated with cultivation and domestic 
activities at water points such as transitional vegetation, similar infection 
prevalence are found among males and females (Pepin and Meda, 2001, Paquet 
et al., 1995, Moore et al., 1999, Abel et al., 2004). Short-term travellers from 
nonendemic areas are less exposed to the vectors because tourists rarely visit 
the rural areas in which Gambiense HAT is transmitted. Immigrants and 
expatriates who have lived in endemic areas for extended periods are usually 
the ones diagnosed with occasional Gambiense HAT (Migchelsen et al., 2011, 
Simarro et al., 2012b).  
It has been observed that more than one member of a given family may be 
infected with disease at the same time and the risk of a child having Gambiense 
HAT increases significantly if the mother had had the disease and siblings are 
more likely to contract the disease if one of them is infected (Pepin and Meda, 
2001). This clustering of cases or familial aggregation could be attributed to 
genetic susceptibility or similar, but not necessarily simultaneous exposure to the 
vector and shared behavioural risk factors (Pepin and Meda, 2001). It has 
however been suggested that the later might be the case rather than the former 
(Khonde et al., 1997, Henry, 1981). 
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Rhodesiense human African trypanosomiasis 
There are two different settings for the transmission of Rhodesiense HAT and 
therefore different situations for contracting the disease (Franco et al., 2014a). 
Wildlife and livestock are the main reservoirs for infection. In areas where wildlife 
constitutes the main reservoir, the more active and working-age groups are the 
ones at highest risk of being infected because they are the ones engaged in 
activities associated with entry into tsetse habitats such as national parks and 
game reserves (Franco et al., 2014a). The people most likely to be infected are 
the ones living very close to the wildlife preserved areas who engage in 
occupational activities and exploitation of national resources such as hunting and 
poaching, fishing, honey and firewood collection.  
This is also the case for tourists who go to national parks for sightseeing as well 
rangers and park wardens who look after these parks (Kinung'hi et al., 2006, 
WHO, 2013a, Simarro et al., 2012b, Pepin and Meda, 2001, Zoller et al., 2008). 
Livestock may also serve as the main reservoir for Rhodesiense HAT in which 
case activities linked to cattle raising increases the risk of infection and those 
living around are also exposed (Franco et al., 2014a). Familial aggregation in 
Rhodesiense HAT is mostly attributed to common exposure to vectors (Zoller et 
al., 2008, Okia et al., 1994). The ecology of Glossina is such that the population 
densities of flies reaches a peak after the rainy season and there is a link 
between the density of Glossina and the transmission of Rhodesiense HAT with 
peaks of transmission occurring in the warmer months after the rainy season 
(Smith et al., 1998).  
 
1.2.3 Incidence of disease and trends in numbers of reported cases 
There is optimism that there is a possibility of eliminating sleeping sickness as a 
result of the decline in the number of cases after a period characterised by 
severe epidemics (Welburn et al., 2009). Various factors have been linked to the 
epidemics of sleeping sickness in Africa; they include increased movements and 
displacement of populations and modifications to the environment (for example, 
clearing of forests and the use of intensive agriculture to generate cash crops) as 
well as conflict and socio-political instability which go hand in hand with 
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persistence and resurgence of infection (Berrang Ford, 2007, WHO, 2013a). 
There have been some major epidemics of the disease since it was discovered 
but since 2000, there have been a sustained decrease in the number of notified 
cases with the figure falling to below 10,000 new cases in 2010 (figure 1.2) as a 
result of the reinforcement of control programmes by WHO in partnership with 
some international organisations and national control programmes of affected 
countries (Franco et al., 2014b) as well as a better understanding of the 
epidemiology of the disease (Simarro et al., 2010). 
 
   
Figure 1.2 Total number of new cases of HAT (1995-2013). Cases 
reported to the World Health Organisation by disease endemic countries. 
Data from the World Health Organisation (WHO, 2013a, Simarro et al., 2013, 
WHO, 2013b, Franco et al., 2014a) 
                            
1.2.4  Epidemics of Gambiense human African trypanosomiasis 
The origin of Gambiense HAT epidemics have been linked to various factors 
chief among which include socio-political changes that have led to sudden 
changes in the environment, displacement of populations as a result of war or 
civil strife, changes in human practices, and inadequate or lack of effective 
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control programmes in affected countries where the health care system is weak 
(Ekwanzala et al., 1996, Stanghellini and Josenando, 2001, Moore and Richer, 
2001). Presently there is a decrease in the number reported cases of gambiense 
HAT of about 76% since 2000 (Franco et al., 2014a) with about 7000 reported 
new cases since 2011 (WHO, 2013a, Franco et al., 2014b, Simarro et al., 2013). 
In as much as this is encouraging, the figure should be regarded with caution 
because the disease is known to affect the poor who live in rural communities 
with little or no access to health infrastructure, and cases may therefore be 
unrecognised or unreported; also some endemic areas are difficult to access 
either because of security problems, challenging topography or extreme 
remoteness of these areas (WHO, 2013a, Franco et al., 2014b, Simarro et al., 
2011, Simarro et al., 2013, Mumba et al., 2011, Chappuis et al., 2010). In the 
light of the above problems the number of reported cases if far below the number 
of actual cases and is estimated currently to be about three times the present 
figure (WHO, 2013a, Franco et al., 2014b, Simarro et al., 2011). 
 
1.2.5  Epidemics of Rhodesiense human African trypanosomiasis 
Rhodesiense HAT can occur in both endemic and epidemic forms depending on 
the main reservoir that is found in a given area (Franco et al., 2014a). In areas 
where both wildlife and livestock are the reservoirs of infection the disease is 
prevalent in its endemic state with stable, low incidence (WHO, 2013a). In areas 
where wildlife constitute the main reservoir, human cases occur occasionally 
although there may be long periods of years when there are no cases (WHO, 
2013a, Allsopp, 1972, Simarro et al., 2011, Kaare et al., 2007). In areas with 
livestock as the main reservoir, there are more opportunities for interaction 
between humans, livestock, and vector and as a result cases usually occur more 
regularly (Odiit et al., 2006, Abaru, 1985). In both cases epidemics can occur as 
a result of civil strife and other major social and environmental disruptions that 
force people to move with their livestock to areas infested with tsetse flies 
thereby increasing human-tsetse fly contact which may result in more people 
being infected (Hide et al., 1996, Jelinek et al., 2002, Kaare et al., 2007, Morris, 
1959, Berrang Ford, 2007, Selby et al., 2013).  
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The movement of domestic animals for economic purposes may result in the 
extension of an existing foci of infection or its introduction into a new area 
(Welburn et al., 2001). Like Gambiense HAT, the number of reported cases from 
endemic countries has declined since 2000 (WHO, 2013a, Simarro et al., 2011, 
Simarro et al., 2013). This trend is particularly true in areas that have witnessed 
an extensive modification of the physical environment in the form increase in 
population density which has led to the expansion of farmed areas and reduction 
of habitats for wildlife (WHO, 2013a, Franco et al., 2014a). Both forms of HAT 
occur in Uganda as a result of movement of infected livestock (Picozzi et al., 
2005). Movement of livestock across the region will mix animals from regions 
endemic for both forms of HAT and a potential long-range spread of the 
parasites in years to come with a consequent major impact on diagnosis and 
treatment of the disease (WHO, 2013a, Picozzi et al., 2005) 
 
1.2.6   Geographical distribution 
The geographical distribution of both Gambiense and Rhodesiense HAT is wide 
but discontinuous, the disease being limited by the patchy distribution of the 
tsetse belt across Africa beyond which the disease does not occur (Welburn and 
Maudlin, 2012) (Figure 1.3). These are areas where the environment supports all 
the three elements in the transmission cycle – the host, the reservoir, and the 
vector and transmission can therefore take place (Franco et al., 2014a). The 
distribution of the disease is however more discrete than its vector species 
because there are areas where tsetse flies are found but HAT is not prevalent in 
contrast to the distribution of AAT which is found right across the tsetse belt 
(Welburn and Maudlin, 2012). Environmental changes brought about by human 
or livestock movements can cause alterations in transmission intensity, but foci 
of transmission remains more or less stable over time (Franco et al., 2014a, 
Paquet et al., 1995). 
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Figure 1.3 Map showing cases of Gambiense and Rhodesiense sleeping 
sickness (2000-2009) and distribution of tsetse fly in sub-Saharan Africa 
(Adapted from (Simarro et al., 2010)). 
 
 
There are currently around 360 HAT foci in 36 sub-Saharan African countries 
with 300 Gambiense HAT foci in 24 countries of Western and Central Africa and 
60 Rhodesiense HAT foci in 13 countries of Eastern and Southern Africa 
(Uganda having both forms), with most of these foci being in rural and remote 
areas (Cecchi et al., 2009, WHO, 1998, WHO, 1986, WHO, 2014a, WHO, 
2013b). For Gambiense HAT, these foci are classified according to the intensity 
of disease transmission from very high levels to moderate to very low levels of 
transmission (Simarro et al., 2013, Simarro et al., 2012a), while for Rhodesiense 
HAT, they are classified according to the pattern of transmission depending on 
whether wild animals or cattle are the reservoir of infection (Simarro et al., 2013). 
In some areas however, both scenarios are prevalent leading to a mixed 
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transmission pattern with the reservoir being either wild animals or cattle (Franco 
et al., 2014a).  
 
1.3 Sleeping sickness 
T. b. gambiense and T. b. rhodesiense HAT occur in two sequential stages, the 
haemo-lymphatic stage occurs first followed by the second or meningo-
encephalitic stage which occurs when the parasites invade the CNS; however 
most of the symptoms of the two stages can overlap without a clear distinction 
between them (WHO, 2013a). Both forms of disease differ in many ways 
including clinical presentation. Whereas T. b. gambiense HAT is a chronic and 
slow-evolving disease with an average duration of about 3 years, with the first 
stage lasting almost as long as the second stage, T. b.  rhodesiense HAT is 
usually an acute febrile illness which progresses rapidly to death within weeks or 
months (Checchi et al., 2008, Odiit et al., 1997). However, variations in clinical 
presentations do occur most likely due to a combination of parasite and host 
genetic factors. 
 
1.3.1 T. b. gambiense infection 
The average duration of T. b. gambiense infection is approximately 3 years 
(Checchi et al., 2008). In some cases patients can recover from first stage 
infections without treatment (Jamonneau et al., 2012). Staging of disease relies 
heavily on the outcome of CSF examination because, although some signs and 
symptoms can be linked with either the first stage (e.g. high fever) or the second 
stage (e.g. neuropsychiatric disorders), none is considered characteristic  for 
each stage (Burri et al., 2014) . It is difficult to ascertain the incubation period of 
T. b. gambiense infection since most infections occur in residents who must 
have been bitten multiple times by tsetse flies, sometimes on a daily basis and 
as a result the exact time of infection is unknown (Urech et al., 2011, Burri et al., 
2014). However, the interval between infection and the manifestation of systemic 
symptoms lasts between weeks or months and the appearance of chancre (if 
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present) can occur in a matter of days following tsetse bite and disappears 
spontaneously in 1-2 weeks (Burri et al., 2014).  
Systemic signs and symptoms are more pronounced and occur more frequently 
during the first stage of the disease than the second stage (Blum et al., 2006). 
Fever is irregular with episodes lasting 24 hours to several days and coincides 
with waves of parasitaemia marking the invasion of the host by the parasites and 
the onset of immune response (Blum et al., 2006). Pruritus occurs in both stages 
but increases in frequency with the duration and severity of the disease and 
therefore more frequent during the second stage (Blum et al., 2006). Local or 
generalised enlargement of the lymph node is typical most especially the 
posterior cervical lymph nodes (Winterbottom‟s sign), but can be found 
elsewhere (Burri et al., 2014).  
Headaches and mood or behavioural changes are nonspecific neurological or 
psychiatric symptoms that are commonly observed in both stages of the disease 
but are seen more persistently and with more intensity as the illness progresses 
(Blum et al., 2006).  
Sleep disturbance is a typical symptom in the second stage though some first-
stage patients complain of nocturnal insomnia or daytime sleep but these 
symptoms are mostly associated with second-stage patients (Blum et al., 2006). 
Mental disorders are common and can be observed during the first stage of the 
disease and may be confused with primary psychiatric illness leading to wrong 
diagnosis (Sahlas et al., 2002, Urech et al., 2011). Most neuropsychiatric 
disturbances are not permanent since they can be reversed by administering 
anti-trypanosomal drugs (Buguet et al., 2005). However, if treatment was 
administered when the disease was at an advanced stage, irreversible sequelae 
of various degrees such as delayed sexual maturity or decreased academic 
performance (observed in children) may occur (Aroke et al., 1998).  
 
1.3.2 T. b. rhodesiense infection 
Unlike in T. b. gambiense infection, a broader spectrum of clinical presentation is 
often seen in T. b. rhodesiense infection and this may vary from a chronic 
disease pattern to the classical acute form, which may even differ between 
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different areas within the same country (Songa et al., 1991, MacLean et al., 
2010). Like in T. b. gambiense infection, the incubation period for T. b. 
rhodesiense disease is difficult to ascertain, but has been estimated to last 
weeks in areas with acute clinical presentation and months in areas with a more 
chronic clinical presentation (Burri et al., 2014). Trypanosomal chancre at the 
site infective bite is seen more frequently than in T. b. gambiense infection 
(MacLean et al., 2010, Boatin et al., 1986, Buyst, 1977, Wellde et al., 1989, 
Urech et al., 2011). There are differences in rhodesiense HAT disease profile 
between distant foci and even those within close proximity with fever and 
headache being the main symptoms in the early stage of the disease in some 
foci whereas tremor and sleepiness were the main symptoms in others 
(MacLean et al., 2010).  
Unlike in gambiense HAT, enlarged lymph nodes are mainly found in 
submandibular, axillary and inguinal regions rather than posterior cervical, and 
oedema of the face and legs are also observed more frequently in rhodesiense 
than in gambiense form of the disease (Kuepfer et al., 2011, Boatin et al., 1986). 
Cardiac involvement is a common feature of rhodesiense HAT which may lead to 
cardiac failure and finally death (Lejon and Buscher, 2005). Neurological signs 
and symptoms which are mainly seen in second-stage of HAT are similar to 
those found in T. b. gambiense infections, however, the progression towards 
coma and death occurs faster in T. b. rhodesiense infections (Burri et al., 2014).  
 
1.4 Diagnosis 
Clinical signs and symptoms of tsetse-transmitted trypanosomiasis cannot be 
taken as being specific for the disease; neither does it justify treatment 
considering the relative toxicity of all drugs currently in use. Demonstration of the 
parasite therefore is of utmost importance (Burri et al., 2014). Invariably, 
diagnosis relies on the employment of direct techniques that confirm the 
presence of trypanosomes in body fluids by microscopic examination or indirect 
serological methods or by molecular techniques (OIE, 2014). The diagnosis of T. 
b. gambiense HAT involves initial screening of suspected cases followed by 
diagnostic confirmation and finally, if positive, staging (Chappuis et al., 2005). 
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For T. b. rhodesiense HAT, screening relies on clinical signs and symptoms and 
diagnosis is usually by direct examination of blood while staging is done in the 
same way as for T. b. gambiense (Jelinek et al., 2002, Chappuis et al., 2005).  
 
1.4.1 Antibody detection test 
The card agglutination test for trypanosomiasis (CATT) is the primary screening 
tool for the diagnosis T. b. gambiense infections. It is a cheap, rapid and easy to 
use serological test that is used for the detection of specific antibodies in 
individuals infected with T. b. gambiense (Magnus et al., 1978). The test can 
also be performed on plasma or serum dilutions to improve specificity and mostly 
used to reduce the number of false-positives prior to parasite detection. 
However, there is no consensus as to the cut-off to be used as the threshold for 
interpreting whether or not the reaction is positive and for this reason 
parasitological test remains the gold standard and should be performed as a 
confirmatory test (WHO, 2013a). At present, there is no similar test for T. b. 
rhodesiense and field screening still relies on clinical signs and symptoms, but 
parasite detection in the blood is relatively easier for this form of the disease 
because trypanosomes are numerous in the blood and diagnosis is therefore 
mostly by examination of stained thin or thick blood film (Jelinek et al., 2002, 
Chappuis et al., 2005, Duggan and Hutchinson, 1966). Alternative serological 
tests, such as enzyme-linked immunosorbent assay (ELISA), 
immunofluorescence assays, and LATEX/T. b. gambiense test are also available 
but are not used for routine field diagnosis. 
 
1.4.2 Trypanosome detection 
Parasite detection is very important in the proper diagnosis of African 
trypanosomiasis (Burri et al., 2014). Body fluids such as blood, lymph node 
aspirate and CSF are examined microscopically for the presence of 
trypanosomes and thus provides direct evidence for trypanosome infection 
(Chappuis et al., 2005). The parasites may also be detected in bone marrow 
aspirates or ascites fluid. Failure to demonstrate parasites does not necessarily 
17 
 
mean lack of infection since parasite numbers can be quite low and below 
detection limit especially in T. b. gambiense infection (Chappuis et al., 2005). For 
this reason it is recommended that methods that allow for the examination of 
larger sample volumes such as concentration techniques be used for the 
diagnosis of T. b. gambiense infections to increase the chances of parasite 
detection (WHO, 2013a). To maximize the chances of parasite detection, it is 
essential to keep the time between sample collection and examination as short 
as possible to avoid immobilisation and lysis of trypanosomes, and if the 
samples are not to be examined immediately after collection (> 1 h), it should be 
stored at 4-8 ˚C (WHO, 2013a).  
Blood films (thin, thick or wet) are used for direct detection of trypanosomes. 
While wet blood films are used for detection of motile trypanosomes, thick and 
thin blood films stained with Giemsa are used for detection of fixed 
trypanosomes. Wet and thin blood films have low sensitivity but examination of 
thick blood film slightly improves sensitivity since a larger volume of blood (about 
20 µl) is examined (Chappuis et al., 2005). Aspirates from chancres or lymph 
nodes are a good source of parasites and can be examined as a wet preparation 
or fixed and Giemsa-stained preparation (Chappuis et al., 2005). 
 
1.4.3 Molecular methods 
A wide range of molecular tests are available; however, none have been 
validated for routine diagnostic purposes (Chappuis et al., 2005, Deborggraeve 
and Buscher, 2010). The current molecular diagnostic methods are not yet 
suitable for use at the primary-care level because of lack of the requisite 
infrastructure in the rural areas where the disease is endemic and as a result, 
use of polymerase chain reaction (PCR) cannot be used for first-line diagnosis of 
HAT in endemic areas (Deborggraeve and Buscher, 2010). Moreover, a positive 
PCR does not necessarily mean the presence of live trypanosomes, and this 
makes it difficult to accurately assess treatment outcome (Deborggraeve et al., 
2011). Also most of the current molecular techniques are not able to exclude 
transient infection with non-pathogenic species of trypanosomes such as T. b. 
brucei (Deborggraeve et al., 2008).  
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Newer and faster techniques such as the human African trypanosomiasis-PCR-
oligochromatography (HAT-PCR-OC), (Deborggraeve et al., 2006) and the Loop-
mediated isothermal amplification (LAMP) (Riehle et al., 2007) are also used.   
For now molecular diagnostic techniques are yet to meet the requirements 
needed for them to be used in primary healthcare facilities and as a result 
diagnosis of sleeping sickness in Africa still relies on conventional methods such 
as  antibody detection in an agglutination test and/or parasite detection by direct 
microscopy (Deborggraeve and Buscher, 2012).  
 
1.4.4 Determination of the stage of the disease 
Following the confirmation of infection, it is vital that the stage of the disease be 
accurately ascertained in order to administer the appropriate treatment to avoid 
unnecessary toxic side effects of the drugs used for treatment (Bouteille and 
Buguet, 2012). For the fact that majority of deaths can be traced to treatment-
related acute encephalopathies (Pepin et al., 1994), it is important that tests be 
carried out to ascertain the stage of the disease before treatment can begin. 
Staging is done by examining CSF obtained by lumber puncture to look for the 
presence of trypanosomes and/or a raised white blood cell count (>5 cells/µl) 
(Organization, 1998). The sleep-wake cycle could be another useful marker for 
second-stage disease. The sleep-wake patterns of second-stage patients are 
completely disrupted but the disruption were ameliorated after treatment for 
second-stage HAT was administered. However, similar alterations may be 
observed in some patients with first- or “intermediate”-stage infection and as a 
result, more work is needed to assess the relationship between the second-
stage HAT and disruption of sleep structure (Buguet et al., 2005).   
 
1.5 The parasite 
Understanding the biology of African trypanosomes is vital because it will enable 
us understand the biological attributes of these organisms that differentiate them 
from that of their mammalian hosts or vectors. These features that distinguish 
trypanosomes from their mammalian hosts and/or vectors must be understood 
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since they represent potential drug targets that may be exploited to meet the 
goal of elimination of HAT. 
 
1.5.1 Classification of African trypanosomes 
The African trypanosomes belong to an evolutionarily ancient protozoan order 
known as the kinetoplastida and genus Trypanosoma (Barrett et al., 2003). 
Based on the mode of transmission by their insect vector, the genus 
Trypanosoma is divided into the stercorarians and salivarians (Hoare, 1966, 
Levine et al., 1980) (Figure 1.4). The stercorarians develop in the posterior gut  
of their vector and infection of the vertebrate host occurs via faeces while the 
salivarians develop in the anterior gut  of their invertebrate vector and later 
migrate towards the salivary glands (T. brucei) or the mouthparts (T. 
congolense) where the infective forms for vertebrates develop and infection of 
the mammalian host occurs via saliva (Baral, 2010).  
All pathogenic African trypanosomes belong to the salivarians because they are 
injected into mammalian blood via saliva when an infected tsetse fly takes a 
blood meal (Rotureau and Van Den Abbeele, 2013). The T. brucei group which 
has three subgenera (T. b. brucei, T. b. gambiense and T. b. rhodesiense) infect 
cattle and humans: while T. b. brucei causes N‟gana, a cattle disease in Africa, 
T. b. gambiense and T. b. rhodesiense which are morphologically 
indistinguishable, infect humans causing sleeping sickness in West and Central 
Africa and East and Southern Africa respectively (Baral, 2010). While T. 
equiperdum causes dourine, a venereal disease in horses and related animals 
and T. evansi causes surra in vertebrate animals, T. congolense and T. vivax are 
however, the major causes of animal African trypanosomiasis (Baral, 2010).  
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Figure 1.4 Classification of mammalian trypanosomes (Levine et al., 
1980). 
 
 
1.5.2 Morphology 
African trypanosomes are unicellular, flagellated protozoan parasites that live 
extracellularly in the bloodstream. They are also found in other body fluids such 
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as lymph and cerebrospinal fluid (CSF). Morphologically, African trypanosomes 
are spindle shaped measuring about 20 µm by 5 µm with two principal nucleic 
acid-containing organelles, the nucleus and the kinetoplast and a single 
flagellum which originates at the posterior part of the body and exits the cell 
through the flagellar pocket (FP) (Figure 1.5). The flagellum runs along the cell 
body towards the anterior pole and is attached to the cell body by the flagellum 
attachment zone (FAZ) (Field and Carrington, 2009). Trypanosomes spend most 
part of their life cycle as two distinct forms- trypomastigotes and epimastigotes 
(Leung et al., 2014).  
The relative positions of the nucleus, kinetoplast and the exit point of the 
flagellum along the anterior-posterior axis differ between these morphological 
stages.  In trypomastigotes the flagellum emerges near the posterior end while in 
epimastigotes the position of emergence of the flagellum is at the centre of the 
cell (Leung et al., 2014) (Figure 1.6). The kinetoplast is the parasite‟s 
mitochondrial genome which is said to be larger than the mitochondrial genomes 
in other eukaryotic cells (WHO, 2013a). The flagellum apart from its involvement 
in the motility of the parasites is considered to play a role in microfluidic constant 
sweeping of the trypanosome cell surface and this is considered to be important 
particularly in the removal of surface bound antibodies leading to endocytosis 
and subsequent destruction (Engstler et al., 2007).   
 
 
 
22 
 
                             
Figure 1.5 Structure of blood form African trypanosome showing the main 
intracellular features (WHO, 2013).  
                                                               
1.5.3 Life cycle of African trypanosomes 
African trypanosomes have a complex life cycle which alternates between 
mammalian hosts and arthropod vectors. These trypanosomes must undergo 
cyclical development in the tsetse fly before they can infect a vertebrate. After 
completion of the parasitic cycle in the vector, it becomes infective and the fly 
can transmit the parasites to a vertebrate host when taking a blood meal and 
remains infective for life. For this reason African trypanosomes are said to be 
cyclically transmitted by tsetse flies. The life cycle involves different stages with 
distinct morphological forms and biochemical physiology (Figure 1.7). The flies 
become infected after taking up the parasites during a bloodmeal from an 
infected mammal. Once inside the fly, the bloodstream form trypanosomes 
transform, within a few hours into procyclic forms (Turner et al., 1988). In the 
case of T. brucei and T. congolense which have a midgut stage, the bloodstream 
form trypanosomes enter the endoperitrophic space, transform into procyclics  
before colonising the ectoperitrophic space where they establish midgut 
infections (Maudlin, 1991). From the midgut shelter, the trypanosomes migrate 
anteriorly towards the mouthparts with a temporary,  but essential stopover at 
the proventriculus (PV) or cardia. While at the PV, the T. brucei species 
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undergoes asymmetric division yielding two forms of epimastigotes (one long 
and one short epimastigote) (Peacock et al., 2012a).  
For T. brucei, it is the short epimastigote that invades and colonises the salivary 
gland while for T. congolense the proventricular form migrate to the proboscis 
and it is here that they differentiate into epimastigotes after attachment in the 
labrum of the proboscis (Sharma et al., 2008, Van Den Abbeele et al., 1999, 
Sakurai et al., 2009). The attached epimastigotes proliferate and differentiate 
into animal-infective metacyclic forms, which re-expresses a VSG coat and are 
therefore ready for life in the mammalian host (Tetley and Vickerman, 1985, 
Gray et al., 1981). This differentiation step known as metacyclogenesis, occurs 
in the salivary glands and labrum/hypopharynx in T. brucei and T. congolense 
respectively (Lloyd and Johnson, 1924, Thevenaz and Hecker, 1980). The 
reacquisition of a VSG coat is a typical feature of metacyclogenesis (Vickerman, 
1985, Kolev et al., 2012, Tetley et al., 1987). In T. vivax there is no midgut stage 
(Figure 1.7) and it is thought that the procyclic stage occurs in the cibarium after 
which there is rapid transformation to epimastigotes which migrate to the 
proboscis where metacyclogenesis occcurs just as in T. congolense (Vickerman 
et al., 1988). 
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Figure 1.6 Life cycle of the three main types of African trypanosomes (T. 
brucei, T. congolense and T. vivax). Successive parasite stages found in the 
mammalian host and the tsetse fly vector are shown. SL: slender 
trypomastigote, ST: stumpy trypomastigote, PC: procyclic trypomastigote, MS: 
mesocyclic trypomastigote, DE: long dividing epimastigote, SE: short 
epimastigote, AE: attached epimastigote, ET: epi-trypo dividing epimastigote, 
pMT: pre-metacyclic trypomastigote, MT: metacyclic trypomastigotes (adapted 
from ILRI and Rotureau and Van Den Abbeele, 2013).  
 
 
The infective metacyclic forms are injected into a mammalian host when an 
infected fly takes a bloodmeal. Inside the mammalian host the non-dividing 
metacyclics which have undergone cell cycle arrest while in the fly multiply by 
binary fission forming a heterogenous population of dividing slender forms and 
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non-dividing stumpy forms (Vickerman, 1985). The slender forms are seen 
during the ascending phase of parasitaemia while the stumpy forms which are 
irreversibly pre-adapted for life in the midgut of the fly are seen mainly when 
parasitaemia is at its peak (Matthews et al., 2004). The stumpy forms are also 
equiped with machinery to deal with the environmental shock (having been 
removed from a seemingly protective and well buffered environment to a harsh 
and harmful  one) that these parasites will encounter in the digestive milieu of 
the insect midgut if taken up in a bloodmeal by the tsetse fly (Nolan et al., 2000). 
It is these stumpy forms that re-establish the life cycle by initiating differentiation 
into the replicative procyclic forms in the gut of the fly with the VSG surface coat 
being replaced by procyclins (Fenn and Matthews, 2007).  
 
 
1.6 Genetic exchange in African trypanosomes 
Genetic exchange is not an obligatory process in the life cycle of trypanosomes, 
but it can however occur between the midgut and the salivary glands stages of  
the life cycle (Peacock et al., 2011). The mechanism of genetic exchange is not 
fully understood but it is thought to be a truly Mendelian process that involves 
meiosis (Gibson and Stevens, 1999). Although it is not easy to identify the 
sexual stages, genetic exchange is known to occur in the laboratory between 
croses of T. brucei in the tsetse fly (MacLeod et al., 2005) and this has been 
demonstrated by co-infecting flies with red and green fluorescent parental 
trypanosomes leading to the production of yellow fluorescent hybrids in the 
salivary glands (Gibson et al., 2008). Also measurement of nuclear DNA 
contents revealed haploid promastigote-like cells relative to diploid metacyclics 
(Peacock et al., 2014). 
In the field, if tsetse flies ingest more than one strain of trypanosome, there is the 
possibility of genetic exchange occuring between the two strains leading to an 
increase in genetic diversity among the African trypanosomes. Although the rate 
at which genetic exchange occurs in the field is low its implications for the 
epidemiology and control of trypanosomiasis could be far reaching (Gibson and 
Stevens, 1999). It could lead to the spread of important traits such as drug 
resistance and virulence since these can be transferred between pathogen 
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strains (Peacock et al., 2011). The use of chemotherapy in combination with 
other control measures such as vector control and systematic screening of 
pataients in at-risk areas have contributed to the recent success in reducing the 
number of cases (Nimmo, 2010). With no vaccine currently available and with 
few treatment options, the emergence of drug resistance is a major threat to the 
control and eradication of the disease (Baker et al., 2013). 
 
1.7 Immune evasion 
Unlike most pathogens that cause chronic infection, African trypanosomes do 
not seek refuge inside the cell, but rather they live extracellularly in their 
mammalian host and are therefore constantly bathed by the host immune 
defences. The human serum contains a trypanolytic factor that destroys T. b. 
brucei but not the human-infective subspecies T. b. gambiense and T. b. 
rhodesiense (Pays et al., 2006). Being highly immunogenic, they are prone to 
antibody-mediated immune response and therefore elicit immunological 
response from their mammalian host as well as complement in the blood of their 
mammalian host (Schwede and Carrington, 2010). Ironically, these parasites are 
able to maintain a chronic infection in their mammalian host despite these 
challenges.  
African trypanosomes have developed several mechanisms to avoid being 
destroyed by the host immune system. First, the parasite population can 
withstand the host immune response as result of their ability to constantly 
change the major constituent of their cell surface, the variant surface 
glycoprotein (VSG) – a phenomenon called antigenic variation (Hall et al., 2013). 
Second, the compact surface coat which is mainly VSG, protects the invariant 
surface proteins from the effects of the immune system and prevents 
complement activation (Ferrante and Allison, 1983). Third, there is a rapid and 
effective internalisation of the immune complex formed as a result of the binding 
of antibody to VSG leading to the removal of host antibodies from the cell 
surface while the VSG is recycled and brought back to the surface (Engstler et 
al., 2007).  
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Finally, through mechanisms which are not fully understood, trypanosomes are 
able to modulate host immune responses to their advantage enabling them to 
maintain infection while at the same time allowing their host to survive for a 
period of time thereby enhancing their continued transmission (Mansfield and 
Paulnock, 2005). The parasites are capable of destroying the host‟s 
immunological memory through the abrogation of B-cell homeostasis while in the 
mammalian host, enabling them to evade immune reactions of the mammalian 
host thereby enabling the parasites to maintain a chronic infection (La Greca and 
Magez, 2011). During the course of trypanosome infection, there is a build-up of 
antibodies against the VSG that is already expressed which eventually leads to 
the clearance of the VSG and inevitable destruction of parasites expressing that 
particular VSG. However, prior to this, some parasites have already switched 
their VSG surface coat and are able to survive the onslaught of the antibodies 
and proliferate to form a new population of parasites that are subsequently 
recognised by the host antibodies and destroyed, and the cycle continues 
(Schwede and Carrington, 2010). By this mechanism African trypanosomes are 
able to pre-empt host specific immune responses, which enables them to 
maintain infection despite attempts by the host to eradicate them (Hall and 
Plenderleith, 2014). 
 
1.7.1 Antigenic variation 
The surface of the bloodstream form of African trypanosomes are covered with a 
monolayer of single VSG species (Pays, 2006). They are activated in the 
metacyclic stage of the parasite in the tsetse fly salivary glands (Tetley et al., 
1987), though heterogeneous at this stage and remain active throughout the 
bloodstream stage until they are inactivated in the midgut of the tsetse fly after 
being ingested by the later (Horn, 2014). The fact that the VSG genes are 
activated just before the parasite leaves the salivary gland of the fly underlines 
the importance of the VSG for the continuation of its life cycle in the mammalian 
host. The genetic or epigenetic changes that result in the expression of a 
different VSG and the ability to ensure the activation of only a single VSG 
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through monoallelic expression of the active VSG gene are important for 
antigenic variation to occur (Schwede and Carrington, 2010).  
The switching process in antigenic variation is stochastic rather than 
deterministic since it does not depend on host immune responses, however, the 
observed hierarchy of VSG expression is as a result of antibody selection 
(Morrison et al., 2009) (Figure 1.8). It also occurs spontaneously, having been 
observed in culture (Horn and Cross, 1997, Doyle et al., 1980) and in 
immunodeficient animals (Magez et al., 2008). VSG switching therefore occurs in 
anticipation of immune reaction and is controlled by a series of discrete events 
leading to the formation of a resident population of parasites displaying an 
abundant array of antigen (Hall and Plenderleith, 2014).  
It has been argued that the first peak of parasitaemia is controlled by a 
combination of growth arrest as the density of the population increases and host 
immunity (Morrison et al., 2005, Lythgoe et al., 2007). Subsequently, as the 
infection progresses, there is a sequential expression of VSGs (Figure 1.8) as a 
result of mounting antibody responses which picks out the VSGs that are 
currently activated (Morrison et al., 2005). Switching of VSGs can occur in two 
ways: (i) transcriptional switching which does not require genetic rearrangement, 
rather as one of the multiple expression sites (ESs) is transcriptionally silenced 
another is activated. How this occurs is not fully understood but the two 
processes are not connected and are thought to involve several processes that 
lead to the rapid silencing of an old ES and complete activation of a new one  
(Figueiredo et al., 2008a), (ii) recombinatorial switching which typically occurs by 
gene conversion in which a silent VSG gene is copied into an active expression 
site (Horn and McCulloch, 2010). In addition to the VSGs that are present in the 
ESs, there are thousands of silent (inactivated) VSG genes and pseudogenes 
present in the subtelomeres forming a massive archive of VSG genes (Marcello 
and Barry, 2007). In natural infections recombination rather than transcriptional 
switching predominates in antigenic variation giving the parasite the ability to 
draw from its huge VSG archive by copying and pasting a different gene into an 
active ES (Robinson et al., 1999, Horn and McCulloch, 2010). 
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Figure 1.7 VSG switching hierarchy in T. brucei. (A) For each process, 
intensity of shading indicates the relative importance in activating novel VSG 
over the course of infection. Recombinatorial switching assumes prominence 
over transcriptional switching beyond the early stages of infection. Telomere-
resident VSG in silent ES and minichromosomes are activated more readily 
than those in the VSG arrays. Pseudogenic VSG require low-probability 
segmental gene conversion events to be accessed and tend not to appear until 
the chronic stage of infection in the form of mosaic VSG. (B) Expressed VSGs 
are diverse, and mosaic VSGs become increasingly predominant as infections 
progress and immunity neutralises readily activated single-donor VSG. Shaded 
rectangles are a stylised representation of expressed VSG that might be 
sampled at different points of infection. Different shades represent different 
donors (Morrison et al., 2009, Hall and Plenderleith, 2014).  
 
 
 
A feature of antigenic variation at the population level which helps the parasites 
to prolong infection in the host, is that the expression of VSGs is done in a 
hierarchical manner (Figure 1.8), with some VSGs being expressed at the early 
stage of infection, others are expressed midway during infection and yet others 
are expressed only during late infection (Barry, 1986, Barry and Turner, 1991, 
Gray, 1965). Some VSGs are more readily activated than others and are 
therefore expressed early on during an infection but can still be seen later in the 
course of an infection since they are still likely to be activated; but the problem is 
that parasites expressing these VSGs are prone to be destroyed if the antibodies 
A 
B 
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initially raised against them are still active (Morrison et al., 2005). Once the host 
immune responses destroy the easily-activated VSGs, those that are not easily 
activated because they require complex mechanisms to become active are then 
brought into play (Hall and Plenderleith, 2014). VSGs which appear late during 
infection are the incomplete or pseudogenes which need to be assembled by 
segmental gene conversion into mosaics and therefore appear late during 
infection (Roth et al., 1989). However, the pattern of the hierarchy is not rigid but 
rather flexible since the early VSGs can be interchanged with late VSGs (Laurent 
et al., 1984). 
 
1.7.2 The trypanosome cell surface  
The outer covering of the cell membrane of bloodstream trypanosomes are 
unusual in that it is covered predominantly with a glycosylphosphatidylinositol 
(GPI)-anchored protein, the VSG rather than the single hydrophobic 
transmembrane helix (Ferguson et al., 1988, Mehlert et al., 2002). Over 95% of 
the trypanosome external cell surface proteins and about 15% of the total cell 
protein is made up of VSG which forms approximately five million dimers per cell 
(Schwede and Carrington, 2010). The choice of a GPI-anchor comes with some 
advantages such as: (i) it enables the parasite to achieve a higher packing 
density on the cell surface without congesting the cytoplasmic face of the cell 
membrane and this is important since the VSG is packed on the surface at the 
highest possible density (Schwede and Carrington, 2010), (ii) it helps in VSG 
trafficking and recycling because without a GPI-anchor, VSG is rapidly delivered 
to the lysosome where it is degraded (Triggs and Bangs, 2003), (iii) GPI-anchor 
is essential for surface expression of VSG since in its absence the VSG is not 
expressed on the cell surface but is mislocalised to non-lysosomal 
compartments near the flagellar pocket (Bohme and Cross, 2002), (iv) 
Differentiation from bloodstream to procyclic form requires the rapid removal of 
the VSG coat by the synergistic action of the GPI-specific phospholipase C and 
a zinc metalloprotease (Grandgenett et al., 2007).  
VSGs are also N-glycosylated, though the number of N-glycosylation sites vary 
between VSGs (Mehlert et al., 2002). It has been suggested that glycosylation 
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may enhance the volume of VSGs and thus its function as a protective coat 
(Blum et al., 1993). The VSG dimer forms a thick coat of about 12 to 15 nm that 
is attached perpendicularly to the cell surface (Vickerman, 1969) and physically 
blocks the binding of immunoglobulins to the cell surface (Schwede and 
Carrington, 2010). It has also been shown that antibodies cannot recognise VSG 
epitopes beyond 8 nm (Hsia et al., 1996).   
 
1.7.3 Endocytosis, membrane recycling and sorting of antibody-bound 
VSGs 
The lack of transmembrane domain allows the VSG coat to move freely across 
the surface of the parasite and there is evidence that the fluidity of the VSG coat 
helps in the removal of immunoglobulins that are bound to the VSGs especially 
at low to moderate antibody concentration thereby augmenting the immune 
evasion mechanisms of the parasite (Engstler et al., 2007). The immunoglobulin-
VSG immune complex moves more rapidly than free VSG (Schwede and 
Carrington, 2010). The directional movement of the Ig-VSG complex towards the 
flagella pocket at the posterior end of the parasite is aided by the hydrodynamic 
flow acting on the trypanosome as it swims and this drags the Ig-VSG complex 
as the cell swims forward (Schwede and Carrington, 2010). 
 
1.8 The vector (Tsetse fly) 
Tsetse flies belong to the order Diptera (two-winged fly), family Glossinidae and 
genus Glossina. There are 33 extant taxa with 22 species and subspecies and 
all are restricted to sub-Saharan Africa (Elsen et al., 1990, Leak, 1999). Three 
groups or subgenera are recognised within the Glossina genus: Morsitans 
(Glossina Wiedemann), Palpalis (Nemorhina Robineau-Desvoidy) and Fusca 
(Austenina Townsend). They occur in a broad range of habitats distributed 
discontinuously throughout their range in the sub-Saharan continent with each 
group occupying a relatively specific habitat (Leak, 1999). The Morsitans group 
are found mainly in Savannah, woodlands and low land forests in East Africa 
and near rain forests in West Africa.  
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Flies of the Palpalis group are found in West Africa, mainly in the lowland 
rainforests, particularly along rivers and streams (Rogers, 2004). Fusca group of 
flies are found in West Africa where they live in moist forests and savannah 
(Caljon et al., 2014), some species such as G. brevipalpis are found 
discontinuously in East Africa, Democratic Republic of the Congo, and 
Mozambique (Benoit et al., 2015). In terms of host preference, flies in the 
Palpalis group are strongly anthropophilic while flies in the Morsitans and Fusca 
groups are more zoophilic (Benoit et al., 2015). Unlike mosquitoes, both male 
and female flies are obligate blood feeders and feed on vertebrate blood every 3-
4 days (Leak, 1999).  
 
 
1.8.1 Classification 
Tsetse flies are classified into a single genus, Glossina and classification is 
based largely on morphological differences in the structure of the genitalia, 
geographical distribution and some bio-ecological features, but also on some 
external features such as colour, shape of antennae and presence of bristles on 
thoracic pleura (Newstead, 1911), of the male genital armature. Three groups or 
subgenera are identified within the genus - Nemorhina (Palpalis group), Glossina 
(Morsitans group), and Austenina (Fusca group) (WHO, 2013a). The species in 
the Palpalis group which are the main vectors of HAT in West and Central Africa 
are found in vegetations close to water, in mango and banana platations, as well 
as in peri urban areas (Robays et al., 2004). The Morsitans group are found 
mainly in savannah woodland and dense or clear forests mainly linked to the 
presence of wild fauna and cattle and species in this group are the main vectors 
of African animal trypanosomiasis, although some are involved in the 
transmission of T. b. rhodesiense (WHO, 2013a). Species in the Fusca group 
are bigger in size than those in both the Palpalis and Morsitans groups and they 
live in forest belts in East and Southern Africa.  
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1.8.2 Reproductive physiology and anatomy 
Tsetse flies exhibit an unusual mode of reproduction among insect disease 
vectors. They are viviparous because they bring forth live young which has 
developed in the uterus of the female. Tsetse flies reproduce by adenotrophic 
viviparity (a form of matrotrophic viviparity) in which the female does not lay eggs 
but nurtures a single larva at a time within its uterus with nutrients secreted 
through glands until a mature larva is larviposited (Benoit et al., 2015). Tsetses 
also have a low reproductive rate, producing no more than eight to ten offsprings 
during its life span (Attardo et al., 2006). Unlike many higher Dipterans, their 
reproductive tracts have undergone considerable modifications (Tobe and 
Langley, 1978), along with other members of Hippoboscoidea, to allow for 
complete intrauterine larvae development, which include reduction of the number 
of ovarioles per ovary to two compared to ovaries from other dipterans, the 
uterus which is greatly expanded, is muscular and supplied with numerous 
trachea, and the possession of accessory or milk glands that connects to the 
uterus (Attardo et al., 2006, Pellegrini et al., 2011, Tobe and Langley, 1978). 
 
1.8.3 Life Cycle of Tsetse Flies 
Female tsetses produce a single larva per gonotrophic cycle which begins when 
females emerge from the puparium (Tobe and Langley, 1978). The first oocyte 
begins development (at the right ovary) following the emergence of teneral 
females from the puparium. During mating, which occurs 3-5 days post eclosion, 
sperm are deposited in the spermatheca where they are stored until fertilization 
during ovulation and the first ovulation occurs at about 10 days after emergence. 
This is followed by intrauterine embryogenesis and larvigenesis. From 
embryogenesis to larvigenesis takes approximately 10 days with the former 
lasting 3-4 days while the later takes 5-6 days respectively (Saunders and Dodd, 
1972, Tobe and Langley, 1978). The second oogenesis commences within the 
left ovary during intrauterine embryonic and first instar larval development in the 
right ovary and is completed before the completion of the first larval 
development. Female tsetses deliver their first offspring approximately 20 days 
after emergence following the deposition of larvae which develops into pupae 
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within 1-2 hours and the adult emerges after 30 days (Tobe and Langley, 1978). 
Ovulation occurs at the left ovary 20-35 minutes after the deposition of the first 
larva and the second larva is deposited 9-10 days after the first. The availability 
of blood meal and type of host, exposure to conditions that interfere with 
oogenesis or milk production, as well as environmental factors affects the 
duration of the developmental cycle (Tobe and Langley, 1978, Saunders and 
Dodd, 1972). Oogenesis is shared between the two ovaries during each 
gonotrophic cycle (Saunders, 1960, Saunders, 1961). 
 
              
Figure 1.8 Life cycle of Glossina morsitans morsitans female under 
optimal and nutritional conditions. The different stages of intrauterine and 
pupal developments are shown (adapted from Benoit et al., 2015). 
 
 
Pregnant females carrying a mature oocyte do not ovulate until after parturition 
or abortion. This shows that ovulation in tsetse is regulated and coordinated by 
the mating and pregnancy status of the fly (Benoit et al., 2015). Two major 
events regulate ovulation, namely mating status and oocyte development and 
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mating status is determined by the stimulus generated from a lengthy copulation 
which lasts between 90-120 minutes (Chaudhury and Dhadialla, 1976, Saunders 
and Dodd, 1972). However, the mating status of a female does not trigger 
ovulation because for most females mating does not occur until after 2-3 days 
following emergence from the pupae and will not ovulate until their first oocyte is 
mature at 8-10 days posteclosion (Tobe and Langley, 1978). The presence of a 
mature oocyte in mated females which is thought to release an ovulation-
stimulation factor into the haemolymph seems to be the trigger for ovulation 
(Robert et al., 1984, Foster, 1974, Chaudhury et al., 1981). After ovulation the 
embryo develops in the uterus and goes through three larval instars before 
finally being deposited as a fully developed third instar larva which burrows into 
the ground and pupariates (Buxton, 1955, Denlinger and Ma, 1974, Moloo, 
1971b) (Figure 1.8).  
During larvigenesis the fly nourishes the larva by supplying milk from an 
accessory gland that has undergone extensive physiological modification to 
cater for a larva that increases over a hundred-fold in dry mass in the course of 
six days (Langley and Pimley, 1975, Denlinger and Ma, 1974). Milk secretions 
not only provide nourishment for the developing larva, it is also the means 
through which microbial symbionts are transferred to their offspring during 
intrauterine development (Ma and Denlinger, 1974, Balmand et al., 2013). It also 
ensures that the microbiota is passed on with the highest fidelity preventing the 
exposure of the larvae to unwanted microbes (Weiss et al., 2011). Starved flies 
were found to be more permissive to trypanosome infection.  
 
1.8.4 Tsetse immune system 
Insects represent one of the most successful and largest groups of animals, 
occupying virtually all ecological niches and as a consequence contend with a 
large number of pathogens (Vilmos and Kurucz, 1998). It is no surprise therefore 
that they have evolved a complex and effective innate immune system to deal 
with the threat of these pathogens. The insect immune mechanism is a complex 
and tightly regulated system which has the ability to recognise, control or 
eliminate the invading organisms in a way that strikes a balance between 
36 
 
mounting anti-microbial effector molecules and controlling pathogenicity (Caljon 
et al., 2014). The tsetse fly, like all insects is a heaven for microorganisms 
ranging from commensals and symbionts to opportunistic microbes and 
pathogens (Caljon et al., 2014). The first line of defence is the cuticle and 
peritrophic matrix which act as physical barriers against invading 
microorganisms (Lehane, 1997).  
The insect immune response is divided into cellular and humoral mechanisms. 
Cellular immune response includes phagocytosis and encapsulation, while 
humoral or molecule-based mechanisms involve synthesis and secretion of 
antimicrobial peptides (AMPs), lectins, reactive oxygen species (ROS), 
proteases and nitric oxide, coagulation and melanisation cascades (Boulanger et 
al., 2002). Humoral immune responses have been shown to be involved in the 
clearance of trypanosomes, but there is no documented evidence of a cellular 
involvement in trypanosome clearance since trypanosomes do not enter the 
haemocoel (Caljon et al., 2014). An important aspect of tsetse immunity is the 
expression of several AMPs (Boulanger et al., 2002). Also the nutritional state of 
the fly at the time of blood meal has an effect on the ability of the fly to withstand 
trypanosome infection, and starvation correlated to low expression of the 
antimicrobial peptides attacin and cecropin and increased susceptibility to 
trypanosome infection (Akoda et al., 2009). Also midgut lectins are thought to 
play a role in the determination of parasite establishment and infection of tsetse 
because feeding lectin inhibitory sugars to tsetse significantly increases 
trypanosome midgut infection (Maudlin and Welburn, 1987, Ibrahim et al., 1984, 
Mihok et al., 1992, Welburn et al., 1994). 
Reactive intermediates of oxygen and nitrogen such as reactive oxygen species 
(ROS) and reactive nitrogen species (RNS) are also involved in innate immune 
response in tsetse. Adding antioxidants to the infective blood meal increase 
susceptibility to trypanosome infection confirming the trypanocidal activity of 
ROS (MacLeod et al., 2007b). Also ROS-induced stress leads to the production 
of trypanocidal nitric oxide (NO) by nitric oxide synthase (NOS) in the gut 
(Bogdan, 2001), which in turn triggers AMP production in the fat body, thus 
representing an important link in organ-organ immunological communication (Wu 
et al., 2012). It has also been suggested that hydrogen peroxide (H2O2) may be 
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involved in eliminating trypanosomes early in the infection process because 
H2O2 level was found to be significantly increased in flies that have been fed 
infective blood meal (Hao et al., 2003).  
 
1.8.5 Signaling pathways controlling trypanosome infection in tsetse 
In insects, three immunity signaling pathways (Toll, IMD and Jak/Stat) are known 
to be involved in immune responses against invading pathogens. Following the 
induction of these signaling pathways is the activation of transcription factors and 
the subsequent expression of antimicrobial peptides (Kingsolver and Hardy, 
2012). The inducible expression of antimicrobial peptides is overseen by the Toll 
and immune deficiency (IMD) pathways (Tanji et al., 2007), and it has been 
shown that without these two pathways, flies become more susceptible to 
microbial infections, even to those that are ordinarily non-pathogenic because of 
the failure to induce antimicrobial peptide genes (Gottar et al., 2002, Tzou et al., 
2002, Vodovar et al., 2005). The Toll pathway is activated by fungal and gram-
positive bacterial infections while the IMD pathway is activated by gram-negative 
bacterial infection (Lemaitre, 2004). Microbe detection and subsequent response 
of the insect innate immune system involves a multistep process which occurs 
as a result of the direct contact between the insect pattern-recognition receptors 
such as the peptidoglycan recognition proteins (PGRPs), for bacterium 
recognition and pathogen-associated molecular patterns (PAMPs) (Beschin et 
al., 2014). 
In tsetse, the IMD pathway and PGRP-LB is known to control trypanosome 
infection (Beschin et al., 2014). Stimulation of tsetse IMD pathway through 
bacterial challenge before trypanosome infection increases the fly‟s resistance to 
trypanosome infection (Hao et al., 2001). Three antimicrobial peptide genes, 
defensin, attacin, and cecropin are differentially expressed when tsetse flies are 
stimulated by bacteria or different life stages of trypanosomes, suggesting that 
the immune machinery of tsetse are able to discriminate between specific 
molecular signals from different pathogens (Hao et al., 2001). Also newly 
emerged flies presented a weakened immune response when challenged with 
trypanosomes, in contrast to adult refractory flies in which there were higher 
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levels of genes associated with the IMD pathway (attacin and PGRP-LB) (Weiss 
et al., 2013). 
The establishment of midgut infection was found to be significantly higher in 
tsetse when attacin or the IMD transcriptional activator relish was suppressed 
through RNAi knockdown, implying that IMD-regulated AMPs play a role in 
resisting trypanosomes in the midgut of tsetse flies (Hu and Aksoy, 2006). 
Neither the parasite-specific components nor the tsetse fly recognition proteins 
involved in triggering the IMD pathway is not fully known, but it must be said that 
several factors are involved in the recognition and subsequent response of a 
typical insect like tsetse, to microbial infection and requires direct contact 
between the parasite-specific components in the form of pathogen-associated 
molecular patterns (PAMPs) and tsetse pattern-recognition receptors like 
PGRPs (Beschin et al., 2014).  
The Glossina genome contains six PGRP genes made up of four long and two 
short subfamilies (Attardo et al., 2014). Tsetse PGRP-LB is involved in regulating 
the density of bacterial symbiome as well as controlling trypanosome infection. 
This is evident when, following the depletion of PGRP-LB, the IMD signalling 
pathway is activated which leads to the synthesis of AMPs that reduces the 
density of Wigglesworthia with a surprise increase in trypanosome infection rate 
despite the synthesis of AMPs (Wang et al., 2009). When both PGRP-LB (Toll) 
and IMD pathway are suppressed, flies become more susceptible to 
trypanosome infection suggesting that both may be acting synergistically. 
Moreover, trypanosome infected adult flies have significantly lower PGRP-LB 
expression levels than self cured flies (Wang et al., 2009). The PGRP-LB protein 
has been shown to be trypanocidal (Wang and Aksoy, 2012). It is also 
maternally transferred to the larva through the mother‟s milk, during intrauterine 
development and the amount of PGRP-LB transferred is directly proportional to 
the density of Wigglesworthia in the milk gland and it has been suggested that 
the level of trypanosome resistance exhibited by teneral (young and unfed) flies 
is directly linked to the amount of PGRP-LB present in the midgut (Weiss et al., 
2013, Wang and Aksoy, 2012).  
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1.9 Tsetse flies as cyclical vectors of trypanosomes 
Tsetse flies (both males and females) are the only cyclical vectors of African 
trypanosomes and therefore occupy an important position in the epidemiology of 
African trypanosomiasis. The cyclical transmission of African trypanosomes by 
tsetse flies is a complex phenomenon that involves the parasites undergoing a 
developmental cycle in the fly resulting in a final infective stage that is 
transmitted to a new mammalian host during a blood meal by the fly. An interplay 
between various factors determines the susceptibility or otherwise of the flies to 
trypanosome infection. The cyclical transmission of trypanosomes by tsetse flies 
is a complex process that is dependent on a number of factors such as: (1)  
availability of an infected tsetse fly (vector), (2) the ability of the parasite to 
successfully undergo complete developmental cycle leading to the production of 
mammalian infective metacyclics in the fly, (Sbicego et al., 1999, Van Den 
Abbeele et al., 1999) and (3) the injection of the parasite to a new mammalian 
host during a blood meal by the infected fly.  
Consequently, three critical stages in the cyclical transmission of African 
trypanosomiasis can therefore be identified as follows: (i) invasion of the midgut, 
(ii) establishment of infection/multiplication of parasites in the midgut, and (iii) 
maturation of parasites in the mouthparts (Vickerman et al., 1988, Maudlin and 
Welburn, 1994, Van Den Abbeele et al., 1999). Vector competence which is the 
ability of the fly to acquire trypanosome infection, favour the maturation of the 
parasite, and transmit it to a mammalian host is therefore vital to the 
transmission of African trypanosomiasis.   
A better understanding of the molecular nature of tsetse-trypanosome 
interactions offers potential opportunities for the development of fly-based control 
strategy. Different models have been designed to explain the mechanisms 
underlying trypanosome transmission by tsetse flies (Gouteux and Artzrouni, 
1996, Rogers, 1988). However, the phenomenon of tsetse refractoriness to 
trypanosome infection remains poorly understood.   
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1.10 Tsetse-trypanosome molecular interactions 
It is an established fact that tsetse flies are naturally resistant (refractory) to 
trypanosome infection; even under ideal laboratory conditions the proportion of 
flies that harbour mammalian infective forms of the parasite is low (Aksoy et al., 
2003, Rio et al., 2004). Once an uninfected tsetse fly acquires bloodstream form 
(BSF) parasites through a blood meal from an infected mammalian host, an 
intriguing and intricate molecular war ensues between the trypanosomes and 
their tsetse fly vector, each having devised mechanisms to mislead and outwit 
each other in order to come out triumphant at the end of the molecular dialogue. 
Once in the gut of fly the parasites are faced with a host of physical and 
immunological defence mechanisms (Weiss et al., 2013), and a myriad of 
immune molecules that are produced by the fly to prevent trypanosomes from 
establishing infection in the midgut. The molecular cross-talk between 
trypanosomes and their tsetse fly vector are of considerable importance in the 
epidemiology of African trypanosomiasis. The major conditions that influence fly 
infection rate are discussed below. 
 
1.10.1 Factors that influence the outcome of tsetse-trypanosome 
interaction 
 There are various factors associated with the fly that interferes with 
trypanosome colonisation of the midgut and subsequent maturation in the 
salivary glands or mouthparts. The probability that a tsetse fly will become 
infected after taking a blood meal from an infected mammal will depend on the 
vectorial capacity  (ability to become infected and  support the complete 
developmental cycle of the parasite) of the vector  (De Deken, 2013). The main 
factors that influence the outcome of the interaction between tsetse and 
trypanosomes are discussed below. 
 
1.10.1.1 Fly age at the time of infective blood meal  
Tsetse flies are generally believed to be more susceptible to trypanosome 
infection if their first blood meal is infected. In order words, newly emerged flies 
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that have not yet had a blood meal after eclosion are most susceptible to 
trypanosome infection – the so-called teneral phenomenon (Distelmans et al., 
1982, Welburn and Maudlin, 1992, Mwangelwa et al., 1987, Wijers, 1958). The 
susceptibility of newly emerged flies to trypanosome infection was found to be 
evident in both sexes, although males were found to have a higher infection rate 
than females in flies that had infective blood meal within 32 hours after eclosion 
(Makumyaviri et al., 1984, Wijers, 1958, Distelmans et al., 1982). Because newly 
emerged flies are more susceptible to trypanosome infection, there is the 
assumption that, in its teneral state, the fly is not yet well “equipped” to resist the 
invading parasites. A number of theories have been put forward to explain the 
teneral phenomenon. For example, the role of the peritrophic membrane 
(Lehane and Msangi, 1991), the role of midgut lectins (Maudlin and Welburn, 
1987, Welburn et al., 1989, Yoshino and Vasta, 1996), the role of 
antitrypanosomal factors such as midgut trypanolysin and trypano-agglutinins 
released during trypanosome infection (Molyneux and Stiles, 1991).  
 
1.10.1.2 Role of the peritrophic matrix 
The peritrophic matrix in the midgut of insects is a protective, chitinous layer that 
protects the midgut epithelium from invading microorganisms and parasites and 
the abrasive action of digestive enzymes. In tsetse, the PM is produced by a 
group of specialised cells present on the proventriculus (PV) in the anterior 
section of the midgut and secreted continuously as an unbroken, concentric, 
“sleeve-like” structure (Type II) (Tellam et al., 1999). It has been assumed that in 
order to establish infection in the midgut, trypanosomes must cross the PM to 
enter the ectoperitrophic space where they multiply and continue the process of 
differentiation (Freeman, 1973, Ellis and Evans, 1977, Gibson and Bailey, 2003). 
In as much as the PM forms a physical barrier to keep out pathogens from blood 
meal (Lehane, 1997, Hegedus et al., 2009), it has been suggested that the PM 
can also play an indirect role in trypanosome establishment since, in the 
absence of a robust PM, the gut epithelia is prematurely exposed to antigens 
from invading trypanosomes and therefore elicits an early immune respons e 
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which does not surprisingly confer long term protection from trypanosome 
establishment (Weiss et al., 2013).  
It has been demonstrated that the length of the fly‟s PM determines the 
susceptibility or otherwise of tsetse to trypanosome infection because the shorter 
the PM, the more susceptible the flies are to trypanosome infection and vice 
versa, since midgut infection prevalence is lower in adult flies with fully formed 
PM compared to teneral flies whose PM are not fully formed (Walshe et al., 
2011b). The molecular mechanisms underlying the involvement of the PM in 
tsetse refractoriness to trypanosome infection is yet to be unravelled, but it has 
been suggested that the PM regulates the timing of host immune induction 
following trypanosome challenge as well as acting as a physical barrier between 
ingested microbes and the immune-reactive gut epithelia (Weiss et al., 2013). A 
model depicting the role of tsetse PM in modulating trypanosome infection 
outcome is depicted in Figure 1.9. Although the PM forms a physical barrier 
between trypanosomes and the gut epithelia, some parasites succeed in 
breaching this barrier through a mechanism that is yet unknown, but are 
subsequently eliminated in a majority of flies within the first three days as a result 
of a robust immune reaction mounted by the fly (Gibson and Bailey, 2003). 
However, parasites that can survive the initial immune responses go on to 
proliferate in the tsetse‟s gut even in the presence of AMPs indicating that 
tsetse-trypanosome interaction is a much more complex process (Hao et al., 
2001). 
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                        Figure 1.9. Models depicting the role of tsetse PM in modulating  
                the immune response following challenge with trypanosomes.  
                The presence of an intact PM in the gut separates the luminal contents 
(including trypanosomes) from immune-competent epithelial cells. (A) In 
teneral flies with immature PM are more susceptible to trypanosome 
infection despite the early exposure of the parasites to epithelial immune 
response. (B) Adult flies with fully formed (mature) PM covering the entire 
gut succeed in clearing the invading parasites (Adapted from (Weiss et 
al., 2014).  
 
  
 
1.10.1.3 Fly species and genetic variation between individual flies 
Susceptibility to trypanosome infections varies between tsetse species. For 
example, tsetse flies belonging to the morsitans group are relatively more 
susceptible to trypanosome infection compared to palpalis-group flies (Harley 
and Wilson, 1968, Moloo and Kutuza, 1988b, Moloo and Kutuza, 1988a, Jordan, 
1964, Roberts and Gray, 1972). Even within the same species susceptibility to 
trypanosome infection may vary. Salmon eye colour mutation in G. m. morsitans 
was found to be associated with increased susceptibility to T. congolense 
infection (Distelmans et al., 1985). Refractoriness in tsetse is not an all-or-
nothing phenomenon as it occurs in the proportion of flies infected (Dyer et al., 
2013). This is demonstrated in the pattern of selection of lines of G. m. morsitans 
44 
 
and G. m. centralis susceptible or refractory to T. congolense infection (Maudlin 
and Dukes, 1985, Moloo et al., 1998). Since susceptibility to midgut infection 
was solely maternally inherited, with no input from the male, it is said to be 
extrachromosomally inherited (Moloo et al., 1998, Maudlin, 1982). The 
extrachromosomal factor was thought to be rickettsia-like organisms (RLOs) 
present in the midgut of tsetse (Maudlin and Ellis, 1985), which produces 
chitinase which in turn releases glucosamine thereby inactivating lectins  
(Maudlin and Welburn, 1988b). The RLOs were later identified as Sodalis 
glossinidius (Weiss and Aksoy, 2011). It should therefore be expected that tsetse 
selected for either susceptibility or refractoriness to T. congolense would not 
exhibit the same phenotype when tested with T. vivax since the latter‟s 
developmental cycle is restricted to the proboscis (Maudlin et al., 1986). 
However, this was not the case as the refractory lines were found to be more 
refractory to T. vivax and other trypanosome strains and species indicating that 
the extrachromosomal susceptible factor exerts its effects outside the midgut 
(Moloo et al., 1998). Selective elimination of Sodalis without affecting the 
obligate symbiont, Wigglesworthia glossinidia significantly reduces the vectorial 
capacity of tsetse (Dale and Welburn, 2001). 
 
1.10.1.4 Sex of the fly 
Among dipterans that are vectors of disease, tsetse fly is unusual because both 
male and female flies are obligate blood feeders and therefore capable of 
transmitting trypanosomes. However, males are known to be more susceptible to 
T. brucei infection than females (Dale et al., 1995, Maudlin et al., 1990, Moloo et 
al., 1992). Males are also known to show higher rate of infection maturation than 
females even though females have similar or higher rate of immature (midgut) 
infection (Distelmans et al., 1982, Mwangelwa et al., 1987, Maudlin et al., 1990). 
It has been proposed that the female tsetse SG environment may be more 
hostile to trypanosome establishment compared to their male counterparts 
leading to lower rates of SG infection in the former, though the molecular 
mechanisms responsible for this is not yet known (Peacock et al., 2012b). Since 
female tsetse relatively live longer than the males (Phelps and Vale, 1978), and 
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since T. brucei undergo a long developmental cycle in the fly, the females are 
more likely to be exposed to SG infection. 
 
1.10.1.5 Variation between trypanosome species and strains 
Different species and strains of trypanosome vary in their ability to establish 
infection in tsetse. Not all strains of T. b. gambiense were able to establish 
salivary gland infections in G. palpalis even though they established midgut 
infections in the flies, and the strains that failed to establish salivary gland 
infection were said to be non transmissible (Duke, 1930). However, strains of T. 
b. rhodesiense were always able to produce salivary gland infections in tsetse 
(Duke, 1933). Therefore, tsetse transmissibility varies between trypanosome 
species as well as between strains. Strains of the human pathogenic T. b. 
rhodesiense are less likely to produce mature infection in G. m. morsitans 
compared to its closely related T. b. brucei strains (Macleod et al., 2007a). Also 
virulent strains of T. congolense produced higher midgut infections than strains 
of moderate or low virulence (Masumu et al., 2006). Since T. congolense is 
believed to be monomorphic, existing only in one form, therefore no variation in 
infectivity would normally be expected. However, parasites from the acute phase 
of infection in mice produce higher rates of midgut infection in tsetse than those 
from the chronic phase, regardless of the level of parasitaemia (Masumu et al., 
2010). Also differences on the ease with which trypanosomes develop in the fly 
have been observed between flies fed on infected mouse blood between 4 to 10 
days post-infection, indicating that the rate of maturation of trypanosome in 
tsetse depends on the phase in the parasite‟s development in the mammalian 
host (Akoda et al., 2008).  
 
1.10.1.6 Gut pH, proteases and lectins 
In tsetse blood meal digestion is carried out in the digestive tract which can be 
divided into: the anterior midgut for storage of blood meal, middle portion for 
secretion of digestive enzymes, and the hindgut for blood meal digestion and 
absorption of nutrients. The ingestion of a blood meal by tsetse triggers the 
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secretion, in the midgut, of proteases (Imbuga et al., 1992b), trypanolysins 
(Stiles et al., 1990, Osir et al., 1999), lectins (Maudlin, 1991, Stiles et al., 1990) 
and other unidentified factors and the accumulation of these factors makes the 
environment very hostile to the ingested parasites, majority of which are 
destroyed within 3 days of being ingested (Stiles et al., 1990, Abubakar et al., 
1995). The few parasites that survived enter the ectoperitrophic space where 
they establish midgut infections (Maudlin, 1985, Maudlin and Welburn, 1987). T. 
b. brucei were found to be capable of inhibiting tsetse midgut trypsin extracts 
(Imbuga et al., 1992a). In addition, a tsetse midgut lectin-trypsin complex was 
capable of inducing the transformation of the stumpy bloodstream forms to 
procyclic forms (Abubakar et al., 2006, Dean et al., 2009). 
 
1.10.1.7 Blood meal species 
The source of mammalian blood meal seems to play a role in determining the 
refractoriness or permissiveness of tsetse to trypanosome infection. In the 
laboratory, tsetse flies fed on infected goat or pig blood recorded more midgut 
infections than flies fed infected blood from other mammalian sources (Aksoy et 
al., 2003). When flies are fed PCF trypanosomes suspended in PBS-washed red 
blood cells containing heat-inactivated serum, midgut infection rates were 
observed to be high (Evans, 1979), suggesting that serum complement may be 
controlling trypanosome infection in tsetse. Also PCF trypanosomes are known 
to be susceptible to vertebrate complement in vitro (Walshe et al., 2011a). 
Despite the fact that trypanosomes in the midgut are exposed to constant 
contact with serum complement since the fly takes a blood meal every 48 hours, 
the parasites are still able to complete their life cycle in the fly. This implies that 
the parasites in the midgut of tsetse could have evolved ways to either 
circumvent or inactivate the action of complement.  
 
1.10.1.8 Nutritional status 
The nutritional state of the fly at the time of infective blood meal also affects its 
ability to fight trypanosome infection because flies subjected to extreme 
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starvation (>3 days after eclosion) were found to offer less resistance to 
trypanosome infection (Kubi et al., 2006). It has been demonstrated that 
nutritional stress leads to a reduction in the levels of the AMPs attacin, defencin 
and cecropin expressed in the fat body, which may lead to increased 
susceptibility to trypanosome infection in starved flies (Akoda et al., 2009). 
Although it is an established fact that newly emerged flies are highly susceptible 
to trypanosome infection, the ability of adult flies to acquire mature trypanosome 
infection is also relatively high, especially for T. congolense (Kubi et al., 2006). 
Starving young and adult tsetse flies prior to infection increases their 
susceptibility to trypanosome infection, suggesting that the mechanisms involved 
in the resistance of tsetse flies to trypanosome infection may have been 
undermined by starvation (Kubi et al., 2006). The authors argued that starvation 
depletes the fat body energy reserves leading to a possible suppression of the 
ability of the fly to mount a robust immune response. Also nutritional stress leads 
to a decrease in the expression of AMPs thereby altering tsetse immune 
response to trypanosome infection (Akoda et al., 2009).   
 
1.10.1.9 Tsetse innate immune response in trypanosome infection    
Upon infection, insects mount a rapid innate immune response that is made up 
of various molecules such as antimicrobial peptides (AMPs), haemocytes, and 
phenoloxidase-based melanisation (Brennan and Anderson, 2004, Hultmark, 
2003, Lemaitre, 2004, Tanji and Ip, 2005). The sequencing of the genome of the 
tsetse fly (Glossina morsitans) has revealed that its innate immune system is 
similar to that of Drosophila (Kounatidis and Ligoxygakis, 2012, Attardo et al., 
2014). The establishment of an endogenous microbiome during intrauterine 
larval development of tsetse is important for the development of a fully functional 
innate immune system later in the mature adult (Weiss et al., 2011, Weiss et al., 
2012).  
Reactive oxygen species (ROS)-mediated immune response in the alimentary 
tract of tsetse flies also modulate trypanosome infection outcome in the fly 
(Beschin et al., 2014). ROS which is produced by dual oxidase (Duox) exhibit 
oxidative antimicrobial activity in dipterans (Ha et al., 2005a) as well as 
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antiparasite activity (Kumar et al., 2003). They can also act as messenger 
molecules which help to evoke systemic immune response in the fat body as 
well as nitric oxide (NO) production through the activation of inducible nitric oxide 
synthase (iNOS). After ingesting trypanosomes during a blood meal, there is an 
increase in the level of hydrogen peroxidise in the midgut/proventriculus of the fly 
apparently in a bid to clear the invading trypanosomes early on during infection 
(Hao et al., 2003). Self-cured flies are known to mount a systemic oxidative 
stress response (caused by an increase in ROS) in the fat body suggesting a 
role for oxidative stress in refractoriness of tsetse to trypanosome infection 
(Lehane et al., 2008) as well as an up-regulation of iNOS and Duox, genes 
associated with ROS-mediated immunity (Weiss et al., 2013). Inhibiting the 
action of ROS by supplementing infective blood meal with antioxidants such as 
L-glutathionate and ascorbic acid, leads to an increase in midgut infection rate, 
thus supporting the view that ROS play a role in trypanosome clearance in the fly 
(MacLeod et al., 2007b). Oxidative stress has also been implicated in immune 
defences in Drosophila and Rhodnius prolixus (Ha et al., 2005b, Whitten et al., 
2001). 
The TsetseEP protein is another immune responsive protein which is present in 
the midgut, haemolymph, as well as salivary glands. Tsetse EP protein is named 
because of its possession of an extensive tandem repeat units of glutamic acid 
(E) and proline (P) which make up more than 40% of the amino acid residue 
(Haines et al., 2010), with the repeat units showing remarkable sequence identity 
to that of T. b. brucei EP composition (Vassella et al., 2001). Although not much 
is known about tsetse EP protein, the fact that it is constitutively expressed both 
in adult fat body and midgut and is upregulated following immune challenge 
(Haines et al., 2005). Also suppression of TsetseEP by RNAi leads to an 
increase in midgut trypanosome infection rate (Haines et al., 2010). 
Trypanosomes once inside the alimentary tract of the fly are met with stiff 
opposition mounted by the fly innate defence system already existing, albeit at a 
basic level, i.e., at pre-immune challenge level but is induced systemically (in the 
fat body) and locally in the form of epithelial response in the alimentary tract 
(Figure 1.10) (Beschin et al., 2014). These defensive mechanisms are deemed 
to be very effective since they succeed in eliminating the parasites in most cases 
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which is reflected in the low number of flies that are susceptible to trypanosome 
infection in the field.  
The trypanosomes on their part have also devised some strategies to bypass the 
defensive mechanisms of the fly, for example, the BSF once in the midgut, 
switches its VSG surface coat to a new stage-specific coat – the procyclin, a 
move designed to curtail the effectiveness of the tsetse innate immune response 
(Güther et al., 2006, Pearson, 2001). Parasites that succeed in establishing 
infections in the midgut may be either resistant to tsetse immune responses or 
the host immune responses are induced in a such a way as to reduce parasite 
densities to reduce fitness cost to infected flies. It seems however, that the 
former is the case since during the course of infection in the fly‟s midgut, 
trypanosomes switch their surface coat from one composed of GPEET to one 
composed predominantly of immune-invasive EP proteins (Ruepp et al., 1997, 
Urwyler et al., 2005). The expression of a less antigenic surface coat may be an 
adaptation on the part of the parasites that enables them to curtail immune 
reaction from the fly thereby enabling them to survive in the immunocompetent 
gut of the fly. This adaptation may have arisen because of the long-term host-
parasite co-evolutionary process between tsetse and trypanosome (Mattioli and 
Wilson, 1996) since the former must undergo developmental changes in the later 
to complete its life cycle.  
Intriguingly also, the defence system of the tsetse fly has been co-opted by the 
trypanosome and used as a tool to stimulate its own maturation in the fly as seen 
in the positive role of tsetse lectin in the maturation of midgut infections (Maudlin 
and Welburn, 1988a, Welburn and Maudlin, 1989). Inhibition of lectin activity 
prevented the maturation of the parasites beyond the procyclic stage but this 
was reversed following the restoration of lectin indicating that the process of 
trypanosome maturation is dependent upon a signal from the fly and not 
predetermined by a fixed number of division cycles by the parasites (Welburn 
and Maudlin, 1989). Also some tsetse salivary gland proteins are thought to be 
intimately associated with the maturation and development of trypanosomes in 
the salivary glands (Haddow et al., 2002). For instance, the expression of tsetse 
TSGF-1, a salivary protein with adenosine-deaminase activity is thought to allow 
survival of African trypanosomes in the salivary glands since these parasites are 
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known purine scavengers but lack adenosine deaminase, an enzyme involved in 
purine metabolism (Ogbunude et al., 1985). The development of T. b. brucei 
within the alimentary tract and salivary glands in G. m. morsitans are shown in 
Figure 1.10.  
 
        
 
       Figure 1.10 The spatio-temporal course of T. b. brucei infection in G. m. morsitans.  
The major sites of the major developmental pathway are shown. Following an infective 
bloodmeal, bloodstream forms (BSFs) taken by the fly rapidly differentiate to procyclics in 
the fly midgut (MG). The parasites migrate anteriorly to the proventriculus (PV) at 6 days 
transforming to long trypomastigotes which divide asymmetrically producing long and 
short epimastigotes. Colonization of the salivary glands occurs from day 8 with attached 
epimastigotes and develops into infective, metacyclics from day 12. The completion of 
this developmental cycle takes approximately 3 weeks (Adapted from (Langousis and Hill, 
2014, Caljon et al., 2014).      
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Figure 1.10 Overview of tsetse fly immune responses to trypanosome 
infection. Trypanosomes are ingested by the tsetse fly through blood meal on 
an infected host. Once inside the gut, the parasites have to go through a series 
of complex developmental changes in different compartments of the alimentary 
tract with the final infective metacyclic stage in the mouthparts (T. congolense) or 
salivary glands (T. brucei) (indicated by the purple line and arrows). The parasite 
elicits both local epithelial as well as systemic defence reactions in the fly, 
resulting in several effector molecules including reactive oxygen species (ROS), 
immune deficiency (IMD)-regulated antimicrobial peptides (AMPs) and the 
PGRP-LB scavenger receptor. The PGRP-LB level in the adult‟s midgut seems 
to be regulated by the obligatory bacteriome (Wigglesworthia) during larval 
development. The latter also affects the integrity of the midgut peritrophic matrix 
of the emerging adult fly. The peritrophic matrix is suggested to regulate the fly‟s 
ability to immunologically detect and respond to the parasite (Beschin et al., 
2014). 
 
1.11 Tsetse microbiota 
Insects harbour bacterial endosymbionts which play important physiological roles 
such as metabolism, maintenance of fecundity and immune system development 
(Douglas, 2011). Tsetse flies are known to harbour three endogenous 
symbionts, obligate mutualist Wigglesworthia glossinidia, commensal Sodalis 
glossinidius and parasitic Wolbachia pipientis, which influence reproduction, 
immunity and fly fitness (Attardo et al., 2008, Pais et al., 2008, Alam et al., 
2011). Both Wigglesworthia and Sodalis belong to the Enterobacteriaceae family 
and Wigglesworthia is made up of two distinct populations, one in the bacteriome 
that surrounds the anterior midgut of the tsetse fly (Aksoy, 1995, Aksoy, 2000), 
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and another found extracellularly in milk gland secretions (Attardo et al., 2008). 
Sodalis, however, exhibits a wide range of tissue tropism and is widespread in 
numerous tissues in the fly including midgut, fat body, milk gland, salivary glands 
and haemocoel (Cheng and Aksoy, 1999, Balmand et al., 2013). Wolbachia is 
found exclusively in germ line tissues and have been detected in early oocyte, 
embryo and larvae (Cheng et al., 2000, Balmand et al., 2013).  
The presence of Wigglesworthia offers both nutritional and immunological 
benefits to tsetse. It supplements its tsetse host with nutrients such as vitamins 
that are either lacking or at low amounts in the vertebrate blood (Balmand et al., 
2013). It has also been demonstrated that the presence of Wigglesworthia during 
intrauterine development is essential for proper immune functioning during the 
adult stage (Weiss et al., 2011, Weiss et al., 2012, Weiss et al., 2013, Wang et 
al., 2009). Unlike Wigglesworthia, several natural tsetse populations lack 
Sodalis, (Geiger et al., 2005, Lindh and Lehane, 2011) suggesting that the 
association between Sodalis and tsetse may be essentially commensal (Wang et 
al., 2013).  
However, it has been shown that the presence of Sodalis increases the 
susceptibility of tsetse to trypanosome infection (Welburn et al., 1993) and the 
elimination of Sodalis through streptozotocin treatment results in tsetse being 
more resistant to trypanosome infection (Dale and Welburn, 2001). Also, there is 
a correlation between trypanosome infection prevalence and the presence of 
Sodalis (Farikou et al., 2010, Soumana et al., 2013). While the presence of 
Wigglesworthia increases tsetse refractoriness to trypanosome infection, it can 
be said that the presence of Sodalis favours trypanosome infection 
establishment in Sodalis-harbouring populations of tsetse. In tsetse, Wolbachia 
induces cytoplasmic incompatibility in which mating between Wolbachia-cured 
females and Wolbachia-infected males produces offspring that die early during 
embryogenesis (Alam et al., 2011). Both Wigglesworthia and Sodalis are 
transmitted via milk gland secretions while Wolbachia is transmitted 
transovarially via germ line cells.  
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1.12 Alteration of tsetse feeding behaviour by trypanosomes  
In host-parasite interactions, alteration or modification of host behaviour by the 
parasite is designed to increase the chances of the parasites completing their life 
cycle and these modifications can include a change in preferred substrate, 
temperature preferences, locomotor activity, visual cycle, circadian rhythms, 
geo- or phototropism, cessation of food consumption, feeding rate and any other 
behaviours that may enhance the survival and transmission of the parasite 
(Adamo, 2002, Hurd, 2003, Lefevre and Thomas, 2008, Rogers and Bates, 
2007, Schaub, 2006, Thomas et al., 2005, Webster, 2001). It has been 
demonstrated that in an arthropod vector-parasite association, the behaviours, 
particularly feeding behaviour, of the vector is modified by the parasite in order to 
increase the contact of the vector with the vertebrate host thereby maximising 
chances of transmission of the parasite to the vertebrate host (Schaub, 2006, 
Moore, 1993).  
Tsetse flies infected with trypanosomes are known to exhibit increased probing 
rate and feed with more voracity than uninfected flies (Jenni et al., 1980, 
Roberts, 1981). However, the molecular mechanisms involved in these 
behavioural changes are not well understood (Biron et al., 2005, Libersat et al., 
2009). There is evidence that trypanosomes can alter the head proteome of 
tsetse flies through modifications in energy metabolism, signal transduction and 
heat shock response (Lefevre et al., 2007) and this shows that a parasite has the 
ability to induce a global metabolism disorder that leads to nutritional stress and 
consequently to new feeding attempts (Lefevre and Thomas, 2008). It has also 
been suggested that trypanosomes can modulate the apoptosis pathways of 
tsetse during their interaction (Biron and Loxdale, 2013). 
It has also been shown that the colonisation of the salivary glands of tsetse flies 
by trypanosomes leads to significant decrease in anti-haemostatic activities 
(anti-platelet aggregation and anti-thrombin activities) in addition to the inhibition 
of thrombin-induced blood coagulation; this leads to a decrease in the fly‟s 
feeding ability and makes it feed for longer periods and hence increases contact 
between vector and mammalian host thereby affording the parasites more 
opportunities for transmission (Van Den Abbeele et al., 2010).  
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A better understanding and characterisation of the molecular mechanisms 
involved in the cross-talk between trypanosomes and their tsetse fly vector which 
invariably leads to modifications in the behaviour of the vector that favours the 
transmission of the parasite to a vertebrate host will enable us have a better 
understanding of tsetse immune responses towards trypanosome infection. This 
will in turn enable us to design control strategies aimed at interfering with the 
transmission of African trypanosomiasis. 
 
1.13 Aims and objectives 
Trypanosomes have to overcome a number of natural bottlenecks in the tsetse 
fly vector to eventually reach the salivary glands or mouthparts of the fly where 
they differentiate into a final stage that is infective for a new vertebrate host. 
Based on a number of studies (Msangi et al., 1998, Otieno and Darji, 1979, 
Morlais et al., 1998, Auty et al., 2012, Jamonneau et al., 2004, Peacock et al., 
2012b), it has been established that a high percentage of tsetse flies are 
resistant to trypanosome infection. The outcome of tsetse-trypanosome 
interactions is thought to be dependent on the efficiency of the innate immune 
response of the fly versus the ability of the parasites to suppress or evade the 
immune response of the fly.  
In this thesis, I set out to characterise and functionally analyse several 
differentially expressed genes in the midgut of G. m. morsitans that were 
resistant (or self-cured) to T. brucei infection. A comprehensive bioinformatic 
analysis of immune related genes that were differentially expressed in the midgut 
of refractory flies, previously identified by 454 sequencing, is described in 
Chapter 3. I used RNAi silencing to validate the biological involvement of these 
genes in the susceptibility of the flies to trypanosome infection (Chapter 4). 
Among the four immune related candidate genes in refractory flies, I 
concentrated my efforts in characterising the role of a secreted PLA2 activity. 
This enzyme has trypanocidal activity in vitro and its expression appears to be 
dependent on parasite density and time of infection in the fly. Surprisingly, sPLA2 
expression was found to be high in the midgut of flies infected by the gram-
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positive bacterium, S. aureus, suggesting a possible involvement or modulation 
by the tsetse Toll pathway (Chapter 5). 
The primary objective of this thesis was to investigate the interactions between 
tsetse and trypanosomes with a view to shed more light on the molecular 
mechanisms involved in tsetse-trypanosome crosstalk.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
56 
 
                                              Chapter 2  
                            General Materials and Methods 
 
In this chapter, a general outline of the methods used in the course of this thesis 
is described, except for the bioinformatics methodology which is described in 
Chapter 3. References will be made as appropriate in subsequent chapters  
 
2.1 Rearing and maintenance of tsetse 
The Glossina morsitans morsitans colony was reared and maintained in an 
insectary at the Liverpool School of Tropical Medicine.  The flies originally from 
Zimbabwe, were established in LSTM in 2002 from the University of Bristol 
colony. Flies were maintained at 26°C and 65 - 75% relative humidity and fed 
defibrinated horse blood (TCS Biosciences Ltd., Buckingham, UK) using an 
artificial feeding membrane (Moloo, 1971a).  Male flies were used throughout the 
experiment. 
 
2.2 Trypanosome stock 
The strain of trypanosomes used in this experiment (kindly provided by Prof. 
Wendy Gibson, Bristol),  Trypanosoma brucei brucei TSW196 
(MSUS/CI/78/TSW 196) (CLONE A) was originally isolated in 1978 from a pig in 
Cote d‟Ivoire (Mehlitz et al., 1982). Parasites were taken from rats during peak 
parasitaemia and blood stabilates were cryopreserved at -180°C until use. 
 
2.3 Synthesis of dsRNA 
dsRNA was synthesized with PCR products of the genes tailed with T7 RNA 
polymerase promoter sequence at their 5' ends using the MEGAscript High Yield 
T7 Transcription kit (Ambion, Huntington, UK) according to manufacturer‟s 
instructions. DNA plasmids from a tsetse midgut EST library (Lehane et al., 
2003b) were used as templates while double stranded enhanced green 
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fluorescent protein (dsRNA-eGFP) was used as a negative control. The T7 
primer sequences used are listed below. 
 
 
GMOY000153 (chitinase) 
Forward: TAATACGACTCACTATAGGGCCGCTGTTAAGCACAATCAA 
Reverse: TAATACGACTCACTATAGGGCATTGATAGAAACGCGAGCA 
GMOY002400 (OGT) 
Forward: TAATACGACTCACTATAGGGCGAAGTCAGAGGGTTTCTGG 
Reverse: TAATACGACTCACTATAGGGATACCGCAGCCACGTATTTC 
GMOY009713 (PLA2) 
Forward:  TAATACGACTCACTATAGGGATACGCTTGCACATTTACGAGAT 
Reverse:  TAATACGACTCACTATAGGGTGGCTGCGGCTTTACAACT 
 
GMOY006016 (SPI) 
Forward: TAATACGACTCACTATAGGGCGGCAAATAGTGATGATCCA 
Reverse: TAATACGACTCACTATAGGGCTTGCAAGTTTCCTCGCATT 
GFP 
Forward:  TAATACGACTCACTATAGGGACGTAAACGGCCACAAGTTC 
Reverse: TAATACGACTCACTATAGGGCTTGTACAGCTCGTCCATGCC 
 
The following PCR cycling conditions were used: 95°C for 5 minutes, 30 cycles 
of 95˚C for 1 minute, 55˚C for 30 seconds and 72˚C for 1 minute and a final 
extension of 72˚C for 5 minutes. Purification of dsRNA was done using 
MEGAclearTM columns (Ambion, Huntington, UK) and finally eluted in nuclease 
free water. The concentration of the synthesized dsRNA was measured using 
NanoVueTM Plus Spectrophotometer (GE Healthcare, Buckinghamshire, UK). 
Eluted dsRNA was concentrated to obtain a concentration of 5 µg/µl using DNA-
Mini vacuum concentrator (Fisher Scientific, Loughborough, UK). 
 
2.4 RNAi experimental design 
In order to ascertain the roles of our genes of interest in controlling trypanosome 
infection in tsetse, we carried out RNAi-mediated knockdown of the genes of 
interest followed by quantitative (qPCR) analysis to confirm and validate their 
roles in trypanosome challenged flies. Teneral flies were fed defibrinated horse 
58 
 
blood on the day of emergence and those that did not take a blood meal were 
discarded. Flies were injected with 10 µg/fly dsRNA of gene of interest and 
dsRNA-GFP the following day, fed normal blood meal 24 hours after injection 
and allowed to rest for 24 hours. Flies that did not take a blood meal were 
discarded. The flies were then fed infectious blood meal containing T. b. brucei 
TSW196 bloodstream form parasites on day 5. Again flies that did not take a 
blood meal were discarded. The flies were subsequently maintained every 48 
hours on defibrinated horse blood and dissected 7 days after infection to check 
for midgut infection (Figure 2.1). 
 
2.4.1 Timing of Infectious blood meal 
The infectious blood meal was supplied at the third feed. In the field tsetse flies 
are known to be resistant to trypanosome infection. Even in the laboratory where 
flies are made to take infected blood meal under experimental conditions, the 
proportion of flies that establish midgut infections are still small especially if the 
flies are made to take multiple blood meals prior to the infectious blood meal 
(Distelmans et al., 1982, Kubi et al., 2006). Flies were therefore fed infectious 
blood meal at the third blood meal in order to reproduce the refractory phenotype 
(Figure 2.1).   
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Figure 2.1  RNAi experimental design. Flies were fed with sterile horse 
blood on the day of emergence. The flies were injected with dsRNA of the 
gene of interest (dsRNA-GOI) on day 2. Flies were fed with sterile horse blood 
24 hrs after injection (day 3) and infected with bloodstream form parasites on 
day 5. They were maintained on sterile horse blood every 48 hrs and 
dissected 7 days post-infection to check for midgut infection. Midgut tissues 
were collected for qPCR (transcript) and western blot (protein) analysis. 
Uninjected flies and dsRNA-GFP-injected flies were used as controls. 
 
2.5 Injection dsRNA 
The needles for injection were made in the lab using micro-haematocrit glass 
capillary tubes (2.00 mm outside diameter) (Globe Scientific, New Jersey, USA). 
The tubes were pulled to an approximate external tip diameter of 45 µl after 
heating using a needle puller (PC10; Narishige, Japan). Needles were checked 
to ensure there were no trapped glass particles inside before they were used for 
injection. Flies were injected 24 hours after receiving a blood meal. Flies were 
chilled on ice for 10 minutes to immobilize them prior to injection with dsRNA and 
were injected with 2 µl (10 µg) of dsRNA per fly at the dorsolateral surface of the 
thorax (scutum) and allowed to rest for 24 hours before the next bloodmeal. The 
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needle was angled slightly at 45° to minimise the impact of the pressure to the 
organs. The flies were fed 24 hours after injection. 
 
 
2.6 Trypanosome infection 
The infective blood meal was prepared by mixing T. b. brucei TSW196 stabilate 
in sterile defibrinated horse blood to achieve a final concentration of 
approximately 5x105 parasites/ml. The flies were fed with the infective blood 
meal using an artificial feeding membrane (Moloo, 1971a). Flies that did not feed 
on the infective blood meal were discarded. 
 
 
2.7 Scoring of infection rates in dsRNA knockdown flies 
Flies were dissected 7 days after infection and the midguts were analysed by 
light microscopy for the presence of trypanosomes. Midguts were shredded into 
a drop of phosphate buffered saline (PBS) on a glass slide. Infection prevalence 
was determined by searching 10 random fields by dark field microscopy (x40 
magnification) for the presence of motile trypanosomes. 
 
 
2.8 Bacterial infection 
E. coli strain K12 RM148 and S. aureus strain SH1000 were grown in LB broth 
and incubated overnight at 37°C with shaking. Bacterial suspensions were 
prepared and adjusted to OD600=0.5 in LB broth. The infectious blood meal was 
prepared by mixing 100 µl of bacterial suspension with 1 ml of defibrinated horse 
blood and subsequently fed to flies. Flies that did not take the blood meal were 
discarded.   
 
 
2.9 Optimising conditions prior to RNA extraction 
Obtaining high quality RNA is very critical in any molecular technique involving 
the use RNA. RNA is far less stable than DNA and must therefore be treated 
with extra care to avoid degradation by both endogenous RNAse in tissue and 
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exogenous RNAse. Contamination must be avoided. In this project, nuclease-
free water was used in all experiments involving the use of RNA since water is 
one of the common sources of microbial nucleases. Also surfaces and 
containers were thoroughly cleaned using RNaseZap® spray (Ambion, TX, USA) 
prior to the commencement of RNA extraction. 
 
 
2.10 RNA extraction 
RNA was isolated from midgut tissues from dissected flies using TRIzol 
(Invitrogen, Paisley, UK) reagent. Briefly, frozen samples were homogenized in 
500 µl of TRIzol reagent in 1.5 ml tube using PELLET PESTLE® (Kimble Chase, 
Vineland, NJ) homogenizer. Homogenized samples were left to incubate for 5 
minutes at room temperature after which 100 µl of chloroform was added and the 
tubes were shaken vigorously by hand for 15 seconds and allowed to incubate at 
room temperature for 5 minutes. After incubation, the samples were centrifuged 
at 12,000 g for 15 minutes at 4˚C. The upper aqueous phase was carefully  
transferred to a new tube and 250 µl of isopropanol was added and left to 
incubate at room temperature for 10 minutes. The mixture was then centrifuged 
at 12,000 g at 4˚C for 10 minutes and the supernatant was carefully removed 
from the pellet. The RNA pellet was washed with 1 ml 75% ethanol (made with 
RNAse free water) and supernatant was carefully removed and the RNA pellet 
was allowed to air dry until all the ethanol evaporated. The RNA pellet was then 
dissolved in 30 µl of nuclease free water by gently pipetting up and down. After 
extraction, samples were treated with DNAse to remove contaminating DNA. 
Briefly, 3 µl of 10X TURBO DNase Buffer and 1 µl of TURBO DNase was added 
to the RNA sample mixed gently. The mixture was incubated at 37 ˚C for 30 
minutes. Then 3 µl of resuspended inactivation buffer was added and the mixture 
was incubated at room temperature for 5 minutes with intermittent mixing (3 
times) to redisperse the DNase Inactivation reagent. Finally, the mixture was 
centrifuged at 10,000 x g for 1.5 minutes and the RNA was transferred to a fresh 
1.5 ml tube and stored at -80 ˚C.  
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2.11 RNA analysis 
Following RNA extraction, a NanoVueTM PLus (GE Healthcare, 
Buckinghamshire, UK) spectrophotometer was used to quantify the yield and 
purity by measuring its absorbance at 260 nm (A260). RNA samples that were 
stored at -80°C were thawed on ice prior to measurements. The sample 
measurement pedestal was cleaned with a dry lint-free laboratory wipe before 
initialising it with a blank (2 µl nuclease free water used to dissolve the RNA). 
After this the sample pedestal was cleaned as previously described and 2 µl of 
each sample was put on the sample pedestal and measured. The ratio of 
absorbance at 260 nm versus 280 nm (A260/A280) was used to assess the level of 
protein contamination, while the ratio of 260 nm versus 230 nm (A260/A230) was to 
assess the level of contamination by organic compounds. The values of the 
A260/A280 and A260/A230 ratios of the samples used in these studies were between 
1.6 to 2.2 and 1.5 to 1.8 respectively. These values indicate the absence of 
significant amounts of contaminants and therefore meets the requirements for 
good quality RNA (Green and Sambrook, 2012). 
 
 
2.12 cDNA synthesis 
The quantified RNA was used to generate cDNA for amplification using 
polymerase chain reaction (PCR). The reverse transcriptase method using oligo-
dT primers was used for cDNA synthesis. A sample of 1 µg of RNA was diluted 
in 8 µl of nuclease free water in 0.2 ml PCR tubes and the following reagents 
were added to bring the volume to 13 µl: 1 µl of dNTP mix (10 mM each) and 3 
µl of nuclease free water. The mixture was heated at 65°C for 5 minutes in a 
PCR machine to denature the RNA and thus enable the adhesion of the oligo-dT 
primer onto the denatured RNA. Following this, the tubes were chilled on ice for 
1 minute to enable the primers to anneal. After spinning down to collect the 
contents of the tube, the reverse transcription (RT) mix was added in the 
following order: 4 µl First-strand buffer 5X; 1 µl 0.1 M dithiothreitol; 1 µl 
RNAseOUT™ (40 U/µl) and 1 µl SuperScript III RT™ (200 U/μl). The mixture 
was then incubated at 50°C for 60 minutes in a PCR machine followed by 70°C 
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for 15 minutes to inactivate the reaction. The resultant cDNA was then stored at -
20°C until use. 
 
 
2.13 Primer design for PCR reaction 
To design oligonucleotide sequences specific to the DNA of the genes of 
interest, Primer3Plus (http://www.bioinformatics.nl/cgi-
bin/primer3plus/primer3plus.cgi/), a web-based free software for primer design 
was used. The first step was downloading the sequence for each gene from 
VectorBase. The sequences were pasted on the Primer3Plus site adjusting few 
of the parameters. The “Min” and “Max” of the “Primer GC%” was changed to 
40.0 and 60.0 respectively. The product size range was set at 100-200 for qPCR 
primers and 450-650 for dsRNA primers while the “SantaLucia 1998” method 
was chosen for both “Table of thermodynamic parameters” and “Salt correction 
formula”. To minimise hairpin formation, “Max Self Complementarity” and “Max 3′ 
Self Complementarity” was tuned down. The rest of the parameters were left at 
default setting. After setting all parameters, the “Pick Primers” option was 
chosen. This generates a list of primer pairs that meet all of the input 
requirements. The primer pairs chosen had similar melting temperatures 
(differences of ± 1°C). Primers were checked for potential off-target binding 
using BLASTn search while relaxing the E-value threshold to 200 to detect more 
potential off-targets. α-tubulin and β-tubulin were the housekeeping genes used 
to normalise for the qPCR experiments described in subsequent chapters.  
Primer sequences for β-tubulin were taken from (Weiss et al., 2012). Table 2.1 
shows the list of primers used. 
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Table 2.1 List of primer sets used in this thesis 
Procedure Gene                              Primer sets Product 
Size 
(bp) 
Tm 
(˚C) 
dsRNA GMOY000153 
(Chitinase) 
F-5'-TAATACGACTCACTATAGGGCCGCTGTTAAGCACAATCAA-3' 
R-5'-TAATACGACTCACTATAGGGCATTGATAGAAACGCGAGCA-3' 
472 59 
 GMOY002400 
(OGT) 
F-5'-TAATACGACTCACTATAGGGCGAAGTCAGAGGGTTTCTGG-3' 
R-5'-TAATACGACTCACTATAGGGATACCGCAGCCACGTATTTC-3' 
447 60 
 GMOY009713 
(PLA2) 
F-5'-TAATACGACTCACTATAGGGATACGCTTGCACATTTACGAGAT-3' 
R-5'-TAATACGACTCACTATAGGGTGGCTGCGGCTTTACAACT-3' 
444 58 
 GMOY006016 
(SPI) 
F-5'-TAATACGACTCACTATAGGGCGGCAAATAGTGATGATCCA-3' 
R-5'-TAATACGACTCACTATAGGGCTTGCAAGTTTCCTCGCATT-3' 
441 60 
 GFP F-5'-TAATACGACTCACTATAGGGACGTAAACGGCCACAAGTTC-3' 
R-5'-TAATACGACTCACTATAGGGCTTGTACAGCTCGTCCATGCC-3' 
636 60 
qPCR GMOY000153 
(Chitinase) 
F-5'-AAATTCACACACGCGGCAAA-3' 
R-5'-TGCCGAGTGTTGAAAATTGCA-3' 
155 55 
 GMOY002400 
(OGT) 
F-5'-TATAGGAGTCTCGCCGGAAC-3' 
R-5'-TAAGTTCGGGACAACCAAGG-3' 
152 56 
 GMOY009713 
(PLA2) 
F-5'-TTCACCGGCACCCTAACTTT-3' 
R-5'-ATCCCTTTGTCGATTCCCAGCA-3' 
158 58 
 GMOY006016 
(SPI) 
F-5'-CCGCTGTTAAGCACAATCAA-3' 
R-5'-CATTGATAGAAACGCGAGCA-3' 
198 57 
 α-tubulin F-5'-TGT ATG TTG TAT CGT GGT GAT GT-3' 
R-5'-GAA TTG GAT GGT GCG TTT AGT TT-3' 
146 55 
 β-tubulin F-5'-CCATTCCCACGTCTTCACTT -3' 
R-5'-GACCATGACGTGGATCACAG -3' 
152 55 
 
 
 
2.14 Agarose gel electrophoresis 
Agarose gels were prepared to separate and analyse the amplified DNA (PCR 
products) of the genes of interest. A 1% agarose gel was prepared by mixing 0.5 
g multipurpose molecular grade agarose in 50 ml of Tris-Acetate-EDTA (TAE) 
buffer in a 250 ml flask. This was heated to melt the agarose and swirled to 
ensure even mixing and allowed to cool to about 55˚C. Then 5 µl of SYBR Safe 
(Invitrogen, UK) was added and swirled to get a good mix. The liquefied solution 
was then poured into a Multi Sub Mini 7 x 10cm horizontal agarose Gel Tray 
(Geneflow, Lichfield, UK) that holds 2 8-tooth combs and sealed with rubber tray 
dams at the ends. The gel was left to set at room temperature for 30 minutes 
and then transferred into a gel electrophoresis tank (Geneflow, Lichfield, UK) 
containing TAE buffer which was topped up to ensure the gel is submerged in 
TAE buffer. The combs were then removed carefully and 5 µl of amplified DNA 
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(PCR product) was loaded into each well. The electrophoresis tank was then 
covered with a lid before connecting it to a power source through a gel 
electrophoresis power pack (Consort BVBA, Turnhout, Belgium). The gel was 
run at 90V for 45 minutes. 
 
2.15 Gel imaging 
The gel was taken out of the electrophoresis tank at the end of the run and 
drained of excess TAE buffer. This was then placed in a tray for nucleic acid 
applications with SYBR stains and then placed in the Bio-Rad Gel Doc EZ 
imager (Bio-Rad Laboratories, UK) to view and capture the gel image. The 
captured image was then saved in TIF format. 
 
2.16 Quantitative polymerase chain reaction (QPCR) 
The methodology used to measure gene expression in the quantitative 
polymerase chain reaction in these experiments is the Brilliant III Ultra-Fast 
SYBR® Green dye detection system by Agilent Technologies. This method uses 
the fluorogenic, highly specific, double-stranded DNA-binding dye, SYBR Green 
I to detect the PCR product as it accumulates during the PCR reaction. The dye 
is added at the start of the reaction and binds to all double-stranded DNA 
present resulting in the emission of a strong fluorescent signal. Because many 
dye molecules can bind to each DNA product and since the target sequence is 
amplified as the PCR cycle progresses, the intensity of signal generated is high 
and proportional to the total mass of DNA generated during the PCR reaction. 
Primer pairs for genes of interest were designed and optimised using 
Primer3Plus (see section 2.10) for use with SYBR Green I assay. 
 
2.16.1 QPCR workflow 
Following the synthesis of cDNA from isolated RNA, a serial dilution of the cDNA 
with nuclease-free water was carried out to determine the efficiency of the 
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qPRC. An appropriate volume of PCR master mix (10 µl) containing SYBR 
Green dye, buffer, thermostable hot-start recombinant Taq DNA Polymerase and 
deoxynucleotides (dNTPs) was added to 3 µl of nuclease-free water. A separate 
mixture of 1 µl of each primer stock solution and 5 µl of template cDNA was also 
prepared. Both master mix and stock mix were mixed together in the appropriate 
reaction tubes (0.2 ml strip-capped tubes by pipetting to give a final reaction 
volume of 20 µl. A separate no-template reaction mixture was also set up as 
control. All samples were prepared in triplicate. The tubes were then placed in an 
MxPro – Mx3005P thermocycler (Agilent Technologies) and run after setting the 
programme using the following thermal cycling parameters:  95 ˚C for 10 
minutes, followed by 40 cycles of 95 ˚C for 15 seconds, 60 ˚C for 1 minute and 
then one cycle of 95 ˚C for 1 minute, 55 ˚C for 30seconds, 95 ˚C for 30 seconds.  
 
2.16.2 QPCR data analysis 
The experimental procedures outlined above were aimed at the determination of 
fold changes in the expression levels of the genes of interest. The fold change in 
the expression levels of all genes of interest relative to control was calculated 
using the comparative CT method (the ∆∆CT method) (Livak and Schmittgen, 
2001). The threshold cycle (CT) values (a threshold for detection of DNA-based 
fluorescence when the level of fluorescence gives signal above the background) 
were obtained. These CT values were normalised to two housekeeping genes to 
give the ∆CT value by subtracting the geometric mean of the housekeeping 
genes CT value from the average CT value of the gene of interest (∆CT = CT gene 
of interest – CT housekeeping gene). The ∆∆CT value was then calculated by 
subtracting the ∆CT of the untreated sample (control) from the ∆CT of the gene of 
interest (∆∆CT = ∆CT gene of interest - ∆CT untreated control). This value was 
then substituted into the equation 2‾∆∆Ct (2= fold change in PCR products 
between cycles, ∆∆CT = normalised cycle changes between gene of interest and 
untreated control), to get the fold change. CT values were averaged across 
triplicates and delta CT values were calculated between each test gene and 
control. 
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2.16.3 Reference genes 
Reference or housekeeping genes are used to normalise data in qPCR 
experiments to eliminate, as much as possible, errors arising from biological 
variation of samples (Vandesompele et al. 2009) or experimental errors 
introduced as a result of variation in instrumentation or pipetting techniques 
(Dheda, Huggett et al. 2005). A normalisation strategy based on the use of a 
single housekeeping gene leads to relatively large errors while the use of 
multiple validated stably expressed housekeeping genes for normalisation gives 
a more accurate result (Vandesompele et al. 2002). For this reason, two 
housekeeping genes, α-tubulin and β-tubulin were used as reference genes to 
normalise for gene expression. 
 
2.16.4 Sensitivity and specificity of primer sets for QPCR 
Primer sets used in QPCR reactions were tested in PCR assays against cDNA 
samples. Ten-fold dilution series of cDNA samples were used to test the 
efficiency of PCR amplification used for each primer set. Individual PCR assays 
were performed at each dilution using a reaction volume of 20 µl (3 µl of 
nuclease-free water, 10 µl of PCR master mix, 1 µl each of forward and reverse 
primers and 5 µl of cDNA). Standard curves were generated for each of the 
tested primers to determine the efficiency of the PCR set up. 
 
2.17 Confirmation of gene knockdown and susceptibility to trypanosome 
infection after gene knockdown. 
Flies were fed normal blood meal on the day of emergence (<24 hours post-
eclosion) and unfed flies were discarded. Each fly was then injected with 10 µg 
of dsRNA of genes of interest on the second day. A set of flies were also injected 
with dsRNA-GFP as internal control and another set were left uninjected. All flies 
were then fed trypanosome infected blood meal (T. B. brucei BSFs) 24 hours 
after injection. Again flies that did not take infective blood meal were discarded. 
Flies were dissected 7 days after infection, scored for trypanosome infection and 
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midgut tissues extracted. Midguts were shredded into 50 µl of phosphate 
buffered saline (PBS) on a clean glass slide and observed under light 
microscopy (x40 magnification) to search for motile trypanosomes and establish 
the presence of infection. Extracted midgut tissues were collected in 1.5 ml 
Eppendorf tubes and snap-frozen in liquid nitrogen, and later stored at -80 °C 
until QPCR analysis. 
 
2.18 SDS-PAGE and Western blot analysis 
Western blot analysis is a combination of electrophoretic separation of proteins 
and immunological detection, since proteins are separated by size 
electrophoretically and then detected immunologically by specifically directed 
antibodies. The technique essentially confirms the presence of a target protein in 
any given sample as well as compares the relative levels of protein expression 
between samples.   
 
2.18.1 Separation of proteins by gel electrophoresis 
To separate proteins, the sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) is commonly used. In this method, an electrical 
field is applied which moves through a gel matrix. SDS-PAGE separates proteins 
according to molecular size, just as horizontal agarose gel electrophoresis 
separates DNA molecules, but because DNA molecules are negatively charged, 
they will be pulled toward the positive end of the gel. Proteins, however, are not 
negatively charged and their secondary tertiary structures must be overcome if 
proteins are to be accurately separated based on size. Therefore the treatment 
of proteins with a detergent such as SDS, is to make them unfold into a linear 
shape as well as coating the proteins with a net negative charge, which allows 
them to migrate toward the positive end of the gel and be separated when an 
electrical field is applied.  The incorporation of a reducing agent such as 
dithiothreitol (DTT) in the gel helps in breaking the disulphide bonds holding the 
tertiary structure together. Also heating the protein sample helps in the 
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denaturation and unfolding process allowing chemicals such as SDS and DTT to 
interact with the protein. The SDS-coated protein molecules move through the 
pores of the gel matrix in the presence of an electrical field, with smaller 
molecular weight proteins moving more quickly than larger ones. The proteins in 
the sample are therefore separated according to their relative molecular weight 
and size. 
 
2.18.2 Detection of bound antibody 
After separation, the proteins are transferred from the gel onto a protein-binding 
membrane. All of the protein bands that were originally on the gel are transferred 
onto the membrane at the end of the transfer process. Following the transfer of 
proteins onto a membrane, the membrane is blocked to prevent the occurrence 
of any non-specific reaction. After this the membrane is incubated with a primary 
antibody that specifically binds to the target protein. Any unbound antibody is 
washed away at the end of the incubation leaving only the bound antibody to the 
protein of interest. The membrane is then incubated with another (secondary) 
antibody that is able to recognise and bind to the first antibody. The secondary 
antibody is conjugated with an enzyme that produces colour or light which can 
be detected. 
 
2.19 Timecourse analysis of PLA2 expression in the midgut after 
trypanosome and bacterial infection 
Time course experiments were carried out to monitor the expression of PLA2 in 
the midgut following trypanosome and bacterial challenge as described below. 
 
2.19.1 Timecourse analysis of PLA2 expression after infection with BSF 
trypanosomes 
To monitor the expression of sPLA2 in the midgut of tsetse over the course of 
trypanosome infection, a time course experiment using midguts taken at different 
time points (0, 5, 10, 14 and 15 days post-infection) was performed to measure 
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PLA2 transcript expression. Flies were dissected to collect midgut tissues from 
infected flies at the time points stated above, snap-frozen in liquid nitrogen and 
subsequently stored at -80 °C. These samples were later analysed for PLA2 
transcript expression using qPCR.  
 
2.19.2 Timecourse analysis of sPLA2 expression after infection with PCF 
trypanosomes 
In order to test if the expression of sPLA2 in the midgut of the fly is influenced by 
the differentiation of the parasites into procyclic stage, flies were infected with T. 
b. brucei PCFs. The infectious bloodmeal was prepared as follows: defibrinated 
horse blood (TCS Biologicals, Buckingham, UK) was centrifuged at 2000 rpm for 
10 minutes, and pelleted (RBCs) were washed three times in complete SDM-79 
medium without antibiotics. Procyclic forms of TSW 196 were grown for one 
passage in SDM-79 medium without antibiotics. This was centrifuged at 1500 
rpm for 5 minutes to collect the cells. The cells were washed three times in SDM-
79 containing 10% FBS without antibiotics. The washed red blood cells were 
reconstituted to 5 ml with SDM-79 medium containing 10% FBS plus PCF 
TSW196. Two concentrations (1 x 105 ml‾ˡ and 1 x 106 ml‾ˡ) were prepared. 
Teneral flies were then infected by artificial feeding on a silicone membrane. 
Flies were dissected to collect midgut tissues at the same time points as above 
and analysed for sPLA2 transcript expression as previously stated (see section 
2.16.1). 
 
2.19.3 Timecourse analysis of sPLA2 expression after infection with heat-
killed PCFs 
To check if the expression of sPLA2 is triggered just by the presence of 
trypanosomes, flies were challenged with blood meal containing heat-killed 
procyclic forms of TSW196. Procyclic forms trypanosomes were inactivated by 
heat treatment. The log phase culture in SDM79 10% FBS was heated at 58 °C 
for 5 minutes.  Cells were checked for viability to ensure that the cells were all 
dead by staining 100 µl of heat-killed procyclics with 3mM methylene blue (final 
concentration) for 15 minutes at room temperature, in the dark. Then 1mL of 
71 
 
SDM79 was added and centrifuged at 2000 rpm for 5 minutes to pellet the cells. 
The cells were then re-suspended in 200 µl of SDM79 and later added to 5 ml 
washed horse RBCs to give a final concentration of 1 x 107 ml‾ˡ and fed to teneral 
flies by artificial feeding on a silicone membrane. Flies were dissected to collect 
midgut tissues at the same time points and analysed for sPLA2 transcript 
expression as previously stated (see section 2.16.1). 
 
2.19.4 Timecourse analysis of sPLA2 expression after challenge with 
bacteria 
E. coli strain K12 RM148 and S. aureus strain SH1000 were grown in LB broth 
and incubated overnight at 37°C with shaking. Bacterial suspensions were 
prepared and adjusted to OD600=0.5 in LB broth. The infectious blood meal was 
prepared by mixing 100 µl of bacterial suspension with 1 ml of defibrinated horse 
blood and subsequently fed to flies. Flies that did not take the blood meal were 
discarded. Flies were dissected at the same time points as stated in section 
2.16.1 to extract midgut tissues for analysis of sPLA2 transcript expression as 
previously stated (see section 2.16.1). 
 
2.19.5 Timecourse analysis of PLA2 expression after challenge with heat-
killed bacteria 
To see if the expression of sPLA2 can be triggered by challenging tsetse with 
dead bacteria, flies were challenged. Bacterial suspensions were prepared to an 
OD600=0.5. Heat-killed bacteria were prepared by incubating E. coli cells at 
75°C for 10 minutes and S. aureus cells at 100°C for 35 min. Bacterial death was 
confirmed by inoculating 5 ml LB liquid culture and streaking 200 µl of each heat-
killed E. coli and S. aureus onto LB plates and incubated overnight at 37 °C. 
These produced no growth after 24 hours. The heat-killed bacteria (500 µl) were 
diluted in 450 µl defibrinated horse blood which was subsequently fed to flies. 
Flies that did not take the blood meal were discarded. Flies were again dissected 
at the same time points as stated in section 2.16.1 to extract midgut tissues for 
analysis of PLA2 transcript expression as previously stated (see section 2.16.1). 
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2.20 Western blot analysis of sPLA2 expression after gene knockdown and 
at different time points after infection of tsetse with T. b. brucei 
12.5% polyacrylamide resolving mini gel (40% (w/v) Acrylamide/Bis-acrylamide; 
1.5 M Tris-Cl; 0.1% (w/v) SDS; 0.05% (w/v) ammonium persulfate (APS); 0.5% 
(v/v) tetramethyleneethylenediamine (TEMED)) was cast at 1.50 mm thickness 
and allowed to set. Once set, the resolving gel was topped with 3% stacking gel 
(40% (w/v) Acrylamide/Bis-acrylamide; 0.5 M Tris-Cl; 1% (w/v) SDS; 0.1% (w/v) 
APS; 0.08% (v/v) TEMED). Protein samples from midgut tissues were used for 
western blot analysis. Samples were mixed with an equal volume of Laemmli 
buffer (0.5 M Tris-Cl, 4% SDS, 20% glycerol, 0.2% bromophenol blue, 3% DTT), 
boiled at 95°C for ten minutes, then samples and molecular weight markers 
(prestained protein marker,  broad range (6-175 kDa); New England Biolabs, 
Herts, UK) were loaded on 12.5% SDS polyacrylamide gel, then run at 200 V for 
45 minutes in running buffer (0.025 M Tris, 0.192 M Glycine, 0.1% SDS pH 8.3) 
at room temperature. Proteins were transferred to HybondTM-P polyvinylidene 
difluoride (PVDF) transfer membrane (Amersham Biosciences, Ersham UK) and 
soaked in blocking buffer (5% skimmed dry milk in Tris Buffered Saline (TBS) 
buffer (pH of 7.4 and 0.01 M Tris Base, 153 mM NaCl)) for 1 hour.  
Membrane was incubated overnight at 4°C in anti-sPLA2 goat polyclonal 
antibody (Santa Cruz Biotechnology) diluted 1:200 in TBST (TBS with 1% Tween 
20 and 2% skimmed dry milk). The following the day, membrane was washed in 
TBST and then incubated for 2 hours with gentle shaking at room temperature in 
1:50000 mouse anti-goat IgG HRPO (Santa z Biotechnology, Santa Cruz, CA). 
Membrane was washed in TBST and HRPO chemiluminescent substrate (Super 
signal West Dura peroxide buffer and Super signal West Dura Luminol/ 
Enhancer solution) (Thermo Fisher Scientific Inc. Rockford, IL)  was 
subsequently added. Kodak Biomax MR Film (Eastman Kodak Company, 
Rochester, NY) was used for chemiluminescence detection. PVDF membrane 
was stained with 0.2% (w/v) nigrosine. The developed film was superimposed on 
the stained PVDF membrane to indicate the precise location of protein bands 
and to establish that equal loading of protein per lane was achieved.  
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2.21 Expression and purification of G. m. morsitans recombinant sPLA2 
protein 
Both the expression and purification of G. m. morsitans PLA2 were done in 
collaboration with Dr. Martin J. Boulanger (University of Victoria, Canada). 
Briefly, a clone encoding Glossina morsitans sPLA2 (aa 4-173) was generated in 
a modified pAcGP67 vector incorporating an N-terminal hexahistidine tag and 
TEV cleavage site. To generate PLA2 (4-173) encoding virus for insect cell 
protein production, the PLA2 clone was transfected with linearized baculovirus 
into Sf-9 cells as follows: 2ml of Sf-9 cells at 0.46 x 106 cells/ml were allowed to 
adhere to the surface of a 6-well tissue culture plate for ~30minutes to form a 
confluent monolayer. Expression was performed by transfecting Hi-5 cells for 48 
hours, after which time the supernatant was harvested, concentrated, and buffer 
exchanged into Binding buffer (50 mM Tris-HCL, pH 8.0, 200 mM CaCl2, 200 
mM KCl, 30 mM imidazole, 0.05% triton x-100). The expressed protein was 
affinity purified using 2.0 ml nickel beads. Protein was eluted using elution buffer 
(50 mM Tris-HCL, pH8, 200 mM CaCl2, 200 mM KCl, 250 mM imidazole, 0.05% 
triton X-100), analyzed by SDS-PAGE, pooled and concentrated. From 3.2 L of 
cells, 1.33 mg of protein was purified. 
 
2.22 Measurement of G. morsitans rec-sPLA2 activity 
PLA2s are soluble in water, but their activity is greatly enhanced in lipid 
interfaces. Radiometric methods are mostly used for the measurement of PLA2 
activity because of their high sensitivity and selectivity, but they are laborious, 
expensive, involves radiochemical hazards and often require chromatographic 
purification of the products (Kitsiouli et al., 1999). The activity of rec-sPLA2 was 
measured  by a fluorimetric method (Kitsiouli et al., 1999) using the fluorescent 
phospholipid 1-palmitoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-
yl)amino]dodecanoyl]-sn-glycero-3-phosphocholine (C12-NBD-PC) (Avanti Polar 
Lipids, Alabaster, AL) as the substrate in the presence of bovine serum albumin 
(BSA) (Kitsiouli et al., 1999). Briefly, the fluorimetric phospholipid was dissolved 
in chloroform to prepare 20 µM stock solution and 10% bovine serum albumin 
was prepared in sterilized distilled water. The reaction mixture (1 ml final volume) 
was prepared by sequentially adding 50 mM Tris-HCL buffer (pH 8.0), 20 mM 
CaCl2 and enzyme extract. The reaction was initiated by addition of 20 µM C12-
NBD-PC substrate and subsequently fluorescence intensity was continuously 
74 
 
monitored with VarioskanTM Flash Multimode Reader (Thermo ScientificTM, 
Waltham, MA). Excitation and emission wavelengths were adjusted to 460 nm 
and 534 nm, respectively. The specific enzyme activity was calculated as 
described (Radvanyi et al., 1989). Commercial bee venom PLA2 was used as 
reference enzyme.  These assays were done at LSTM in collaboration with Lívia 
Cardoso, a visitor from Federal University of Rio de Janeiro, Brazil. 
 
2.23 sPLA2 killing Assay                                                                                                                                                                                                                                                                 
To determine if GmPLA2 has trypanocidal activity, a Minimum Inhibitory 
Concentration (MIC) assay was performed on trypanosomes using the 
chromogenic/fluorogenic substrate alarmarBlue (Onyango et al., 2000), as 
previously described (Haines et al., 2003), but slightly modified. Briefly, healthy 
log phase PCF trypanosomes in log phase were adjusted to 2.0x104 cells/mL in 
fresh medium and 100 µl were seeded into wells of a 96-well polypropylene 
microtitre plates with rounded bottom (COSTAR/Corning Inc, Corning, New 
York) already containing serial dilutions of the recombinant G. m. morsitans 
sPLA2. Incubation was performed at 27°C for 66 hours after which 10 µl of 
alamarBlue (BioSource International, Inc, Camarillo, CA) was added to each well 
and the plate was incubated for an additional 6 hours making a final incubation 
period of 72 hours. At the end of the final incubation, 70 µl of cell free 
supernatant from each well were transferred into a 96-well flat-bottomed 
black/white microplate (Greiner Bio-One, CellStar, Brockville ON) for 
measurement of fluorescence using a Cytoflour 2300 microplate reader 
(Millipore, Bedford, MA). Excitation and emission wavelengths were adjusted to 
540 nm and 590 nm respectively. The alamarBlue assay is a bioassay that 
combines both fluorimetric and colorimetric growth indicators based on detection 
of mitochondrial activity (Ahmed et al., 1994). The bioassay incorporates an 
oxidation-reduction indicator that responds to chemical reduction of a growth 
medium by metabolically active cells by way of fluorescence and colour change 
(Lancaster and Fields, 1997). A chemical reduction of alamarBlue occurs as a 
result of the metabolic activity of cells which causes the indicator to change from 
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oxidised (blue, non-fluorescent) to reduced (red, fluorescent). These assays 
were performed in collaboration with Lívia Cardoso. 
 
 
2.24 Roche 454 sequencing data 
Two groups of teneral flies were fed defibrinated horse blood on the day of 
emergence. Group 1 was maintained on defibrinated horse blood every two days 
while group 2 was infected with bloodstream form T. b. brucei TSW196 on the 
fourth blood meal.  Both groups were dissected 3 days later and the midguts 
were carefully extracted and snap-frozen in an RNAse-free Eppendorf. Total 
RNA was extracted and quality assured using a bioanalyzer.  A cDNA library for 
the two groups was prepared using SMARTer PCR and cDNA synthesis 
(Clontech, Mountain View, US), according to the manufacturer‟s instructions. 
Briefly, 1 µl of total RNA was added to 1 µl of 3′ SMART CDS Primer II A (12 µM) 
followed by mixing in2.4 µl of NFW with a pipette. The mixture was centrifuged 
briefly and incubated at 72˚C in a thermal cycler for 3 minutes and then at 42˚C 
for 2 minutes. The master mix was added in the following order: 2 µl of 5X First-
Strand Buffer; 0.25 µl DTT (100 mM); 1 µl dNTP Mix (10 mM ); 1 µl SMARTer II 
A Oligonucleotide (12 μM); 0.25 µl RNase Inhibitor; 1 µl SMARTScribe Reverse 
Transcriptase (100 U) (added just prior to use). This was incubated at 42°C for 1 
hour followed by 10 minutes at 70˚C to inactivate the reaction.  
The cDNA produced was sequenced using the 454 sequencing platform at the 
Genomics Suite, University of Liverpool. The transcriptome data comprised of 
reads from control (uninfected) flies and flies fed an infective bloodmeal 
containing T. b. brucei TSW196. This latter group contained a mixture of self-
cured (refractory) and infected (susceptible) flies, however susceptibility to 
trypanosomes introduced at the 4th bloodmeal is typically less than 5%.  
Consequently, this group is deemed naturally refractory to infection.  To maintain 
high transcript integrity, the midguts were quickly excised and frozen and 
consequently, not screened for infection prevalence. We therefore refer to these 
two groups of flies as „control flies (Group 1) vs trypanosome-challenged (Group 
2)‟.  
 
76 
 
2.25 Statistical analysis 
Each experiment was repeated independently three times. Error bars represent 
the standard error of the mean of three replicates. Statistical significance of 
results was calculated using standard paired sample t-test and considered 
significant if p-values were lower than 0.05. Level of significance is indicated by 
asterisks, *p < 0.05, **p < 0.01, ***p < 0.001 
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                                                CHAPTER 3  
                    Bioinformatic analysis of differentially expressed   
midgut genes in   refractory G. m. morsitans 
 
3.1 Introduction 
Trypanosomes undergo a complex life cycle in the fly involving a series of 
morphological and biochemical changes that culminate in the development of 
mammalian infective metacyclics in the salivary glands (T. brucei) or the 
mouthparts (T. congolense). Once in the fly‟s midgut, the stumpy forms which 
are thought to be pre-adapted for life in the tsetse midgut differentiate into 
procyclics (Savage et al., 2012, MacGregor and Matthews, 2010). However, the 
majority of flies can effectively  eliminate the parasites before they develop 
further (Aksoy et al., 2003). One would expect that as a result of the high 
disease burden in Africa, there would be a corresponding large number of flies 
that are also infected, yet paradoxically, just very few number of flies (<5%) can 
actually transmit the parasites to susceptible mammalian hosts (Aksoy et al., 
2003). Even under ideal laboratory conditions, where each experimental fly takes 
an infected blood meal, the proportion of flies that harbour infective metacyclic 
trypanosomes are low (Rio et al., 2004, Aksoy et al., 2003). This means that 
tsetse flies are generally resistant to trypanosome infection, but the molecular 
mechanisms underlying this phenomenon are yet to be elucidated. Unravelling 
the molecular mechanism underlying tsetse-trypanosome interaction has 
remained elusive despite the immense amount of research associated with it.  
A crucial step in the development of trypanosomes occurs when the parasites 
invade the fly midgut where they must survive in order to continue their 
developmental cycle. It follows therefore that for trypanosomes to have a chance 
of completing their life cycle in the fly they must first of all establish infection in 
the midgut of the fly. The life cycle of trypanosomes in the fly can be said to 
occur in two phases: firstly, the differentiation, colonisation, and proliferation in 
the midgut, and secondly, the migration, to the salivary glands or mouthparts 
(characterised by several rounds of differentiation) where the parasites mature 
into metacyclic forms which are capable of infecting new mammalian hosts 
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(Vassella et al., 2000). The molecular mechanisms underlying this intricate 
interaction are not fully understood. The tsetse midgut is of tremendous 
importance in the life cycle of trypanosomes, being the first port of call for the 
parasites after they are taken up by a tsetse fly while feeding on an infected 
mammalian host. Here the trypanosomes are met with a completely different 
type of environment, in addition to being exposed to the fly‟s digestive enzymes 
and potent immune molecules; to survive, the trypanosomes must respond to 
these threats to their continued survival in the fly‟s midgut and they do so by 
undergoing series of remarkable biochemical and physiological changes (Aksoy 
et al., 2003). As a result, a molecular cross-talk ensues between the tsetse fly 
and trypanosomes and the parasites can either be stopped in their tracks in the 
midgut or they survive and continue their developmental cycle. So as the fly tries 
to eliminate the parasites, the parasites on their own part try to either evade or 
inactivate the fly‟s immune responses.  
For this reason, what goes on in the midgut between the fly and invading 
trypanosomes is of strategic importance in the development of trypanosomes in 
tsetse fly and also in the quest for an effective and reliable control strategy in the 
fight against African trypanosomiasis. A promising tool in the fight against 
trypanosomiasis is the use of paratransgenetic approach to modulate the 
capacity of the fly to acquire trypanosomes (Cheng and Aksoy, 1999), thereby 
preventing the transmission of the parasites to mammalian hosts. The midgut of 
the fly therefore represents an important point at which to disrupt the life cycle of 
trypanosomes, and hence the transmission of the parasites by the tsetse fly 
vector.  
The advent of next-generation sequencing, in addition to its low cost, has 
enhanced our understanding of the complexity of gene expression, regulation 
and biological pathways as a result of increased transcript coverage (Tariq et al., 
2011). The 454 sequencing platform is fast and offers increased sequencing 
depth of coverage (Metzker, 2009). The analysis of differential expression of 
genes between different experimental conditions, such as differential gene 
expression analysis between uninfected tsetse flies and flies that cleared their 
parasites following challenge with trypanosomes can be accomplished with 454 
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sequencing platform. A 454 sequencing platform was used to sequence midgut 
cDNA from naive flies and flies that cleared their infection following T. b. brucei 
challenge. In this chapter, a bioinformatics analysis of four immune related 
candidate genes, GMOY000153 (Chitinase, CHIT), GMOY002400 (O-GlcNAc 
transferase, OGT), GMOY009713 (secreted phospholipase A2, sPLA2) and 
GMOY006016 (serine proteinase inhibitor, SPI) that were noted to be 
differentially expressed in the midgut of flies that cleared the infection after being 
challenged with T. b. brucei is presented. 
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3.2 Materials and methods 
 
3.2.1 Differential gene expression between uninfected and self-cured flies 
A transcriptome data from a tsetse midgut 454 library consisting of uninfected 
flies that were fed normal blood and flies that cleared the parasites following 
challenge with T. b. brucei, strain TSW196 was kindly provided by Dr. Alistair 
Darby (UoL) for analysis. A tagwise dispersion analysis of the two midgut 
libraries using the bioconductor package, edgeR (Robinson et al., 2010) was 
performed by Alistair Darby which revealed a total of 184 differentially expressed 
genes (p < 0.05) out of which 54 top-ranking ones were selected based on 
highest fold change using arbitrary cut-off values of 1.15 for down-regulated and 
1.2 for up-regulated. Accession numbers of the differentially expressed genes 
were used to retrieve their protein sequences from NCBI and Gene Ontology 
analysis was carried out using Blast2GO (Conesa et al., 2005) to reveal the 
functional categories of these genes. 
 
3.2.2 Sequence analyses 
Nucleic acid and protein sequences for GMOY000153 (Chitinase), 
GMOY002400 (O-GlcNAc transferase), GMOY009713 (phospholipase A2) and 
GMOY006016 (serine proteinase inhibitor) were downloaded for analysis from 
the G. m. morsitans genome assembly database in VectorBase 
(https://www.vectorbase.org/) and Geneious Basic (Kearse et al., 2012). The 
sequences were analysed for the presence of post-translational modifications 
and conserved motifs. The presence of potential signal peptides were analysed 
using the SignalP 4.1 server (http://www.cbs.dtu.dk/services/SignalP/) and 
TargetP 1.1 server (http://www.cbs.dtu.dk/services/TargetP/). The membrane 
topologies were predicted using the TMHMM server v. 2.0 
(http://www.cbs.dtu.dk/services/TMHMM/) and Phobius (Kall et al., 2004), a 
combined transmembrane topology and signal peptide predictor. The protein 
sequences were analysed to identify functional domains using various 
programmes including the Simple Modular Architecture Research Tool (SMART) 
(Schultz et al., 1998, Letunic et al., 2014), the PROSITE dictionary of protein 
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sites and motif patterns (Gasteiger et al., 2003), PATTINPROT (Combet et al., 
2000), a programme used to identify recurring patterns in proteins and TPRpred, 
a tool for prediction of sequence repeats from protein sequences (Biegert et al., 
2006). Also the NetPhos 2.0 server (http://www.cbs.dtu.dk/services/NetPhos/) 
was used to predict the presence of phosphorylation sites. 
 
3.2.3 Phylogenetic analyses 
In order to investigate the evolutionary relationship of the candidate genes to 
various species, the predicted protein sequences of G. m. morsitans chitinase 
(GMOY000153), OGT (GMOY002400), PLA2 (GMOY009713) and SPI 
(GMOY006016) were aligned using MUSCLE with corresponding genes from 
other species obtained from GenBank NCBI,  a bootstrapped maximum 
likelihood tree was generated using PhyML 3.0. The analysis was carried out 
using Phylogeny.fr (Dereeper et al., 2008), a web-based service dedicated to 
reconstruction and analysis of phylogenetic relationships between molecular 
sequences. 
 
3.2.4 Homology modelling 
Homology modelling was carried out to predict the three dimensional (3D) 
structures of GMOY000153, GMOY002400, GMOY009713 and GMOY006016. 
The amino acid sequences of the genes were downloaded from VectorBase and 
uploaded separately to Phyre2 (Kelley and Sternberg, 2009), ModWeb (Eswar et 
al., 2003), CPHmodels 3.2 (Nielsen et al., 2010) and RaptorX (Kallberg et al., 
2012) homology modelling servers. Structure refinement of the predicted models 
was done by ModRefiner (Xu and Zhang, 2011), while the quality of the 
predicted protein structures were evaluated using QMEAN (Qualitative Model 
Energy Analysis). Rampage was also used to depict the Ramachandran plots for 
each predicted 3D structure after refinement. 
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3.2.5 Ligand binding site predictions 
Cofactor, a comparative algorithm for structure-based biological function 
annotation of protein molecules (Roy et al., 2012) was used to predict amino 
acids involved in ligand binding sites.  
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3.3 Results 
 
3.3.1 Differential gene expression between uninfected and self cured flies 
A tagwise dispersion analysis (by Dr. Alistair Darby) of the two midgut libraries 
(flies challenged with trypanosomes and flies fed normal blood) revealed a total 
of 184 differentially expressed genes (p < 0.05) out of which 55 top-ranking ones 
were selected based on highest fold change, using cut-off values of 1.15 for 
down-regulated genes and 1.2 for up-regulated genes (by Alistair Darby). Of 
these, 38 genes (69%) were down-regulated while 17 genes (31%) were up-
regulated (Tables 3.1 & 3.2). Gene Ontology analysis was carried out using 
Blast2GO (Conesa et al., 2005) to reveal the functional categories of these 
genes. The genes were assigned to three main categories as follows: 56% were 
assigned to biological process, 25% to molecular function, and 19% to cellular 
component for up-regulated genes in flies challenged with trypanosomes (Figure 
3.1). 
 In the same set of flies challenged with trypanosomes, down-regulated genes 
included 52% of genes involved in biological process, 26% involved in molecular 
process and 22% cellular component (Figure 3.2). Within each of these 
categories, genes involved in cellular processes (cell cycle and transmembrane 
transport proteins), metabolic processes (oxidation-reduction, biosynthetic and 
lipid metabolism), response to stimuli, immune system processes, single-
organism process, biological regulation, signalling, cell death, organelle, and 
binding were the most abundant (Figures 3.1 and 3.2). 
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Figure 3.11 Gene ontology (GO) terms distribution of BLAST hits of 
upregulated genes from refractory flies. Gene ontology analysis was used to 
categorize the functional distribution of the genes sequenced in this study. For 
up-regulated genes, 56% were involved biological processes, 25% in molecular 
function and 19% in cellular component. 
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Figure 3.2 Gene ontology (GO) terms distribution of BLAST hits of 
downregulated genes from refractory flies. Gene ontology analysis was 
used to categorize the functional distribution of the genes sequenced in this 
study. For down-regulated genes, 52% were assigned to biological processes, 
26% to molecular function and 22% to cellular component. 
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Table 3.1 List of genes that are downregulated (P<0.05) in trypanosome fed 
flies. Genes are listed with accession numbers, description and in descending 
order of fold change (highest fold change at the top) 
Gene symbol Description Comments 
GMOY006073 Homogentisate 1,2-dioxygenase Oxidoreductase activity 
GMOY005501 Synaptic vesicle transporter sVOP Transmembrane transport 
GMOY004234 Fuseless Clustering of voltage-gated calcium 
channels, neuromuscular synaptic 
transmission,neuron-neuronsynaptic 
transmission 
GMOY000550 Hypothetical protein Sulfate transmembrane transporter 
activity, secondary active sulfate 
transmembrane transporter activity 
GMOY005361 Hypothetical conserved protein Hypothetical conserved protein 
GMOY012123 Secreted protein Unknown 
GMOY002485 Hypothetical protein DNA binding 
GMOY010709 Kinase suppressor of ras Protein kinase activity, ATP binding, 
transferase activity, transferring 
phosphorus-containing groups 
GMOY004228 Transferrin 1 Ferric ion binding, immune related 
GMOY009713 Secretory phospholipase isoform a  Phospholipase A2 activity, antibacterial 
GMOY006016 Serine proteinase inhibitor Immune related, Enzyme regulator 
activity 
GMOY000153 Chitinase Chit1 precursor Immune related, hydrolase activity, 
acting on glycosyl bonds, 
GMOY012079 Aquaporin; integral protein b Transporter activity 
GMOY009897 Pyrimidine metabolism Nuclease activity, RNA binding, 
nucleotidyltransferase activity 
GMOY007187 Hypothetical conserved protein Unknown 
GMOY004228 Transferrin Ion binding 
GMOY008344 Immune   reactive putative protease 
inhibitor PrInh6 
Peptidase activity 
GMOY006243 Elongase 1 Long chain fatty acid elongation 
GMOY003209 Aldehyde dehydrogenase (NAD+) Oxidoreductase activity 
GMOY002314 Proteoglycan 4-like Unknown 
GMOY010150 Carbon-nitrogen hydrolase Hydrolase activity, acting on carbon-
nitrogen (but not peptide) bonds 
GMOY007181 Putative uncharacterized protein Oxidoreductase activity, acting on 
paired donors, with incorporation or 
reduction of molecular oxygen; haeme 
binding 
GMOY012352 Karmoisin Transmembrane transport 
GMOY010589 U6 snRNA-associatiated Sm-like protein 
LSm4/Small nuclear ribonucleoprotein 
Sm D1/D3 
RNA biogenesis and function 
GMOY003693 M13 family peptidase  Metalloendopeptidase activity  
GMOY001312 Glutamic acid-rich protein; Glycoprotein Chitin binding 
GMOY005573 Acid sphingomyelinase  
 
Sphingomyelin phosphodiesterase 
activity; hydrolase activity 
GMOY005361 Hypothetical conserved protein Unknown 
GMOY010934 Glycosyl transferase family 8 glycogenin Transferase activity, transferring 
glycosyl groups 
GMOY010150 Biotinidase Hydrolase activity, acting on carbon-
nitrogen (but not peptide) bonds, in 
linear amides 
GMOY006509 Mitochondrial ribosomal protein pVAR1 Alpha glucosidase 
GMOY001312 Glutamic acid-rich protein Chitin binding 
GMOY000943 Hypothetical protein Protein binding 
GMOY009540 Gmfb8d Unknown 
GMOY005442 Retinoid- and fatty acid-binding 
glycoprotein 
Lipid transporter activity 
GMOY010266 Hypothetical conserved protein Haemolymph coagulation-Toll regulated 
protein in Drosophila 
GMOY003656 Serpin 4 Peptidase activity 
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Table 3.2 List of genes that are upregulated (P<0.05) in trypanosome fed 
flies. Genes are listed with accession numbers, description and in descending 
order of fold change (highest fold change at the top). 
Gene symbol Description Comments 
GMOY002502 Hypothetical protein Protein binding 
GMOY006920 Hypothetical protein Nucleic acid binding, zinc ion binding 
GMOY002400 Super sex combs Portein binding 
GMOY002761 Hypothetical secreted protein Unknown 
GMOY012049 Heat shock protein cognate 4 Nucleotide binding, ATP binding 
GMOY002246 Sphingomyelin phosphodiesterase Sphingomyelin phosphodiesterase 
activity, hydrolase activity 
GMOY002244 F-box protein Protein binding 
GMOY001552 S-malonyltransferase Catalytic activity, transferase activity 
GMOY008700 Hypothetical protein RNA binding, protein binding 
GMOY004897 Hypothetical protein Nucloetide binding, nucleic acid binding 
GMOY010433 Smell impaired 21F Unknown 
GMOY002485 GK17163  Unknown 
GMOY003718 Conserved Zn-finger protein Unknown 
GMOY001280 Starvin Chaperone binding 
GMOY008106 Farnesoic acid O-methyltransferase; 
Hypothetical conserved protein 
Methyltransferase activity, transferase 
activity 
GMOY008065 Decondensation factor 31 Histone binding, chromatin organisation 
in Drosophila 
GMOY006187 Hypothetical protein Unknown 
 
3.3.2 The timecourse of trypanosome elimination in tsetse 
Following the ingestion of trypanosomes by tsetse during an infected blood meal, 
there is the struggle to eliminate the parasites on the part of fly and on the other 
hand the parasites try to establish an infection by manipulating the fly immune 
system. From the pattern of expression of most of the immune related genes 
early on during the infection process, it is hypothesized that following 
trypanosome ingestion, the immune response of the fly is suppressed by the 
actions of the parasites to create a favourable environment for establishment of 
infection. Trypanosomes invade tsetse armed with mechanisms capable of 
inactivating the fly‟s immune response. For instance, T. brucei are known to 
possess ISP1 and ISP2 type of serine peptidase inhibitors but lack genes 
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encoding S1A to which they are highly selective, suggesting that the only targets 
of these ISPs can only be serine proteases from the tsetse host (Lima and 
Mottram, 2010). ISP1 and ISP2 are ecotin-like genes found in trypanosomtids 
and they function as dimeric inhibitors which are highly selective for trypsin-fold 
serine peptidases belonging to the chymotrypsin family (S1A) (Lima and 
Mottram, 2010). Host serine proteases such as chymotrypsin-like enzymes 
found in the gut of the insect vectors are the likely targets of these ISPs 
(Ramalho-Ortigao et al., 2003, Yan et al., 2001).By inactivating proteolytic 
enzymes of the host, the parasites are protected from the proteolytic action of 
the enzymes. Also, T. b. brucei are known to be capable of inhibiting tsetse 
midgut trypsin  (Imbuga et al., 1992a). Although tsetse immune defence system 
already exist before trypanosome invasion, it is expressed at the basic (low) 
level (Beschin et al., 2014) and therefore easier for the parasites to initiate their 
development in the fly without much hindrance, at least during the early stages 
of the infection process before the systematic inducement of the fly defence 
system. The trypanosomes therefore seem to experience an environment within 
the tsetse midgut suited to their unrestricted growth during the early days in the 
infection process after which the tsetse immune system recovers to attack the 
parasites. This means that priming the fly‟s immune system prior to trypanosome 
infection will enhance the elimination of the parasites and this is supported by 
the evidence that when flies are immune-challenged before trypanosome 
infection, they become more resistant to trypanosome infection (Hao et al., 
2001).    
  
3.3.3 Sequence analyses 
GMOY000153 (CHT): The 1,570 bp cDNA of GMOY000153 contained 52 
nucleotides upstream of the initiation codon, AUG representing the partial 5 ′ 
untranslated region (UTR). The open reading frame (ORF) terminates with UAA, 
i.e., 1382 bases downstream from the initiation codon. The insert, therefore, 
codes for a polypeptide of 457 amino acids. There are 135 nucleotides after the 
stop codon, which represents the complete 3′ UTR. Present within the 3′ UTR is 
the putative polyadenylation signal (PAS) (AAUAAA) (Figure 3.3), followed by 
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the poly (A) tail, which occurs 24 nucleotides after the PAS signal. The putative 
protein has a signal peptide with the cleavage site situated between residues 24 
and 25 as determined by SignalP v4.1. Also the online tool TargetP v1.1 
predicted a signal peptide for the sequence as well as predicting that the protein 
is secreted. Using the online servers, TMHMM v2.0 and Phobius, residues 1 to 6 
stay inside the cell, residues 7 to 25 make up the transmembrane helix, while 
residues 26 to 240 are outside the cell, thus confirming the presence of a signal 
peptide in the N-terminal region of the protein. NetPhos 2.0 server predicted the 
presence of multiple phosphorylated sites (Figure 3.4).  
The GMOY000153 protein has the characteristic triosephosphate isomerise 
(TIM) barrel catalytic domain found in family 18 chitinases which consists of the 
consensus motif for the active site made up of the amino acid residues 
FDGIDIDWE (residues, 145 to 153) with the motif DxDxE conserved among all 
the family 18 chitinase members. It also contains the conserved residues YxR 
(amino acid residue 182 to 184) of the chitinase insertion domain (CID) (Figure 
3.3).  
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Figure 3.3  Nucleotide sequence and predicted structure of GmmCHT . The 
nucleotide sequence and deduced amino acid sequence of the protein are 
shown. The underlined regions from residues 1 to 24 represent the signal 
peptide. The red dots and red stars represent the active site residues while the 
red squares indicate the conserved protein residues of the chitinase insertion 
domain (CID). The UAA stop codon is marked in asterisk and the putative 
polyadenylation signal sequence (AAUAAA) is circled in red. 
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Figure 3.4 Prediction of putative post-translational modifications in 
GmmCHT. The FASTA-formated protein sequence of GMOY000153 from G. 
m. morsitans obtained from VectorBase was entered into the NetPhos 2.0 
Server to predict serine (S), threonine (T), and tyrosine (Y) residues that may 
be phosphorylated. Scores above 0.5 are considered significant. The horizontal 
line indicates the 0.5 score threshold. Multiple sites were identified as being 
above the threshold probability value defined by the software. 
 
 
GMOY002400 (OGT): The G. m. morsitans GMOY002400 consists of 4053 base 
pairs encoding a protein of 1093 amino acid residues. The putative protein has 
no signal peptide as determined by SignalP 4.1 server and TargetP v1.1. 
According to NetPhos, GMOY002400 is predicted to be phosphorylated with 
several residues having prediction scores above the threshold (Figure 3.6).  In 
silico sequence analysis identified a tetratricopeptide repeat (TPR)-containing 
domain between amino acid residues 149-522 (Figure 3.5a). TPR is a versatile 
structural motif  present in a  wide range of proteins (Lamb et al., 1995). The 
TPR motif is made up of 3-16 tandem-repeats of 34 amino acid residues and 
mediates protein-protein interactions and the formation of protein complexes 
(D'Andrea and Regan, 2003).  PATTINPROT (Combet et al., 2000), a 
programme used to identify recurring patterns in proteins, TPRpred, a tool 
designed to detect TPR motifs and other patterns of protein repeats by using the 
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profile representation of the known repeats and calculates the statistical 
significance for their occurrence (Biegert et al., 2006) and the Simple Modular 
Architecture Research Tool (SMART), a biological database used for the 
identification and analysis of protein domains within protein sequences (Schultz 
et al., 1998, Letunic et al., 2014), were used to search for TPR sequences. 
PATTINPROT scans a protein sequence or a protein database against one or 
several pattern(s).   
A query sequence pattern consisting of a template sequence of TPR formulated 
using the TPR consensus sequence as reported in literature (Lamb et al., 1995, 
Blatch and Lassle, 1999), was used to search for repeating patterns in our 
protein of interest. The repeat length is 34 amino acids and repeating time is 3, 
using different search stringencies and minimum similarity level of 75%, the 
template specifications based on PROSITE syntax are as follows: X(3)-[WLY]-
X(2)-[LIM]-[GAS]-X(2)-[YLF]-X(8)-[ASE]-X(3)-[FLY]-X(2)-[ASL]-X(4)-[PKE]-X(5)-
[WLY]-X(2)-[LIM]-[GAS]-X(2)-[YLF]-X(8)-[ASE]-X(3)-[FLY]-X(2)-[ASL]-X(4)-
[PKE]-X(5)-[WLY]-X(2)-[LIM]-[GAS]-X(2)-[YLF]-X(8)-[ASE]-X(3)-[FLY]-X(2)-
[ASL]-X(4)-[PKE]-X(5), where X represents arbitrary amino acid and the number 
of repetition is indicated in parenthesis, residues indicated in square parenthesis 
are those allowed at the position. Eleven equal length tandem repeats (ELTR) 
TPRs were identified between residues 149-522 (Figure 3.5a) and the 
consensus sequence that is typical of TPRs are evident (Figure 3.5b). The 
validity of each identified TPR repeats was further confirmed by going through 
the individual annotations and conducting individual BLAST searches of each 
TPR sequence.  
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Figure 3.5 The tetratricopeptide repeat region (TPR) of GmmOGT. (A) 
Schematic of the secondary structure arrangement of the 11 TPR motifs of 
GmmOGT. (B) Alignment of 11 TPRs of GmmOGT. The positions of the 
consensus pattern of conserved residues are numbered on top of the 
alignment. Residue type is highly conserved only at positions 8 (Ala or Gly), 20 
(Ala), and 27 (Ala).  
 
 
Figure 3.6 Prediction of putative post-translational modifications of 
GmmOGT. The FASTA-formated protein sequence of GMOY002400 from G. 
m. morsitans obtained from VectorBase was entered into the NetPhos 2.0 
Server to predict serine (S), threonine (T), and tyrosine (Y) residues that may 
be phosphorylated. Scores above 0.5 are considered significant. The horizontal 
line indicates the 0.5 score threshold. Multiple sites were identified as being 
above the threshold probability value defined by the software. 
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GMOY009713 (sPLA2): Bioinformatic analysis of G. m. morsitans GMOY009713 
revealed 2,600 nucleotide base pairs in which the coding sequence starts at 
base 152 and ends at base 859, encoding a protein of 236 amino acids (Figure 
3.7). Based on analysis using signalP v4.1, the putative protein was predicted to 
have a signal peptide with the cleavage site between residues 25 and 26. Also 
the online software TargetP v1.1, predicted that the protein is secreted to the 
extracellular environment and contains a signal peptide. Using two 
transmembrane topology predictors, TMHMM Server 2.0 (Krogh et al., 2001) and 
Phobius (Kall et al., 2004), the putative protein was found to contain no 
membrane helices. Also it is predicted to be phosphorylated according to 
NetPhos 2.0 server (Figure 3.6). The G. m. morsitans GMOY009713 possesses 
the consensus sequence found in group XIIA PLA2 functional domain, which has 
3 cysteines, with histidine and asparpartic acid in the catalytic site as conserved 
residues (C-C-R-E-H-D-H-C) (Figure 3.6). Another hallmark of the group XIIA 
PLA2 (Nevalainen and Cardoso, 2012) found in G. m. morsitans GMOY009713 
is the Ca2+ binding residues in the conserved glycine (residue 109) and the 
aspartic acid residue in the HD dyad that is found inside the catalytic site. In 
addition, the protein has 14 cysteine residues that form 7 disulphide bonds which 
is another conserved feature of group XIIA PLA2s (Burke and Dennis, 2009). 
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          Figure 3.7 Nucleotide sequence and predicted structure of  
            GMOY009713 (PLA2). 
  
 
  
 
Figure 3.7 Nucleotide sequence and predicted structure of GmmsPLA2. 
Nucleotide sequence of GMOY009713 and deduced amino acid sequence of 
the protein. The numbering for each sequence is shown on the left. The 
underlined region (residues 1-25) represents the signal peptide. The red dots 
and stars represent the PLA2 consensus sequence with the histidine residue 
on the active site circled. The 14 cysteine residues that form 7 disulfide bonds 
are numbered 1-14 while the arrows indicate the Ca2+ binding loop residues, 
both are characteristic features of group XIIA sPLA2s in arthropods. 
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Figure 3.8 Prediction of putative post-translational modifications in 
GMOY009713. The FASTA-formated protein sequence of GMOY009713 from 
G. m. morsitans obtained from VectorBase was entered into the NetPhos 2.0 
Server to predict serine (S), threonine (T), and tyrosine (Y) residues that may 
be phosphorylated. Scores above 0.5 are considered significant. The horizontal 
line indicates the 0.5 score threshold. Few sites were identified as being above 
the threshold probability value defined by the software. 
 
GMOY006016 (SPI): To characterise the G. m. morsitans-derived serine 
proteinase inhibitor (Serpin), a database search was conducted by running a 
local BLASTp search against the protein database of G. m. morsitans in 
VectorBase, the corresponding gene which belongs to the kunitz (bovine 
pancreatic trypsin inhibitor) family contained two Kunitz domains (Figure 3.9). 
Using SignalP v4.0, a signal peptide was identified with the cleavage site 
between residues 17 and 18 (Figure 3.9). The online programme TargetP v1.1 
also predicted a signal peptide for the sequence and also indicating that the 
protein is secreted to the extracellular environment. Using TMHMM server v2.0 
and Phobius, the protein was found to be devoid of any transmembrane helix. 
Using NetPhos 2.0 the sequence was found to be phosphorylated (Figure 3.10). 
Analysis of the peptide sequence showed similarity to other members of the 
Kunitz-type serine proteinase inhibitor families that are characterised by 
distinctive features such as the possession of single or multiple kunitz inhibitory 
domains comprising highly conserved cysteine residues that form disulphide 
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bridges and a putative P1 (Lys) inhibitory reactive site. According to the protein 
prediction programme, Scratch Protein Predictor (Cheng et al., 2005), the 
putative protein is predicted to have two kunitz inhibitory domains with six 
disulphide bonds formed by twelve cysteine residues at positions 16, 25, 39, 56, 
64, 77, 99, 116, 124, 137, 152 and 161  and P1 (Lys 26) residue (Figure 3.9). 
Predicted disulphide bonds (cysteine pairs) are as follows: 
                                    Bond Index     Cys1 Position     Cys2 Position 
                                                  1                      16                     25 
                                                  2                      116                   137 
                                                  3                      56                     77 
                                                  4                      39                     64 
                                                  5                      152                   161 
                                                  6                       99                    124 
These features suggest that GMOY006016 is similar to other Kunitz-type serine 
proteinase inhibitors structurally and functionally.  
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              Figure 3.9 Nucleotide sequence and predicted structure of GMOY006016 
 
Figure 3.9 The nucleotide sequence and predicted structure of 
GmmSPI. The nucleotide sequence of GMOY006016 and the deduced 
amino acids sequence are shown. The start codon (ATG) is circled, and the 
termination codon is indicated with an asterisk. The 12 cysteine residues 
that form 6 disulfide bonds (representing 2 Kunitz inhibitory domains) are 
numbered 1-12. The predicted signal peptide (residues 1-16) is underlined 
while the putative inhibitory reactive site (P1) position is circled. 
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Figure 3.10 Prediction of putative post-translational modifications in 
GMOY006016. The FASTA-formated protein sequence of GMOY006016 from G. 
m. morsitans obtained from VectorBase was entered into the NetPhos 2.0 
Server to predict serine (S), threonine (T), and tyrosine (Y) residues that may be 
phosphorylated. Scores above 0.5 are considered significant. The horizontal line 
indicates the 0.5 score threshold. Few sites were identified as being above the 
threshold probability value defined by the software. 
 
3.3.3 Phylogenetic analysis 
A comprehensive analysis was carried out to determine the evolutionary 
relationship of G. m. morsitans chitinase to chitinases derived from various 
species. The deduced amino acid sequence from GMOY000153 was used to run 
a BLASTp search against the GenBank NCBI. A total of 34 chitinase sequences 
(Table 3.3) representing all the major phyla were selected and a multiple 
sequence alignment was created using MUSCLE. A bootstrapped maximum 
likelihood tree was created using PhyML 3.0 and further analysis was carried out 
as described (Dereeper et al., 2008). A summary of the analysis shows that the 
chitinase sequences were clustered into two main clades, one containing the 
vertebrates and invertebrates subgroups and the other formed by the bacteria, 
fungi and viruses subgroups (Figure 3.11). The tsetse chitinase (GMOY000153) 
is more closely related to Drosophila chitinases than to other members of the 
Diptera, indicating that tsetse and Drosophila chitinases had a common origin. 
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Figure 3.11 Phylogenetic analysis of GmmCHT based on amino acid 
sequence of G. m. morsitans and other organisms. Phylogenetic tree was 
constructed by neighbor-joining criteria with the bootstrap replicates set at 
1000. Taxa complete names and the accession numbers of the sequences 
used in the analysis are shown in Table 3.3. 
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Table 3.3 List of chitinase and chitinase-like genes used in phylogenetic 
construction 
Gene Species Accession Number 
Chitinase Aedes aegypti AAZ39947.1 
Chitinase Autographa californica 
nucleopolyhedrovirus 
AAA66756.1 
chitotriosidase-1-like Bombus impatiens XP_003488774.1 
Chitinase Bombyx mori 
nucleopolyhedrovirus 
NP_047523.1 
microfilarial 
chitinase, partial 
Brugia pahangi AAC47324.1 
chitinase precursor Bos taurus NP_777124.1 
chitinase precursor Bombyx mori BAB20017.1 
Acidic mammalian 
chitinase 
Calypte anna KFP05197.1 
Chitnase Choristoneura fumiferana AAM43792.1 
chitotriosidase-1 Culex quinquefasciatus XP_001841678.1 
GH20466 Drosophila grimshawi XP_001986549.1 
Chtinase 4 Drosophila melanogaster NP_524962.2 
Zgc:65788 protein, 
partial 
Danio rerio AAH46004.1 
GJ21926 Drosophila virilis XP_002050059.1 
GK22944 Drosophila willistoni XP_002074826.1 
GMOY000153 G. morsitans morsitans  AAL65401.1 
chitinase, partial Grifola umbellata AAO42981.1 
chitinase Histoplasma capsulatum AAF80370.1 
 Hyphantria cunea 
nucleopolyhedrovirus 
AAD31762.1 
Chitinase 3-like 1 Homo sapiens AAH38354.1 
chitinase-3-like Homo sapiens NP_003991.2 
chitinase Lymantria dispar 
nucleopolyhedrovirus 
NP_047707.1 
acidic mammalian 
chitinase 
Mus musculus AAG60018.1 
Chtinase Paraphaeosphaeria minitans AAG00504.1 
midgut chitinase Phlebotomus papatasi AAV49322.1 
Chtinase Spodoptera  exigua 
nucleopolyhedrovirus 
AAF33549.1 
exochitinase Sodalis glossinidius CAA72201.1 
Chtinase Spodoptera litura 
nucleopolyhedrovirus 
NP_258310.1 
Chtinase Serratia plymuthica CAD32933.1 
Endochitinase Trichoderma asperellum AAF19624.1 
Chitinase Trichoderma virens AAL78812.1 
Chitinase B Vibrio alginolyticus BAB21607.1 
Chitinase Vibrio anguillarum BAA78114.1 
chitinase A 
precursor 
Vibrio harveyi AAK11576.1 
putative chitinase Xenorhabdus nematophila CAC38398.1 
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Phylogenetic analysis was also performed to determine the evolutionary 
relationship of GMOY002400 with other OGTs from various species.  The result 
of the analysis shows that GMOY002400 is more closely related to Drosophila 
OGTs and shares a more distant common ancestry with OGTs from other 
arthropods (Figure 3.12). This is expected since there is synteny between 
Glossina and Drosophila than other arthropods and they therefore may share a 
common ancestry (Attardo et al., 2014). Furthermore, a phylogenetic analysis of 
G. m. morsitans sPLA2 (GMOY009713) and representative group XII PLA2s from 
various species was carried out to determine the evolutionary relationship of 
GMOY009713 to other group XII PLA2 from various species. The phylogenetic 
analysis revealed that the members of the group XII PLA2 are highly conserved 
across the various species and clustered into two main groups namely XIIA and 
XIIB. As expected, GMOY009713 clustered with other arthropod‟s group XIIA 
PLA2s (Figure 3.13), since the arthropods are related to each other and therefore 
a common ancestor. 
          
Figure 3.12 Phylogenetic analysis of OGT based on amino acid sequence 
of G. m. morsitans and other organisms. Phylogenetic tree was produced by 
neighbor-joining criteria with the bootstrap replicates set at 1000. Numbers at 
the branches correspond to % bootstrap values and the scale represents units 
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of amino acid substitutions per site. Taxa complete names and the accession 
numbers of the sequences used in the analysis are shown in Table 3.4. 
 
Table 3.4 List of OGT and OGT-like sequences used in phylogenetic construction 
Gene Species Accession Number 
OGT-1, isoform b Caenorhabditis elegans NP_001040861.1 
OGT Bos taurus NP_001091539.1 
OGT Equus caballus XP_001493422.1 
AGAP006254-PA 
Anopheles gambiae XP_316319.4 
OGT Culex quinquefasciatus XP_001846338.1 
Super sex combs isoform 
B 
Drosophila melanogaster NP_523620.1 
GH21711 Drosophila grimshawi XP_001987067.1 
OGT, putative Phytophthora infestans XP_002896255.1 
OGT, subunit isoform 1 Homo sapiens NP_858058.1 
OGT subunit isoform X1 Anolis carolinensis XP_003228237.1 
Hypothetical protein KGM 
21815 
Danaus plexippus EHJ67792.1 
Hypothetical protein Prochlorococcus marinus WP_011295577.1 
OGT subunit-like Bombyx mori XP_004921733.1 
OGT subunit isoform X4 Gallus gallus XP_004940687.1 
TPR repeat protein 
Janthinobacterium lividum EZP39133.1 
OGT subunit isoform X1 Tribolium castaneum XP_008191442.1 
Hypothetical protein Thiobacillus thioparus WP_026240983.1 
OGT Strongyloides ratti CEF64055.1 
Hypothetical protein Phytophthora sojae XP_009514691.1 
OGT Bactrocera dorsalis XP_011205005.1 
Hypothetical protein Gallionella capsiferriformans WP_041938297.1 
GMOY002400 G. m. morsitans  GMOY002400 
Hypothetical protein 
Calothrix sp.  
WP_042341988.1 
 
A phylogenetic analysis of serine proteinase inhibitors made up of SPI protein 
sequences from arthropods and chordates obtained from GenBank was 
undertaken in order to elucidate the evolutionary relationships of GMOY006016 
with SPIs from various species. Again as expected, GMOY006016 was found to 
be more closely related to Drosophila but shares a more distant common 
ancestry with the SPI from other arthropods (Figure 3.14). 
 
 
104 
 
 
Figure 3.13 Phylogenetic analysis of GmmsPLA2 based on amino acid 
sequence of G. m. morsitans and other organisms including vertebrates 
and invertebrates. Phylogenetic tree was produced by neighbor-joining criteria 
with the bootstrap replicates set at 1000. The tree was constructed with 
representative sequences selected from vertebrates and arthropods.  Taxa 
complete names and the accession numbers of the sequences used in the 
analysis are shown in Table 3.5. Numbers at the branches correspond to % 
bootstrap values and the scale represents units of amino acid substitutions per 
site. 
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Table 3.5 List of PLA2 and PLA2-like genes used in phylogenetic tree construction 
Gene Species Accession Number 
Predicted 
groupXIIA 
PLA2 
Anolis carolinensis XP_003221839.2 
Group XIIA PLA2 Acromyrmex echinatior EGI70870.1 
Predicted GXIIA 
PLA2-like 
Apis florea XP_003694784.1 
Predicted GXIIA 
PLA2 
Arctocephalus forsteri XP_009271911.1 
Predicted GXIIA 
PLA2-like 
Apis mellifera XP_393116.2 
PLA2 group XII Branchiostoma belcheri AEZ56899.1 
Group XIIA PLA2 Camponotus floridanus EFN72747.1 
group XIIB PLA2 Callithrix jacchus XP_009007992.1 
Predicted GXIIB 
PLA2 
Carebera semilaevis XP_008320501.1 
group XIIA PLA2 Equus przewalskii XP_008535645.1 
Predicted GXIIA 
PLA2 
Fukomys damarensis XP_010639903.1 
Predicted PLA2, 
GXIIB 
Gallus gallus XP_421584.1 
PLA2 group XIIA Glossina morsitans (GMOY009713) ADD19849.1 
group XIIA PLA2 Homo sapiens NP_110448.2 
group XIIB PLA2 Homo sapiens NP_115951.2 
group XIIA PLA2 Mus musculus EDL12227.1 
Predicted GXIIA 
PLA2-like 
Megachile rotundata XP_003699810.1 
Group XIIA PLA2 Oncorhynchus mykiss ACO07845.1 
GXIIA PLA2 Pediculus humanus corporis XP_002430693.1 
Group XIIB PLA2 Salmo salar ACI69856.1 
group XIIB Sus scrofa NP_001230267.1 
Group XIIA PLA2 Salmo salar ADM16102.1 
PLA2, group XIIA Xenopus (Silurana) tropicalis AAI57176.1 
group XIIB PLA2 Xenopus (Silurana) tropicalis NP_001007917.1 
Group III sPLA2 Drosophila melanogaster NP_001285008.1 
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Figure 3.14 Phylogenetic analysis of SPI based on amino acidsequence 
from G.m. morsitans and other organisms including insects and human. 
The Phylogenetic tree was constructed with neighbor-joining criteria with 1000 
bootstrap replicates. The SPI proteins comprise three major phylogenetic 
groups. Numbers at the branches represent % bootstrap values. The scale at 
the bottom left is in units of amino acid substitutions per site. Names and the 
accession numbers of the sequences used in the analysis are shown in Table 
3.6. 
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Table 3.6 List of SPI and SPI-like genes used in phylogenetic tree construction 
Gene Species Accession number 
monogrin 1A, partial Argas monolakensis ABI52649.1 
monogrin 1B Argas monolakensis ABI52650.1 
Tick anticoagulant peptide 
(TAP) 
Ornithodoros moubata P17726.1 
Chymotrypsin inhibitor 
precursor 
Rhipicephalus microplus ACF57858.1 
GF16246 Drosophila ananassae XP_001955442.1 
GG11203 Drosophila erecta XP_001982147.1 
Single kunitz protease 
inhibitor 
Simulium vittatum ACH56928.1 
Serine protease inhibitor Haemaphysalis longicornis BAG82647.1 
BPTI-like protease 
inhibitor, partial 
Haematobia irritans irritans AAL87009.1 
Savignygrin Ornithodoros savignyi AAM54048.1 
Kunitz protein 8 Echinococcus granulosus ACM79010.1 
Kunitz/BPTI-like protein 
precursor 
Rhipicephalus appendiculatus ACM86785.1 
Kunitz-type protease 
inhibitor Hg1 
Hadrurus gertschi P0C8W3.1 
Serine protease inhibitor 3 Tabanus yao ACS72290.1 
fXa inhibitor fXaI Ornithodoros savignyi AAN76827.1 
Kunitz-type trypsin 
inhibitor 
Haemaphysalis longicornis BAI99730.1 
Anticoagulant protein 
rhipilin-1 
Rhipicephalus haemaphysaloides ADJ56344.1 
Chymotrypsin inhibitor Haemaphysalis longicornis BAM28739.1 
Kunitz-type serine 
protease inhibitor 
Lychas mucronatus P0DJ45.1 
Kunitz-type serine 
protease inhibitor 
Mesobuthus martensii P0DJ49.1 
Platelet aggregation 
activation inhibitor 
Ornithodoros moubata P36235.1 
Tryptase inhibitor 
precursor 
Rhipicephalus appendiculatus AAW32666.1 
Kunitz type serine 
protease inhibitor, partial 
Ancylostoma ceylanicum AAD51334.1 
Kunitz-type serine 
protease inhibitor 
Mesobuthus martensii P0DJ50.2 
Serine proteinase inhibitor G. m. morsitans GMOY006016 
 
 
 
108 
 
3.3.4 Homology modelling  
Four homology modeling servers were recruited to independently predict the 3D 
structures of GMOY000153, GMOY002400, GMOY009713 and GMOY006016. 
The most reliable models were those predicted by CHPmodels server (Figure 
3.15). The stereochemical qualities of the models predicted by CPHmodels were 
the highest when compared with all the other models taking into consideration 
both the Qualitative Model Energy ANalysis score (QMEAN) (Benkert et al., 
2008), a composite scoring function describing the major geometrical aspects of 
protein structures and percentage identity with the template protein (Table 3.7). 
Refinement of the structures of the predicted models was carried out using 
ModRefiner to generate initial and refined models. After refinement, the 
Ramachandran plots of the initial and final (refined) models were generated and 
compared. All predicted 3D models showed a high percentage of the main chain 
conformation (between 92.8%-99.0%) of residues to be in the favoured regions, 
between 1.0%-4.6% were in allowed regions and between 0%-3.4% were in 
outlier regions as determined by the Ramachandran plot analysis. 
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Table 3.7 Comparison of homology modelling server performance in the 
prediction of 3D models. The higher the QMEAN score the better the quality of the 
protein structure. The percentage identity with template protein and the QMEAN score 
were highest for the models predicted by CPH. 
Gene Server Template % Identity QMEAN 
Score 
     
 Phyre2 c3oa5A 30.0 0.528 
 Modweb 3fy1A 38.5 0.512 
 CPH 3fxy 39.9 0.699 
 Raptorx 3fxyA 32.0 0.656 
     
 Phyre2 C3pe3D 73.0 0.574 
 Modweb 4gywA 73.0 0.635 
 CPH 4n39 73.5 0.671 
 Raptorx 3pe3A 72.0 0.567 
     
 Phyre2 d1pocA 34.0 0.299 
 Modweb 1pocA 36.0 0.510 
 CPH 1poc 41.0 0.530 
 Raptorx 1pocA 40.9 0.498 
     
 Phyre2 C4bd9B 31.0 0.384 
 Modweb 3bybA 35.8 0.421 
 CPH 4bd9 36.9 0.501 
 Raptorx 1bikA 33.8 0.532 
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Figure 3.15 Three dimemsional structures of GmmCHT (A), GmmOGT (B), 
GmmPLA2 (C) and GmmSPI (D). 3D structures were based on 3fxy, 4n39, 
1poc and 4bd9 for A, B, C and D respectively. Helices are in red and β-strands 
are in blue. 
 
 
3.3.5 Ligand binding sites predictions 
In silico analysis identified putative ligand binding sites in the genes under 
investigation (Figure 3.16). For GMOY000153 there are 15 amino acid residues 
in the binding site, for GMOY002400, 8 amino acid residues, for GMOY009713, 
11 amino acid residues and for GMOY006016, 9 amino acid residues (Figure 
3.16). 
 
A B 
C 
D 
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Figure 3.16 Ligand binding sites residues for GmmCHT, GmmOGT, 
GmmsPLA2 and GmmSPI as predicted by COFACTOR. Predictions were 
based on template proteins with similar binding sites to Chitinase, OGT, PLA2 
and SPI. (A) GmmCHT contains multiple ligands and 15 putative binding site 
residues (B) GmmOGT contains a uridine-5'-diphosphate (UDP) ligand and 8 
putative binding site residues (C) GmmPLA2 contains GEL ligand and 11 
predicted binding site residues (D) GmmSPI contains peptide ligand and 9 
putative binding site residues. Proteins are shown in ribbons and ligands in 
space filling models. 
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3.4 Discussion 
 
Genes that were involved in various pathways including immune response, 
metabolism, cell death, cellular and cell signalling were found to be differentially 
expressed in flies that cleared infection after being challenged with 
trypanosomes (Figures 3.1 and 3.2). Since tsetse flies become more resistant to 
trypanosome infection if they are fed normal blood before being infected 
(Welburn and Maudlin, 1999), flies were fed infectious blood containing blood 
stream forms of T. b. brucei at the fourth blood meal to reproduce the refractory 
phenotype and dissected 3 days after receiving the infective blood meal. It has 
been shown that the rate of midgut infection in flies infected at this stage is low – 
less than 5% (Distelmans et al., 1982, Haines et al., 2010).  Also, infected flies 
were dissected at a time (day 3 post-infection) that coincides with the occurrence 
of major events in the midgut in tsetse-trypanosome interaction leading to 
complete elimination of infection in a proportion of flies (Gibson and Bailey, 
2003) to increase the opportunity of identifying genes that play important roles 
during the time the fly tries to eliminate the invading trypanosomes.  
The transcriptome data comprised of reads from control (uninfected) and flies 
fed an infective bloodmeal (containing a mixture of self-cured (refractory) and 
infected (susceptible) flies). Comparison of gene expression was therefore 
between uninfected flies and flies challenged with trypanosomes. It would have 
been ideal to also compare gene expression between susceptible and refractory 
flies, however susceptibility to trypanosomes introduced at the 4th bloodmeal is 
typically less than 5% (Haines et al., 2010, Distelmans et al., 1982).  
Consequently, this group is deemed naturally refractory to infection.   
Pathogens have evolved various strategies to infect and colonise their hosts by 
evading the immune defences mounted by the hosts (Munter et al., 2006). 
Insects mount a robust innate immune response when confronted with 
pathogens (Christophides et al., 2002). The insect innate immune system is 
complex and involves a wide range of gene families involved in various 
pathways. Although the innate immune defence system of tsetse is active prior 
to trypanosome invasion, it exists at the basic level which may not be sufficient 
to deal with the parasites which are already armed with mechanisms capable of 
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inactivating the tsetse immune response. This may tilt the molecular war 
between tsetse and trypanosomes in favour of the parasites, especially during 
the early stages of the infection process. The genes expressed in the midgut of 
the fly during trypanosome infection are of vital importance since the midgut is 
the first port of call for pathogens and where the struggle for survival 
commences.  
The first and most decisive step in the life cycle of the trypanosome in the tsetse 
fly is its establishment in the midgut of the fly. It is in the midgut of the fly that the 
processes of elimination starts after the bloodstream forms ingested when taking 
an infected blood meal differentiate into procyclics within the first 3 days. During 
this period, most flies within a population are able to eliminate the parasites while 
very few become susceptible (Gibson and Bailey, 2003, Aksoy et al., 2003, Van 
Den Abbeele et al., 1999). This process is by no means straightforward because 
the parasites on their part try to increase their chance of survival by inactivating 
or evading the immune response of the fly. This results in a molecular crosstalk 
between the fly and the invading parasites.  
The 454 sequence data reveals genes that were differentially regulated in the 
midgut of tsetse flies that were challenged with trypanosomes. The common 
classes of genes revealed include serine proteases and serpins, genes encoding 
for PM adhesion proteins, genes involved in immune defenses, reactive 
intermediates and genes whose functions are not known.  
A serine proteinase was observed to be up regulated while there was a down 
regulation of protease inhibitors (two serine proteinase inhibitors, a 
metalloendopeptidase and one chymotrypsin inhibitor) in flies that were 
challenged with trypanosomes. The proteases of invading pathogens as well as 
the endogenous proteases have the potential to cause undesirable destructive 
action if allowed to act beyond their intended target. As a result protease 
inhibitors have evolved to play regulatory roles to keep the action of endogenous 
proteases in check (Armstrong, 2006). Also the inactivation of secreted 
proteases of invading pathogens could have negative impact on their invasion 
and proliferation as well as deprivation of nutrients to those parasites that have 
already invaded the host (Armstrong, 2006) thereby protecting the host from 
pathogenic infections.  
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It is not surprising therefore that there was a down-regulation of serine 
proteinase inhibitor (SPI) in flies challenged with trypanosomes since the flies 
will try to secrete more protease to destroy the parasites. The parasites on the 
other hand will try to prevent the inactivation of their protease by suppressing the 
host serine proteinase inhibitors in order to create a favourable environment in 
which to thrive. There was a down regulation of both aquaporin and lipophorin in 
the flies that were infected with trypanosomes. This is in variance to what has 
been observed in Ae. aegypti where aquaporin is over expressed in response to 
infection with alphaviruses (Sanders et al., 2005) and the up regulation of 
lipophorin in Ae. aegypti when infected with Gram-positive bacteria, fungal 
spores and P. gallinaceum (Cheon et al., 2006). The down regulation of both 
aquaporin and lipophorin in flies challenged with trypanosomes could be 
attributed to the fact that majority of the flies must have eliminated the 
trypanosomes which leads to a decrease in the level of expression of these 
genes that are known to be induced upon immune challenge. However, it should 
be noted that gene expression was analysed at just one timepoint (flies were 
dissected at 3 dpi). It would have been ideal to sample the pattern of gene 
expression at multiple timepoints during the infection process. Doing this would 
have presented a more robust argument as to the significance of the difference 
in gene expression. In Ae. aegypti, the survival and proliferation of virus is 
thought to be aided by the presence of alpha glucosidase in the midgut 
(Tchankouo-Nguetcheu et al., 2010). There was an up regulation of a putative 
acid sphingomyelinase (sMase), a gene that is involved in programmed cell 
death (PCD) and stress signalling (Won and Singh, 2006). sMase is involved in 
the synthesis of sphingolipids with the production of pro-apoptotic ceramide a 
key regulator of programmed cell death (Mullen and Obeid, 2012). Acid 
sphingomyelinase is implicated in the killing of bacteria and the initiation of 
apoptosis in infected host cells (Becker et al., 2010). It is therefore possible that 
infected flies up-regulate acid sphingomyelinase to kill the trypanosomes. 
O-Linked β-N-Acetylglucosamine transferase (OGT) was up-regulated in flies 
that were challenged with trypanosomes but that later cleared their infection. The 
enzyme OGT catalyses the addition of a single O-GlcNAc linkage to serine or 
threonine residues of nuclear and cytoplasmic proteins which are involved in a 
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wide range cellular functions (Hart et al., 2007). Overexpression or knockdown of 
OGT has been proven to affect a wide range of signalling pathways and cellular 
processes that include insulin signalling/diabetes, stress response, cell cycle 
regulation, cell regulation and immune response (McClain et al., 2002, Zachara 
et al., 2004, Slawson et al., 2005, Golks and Guerini, 2008). OGT is involved in 
the modulation of cellular processes with regards to nutrient availability, stress, 
immune regulation and cell cycle regulation (Paula et al., 2012). One important 
biological stressor is parasitic infection (Beckerman et al., 2013). Also increasing 
the expression of O-GlcNAc enables cells to become more tolerant to stress and 
improves cell survival (Chatham et al., 2008, Laczy et al., 2009). The up-
regulation of OGT in flies that has been challenged with T. brucei could be a 
mechanism employed by tsetse to fight back infection, and the increase in 
infection rate following RNAi-mediated knockdown of OGT suggests that OGT 
plays a role in immune response in infected flies. 
There was a down-regulation of chitinase in flies challenged with trypanosomes 
compared to flies that received normal blood. Chitin and chitinases have been 
shown to be associated with host immune response in a variety of organisms 
ranging from plants to mammals (Tiffin and Moeller, 2006, Shi and Paskewitz, 
2004, Kramer, 2009, Nair et al., 2003, Lee et al., 2008). In Anopheles gambiae 
chitinase-like proteins are thought to be involved in tissue remodelling and/or 
immune responses (Shi and Paskewitz, 2004). Key features of the arthropod 
innate immune system such as antimicrobial peptides, melanisation and 
phenoloxidase (PO) cascade (Soderhall and Cerenius, 1998, Bulet et al., 1999), 
are thought to be influenced by chitin metabolism. The production of melanin, a 
key feature of invertebrate immune system has been linked to chitin metabolism 
(Walker et al., 2010). Chitinase which is directly involved in chitin metabolism 
(Muthukrishnan et al., 2012) can be said to play an important role in insect 
immune response. The down-regulation of chitinase in trypanosome challenged 
flies could be a ploy by the parasite to suppress the immune response of tsetse 
in order to establish an infection in the midgut since the thickness of the chitin-
rich peritrophic matrix which is regulated by gut-specific chitinases (Filho et al., 
2002) could be compromised and allow the parasites to pass through without 
much hindrance Also it has been suggested that in arthropods the chitin 
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synthesis and degradation pathway is central to the regulation of defences and 
therefore allow an organism to defend itself against multiple threats (Beckerman 
et al., 2013). 
 
 
3.4.1 What does sequence analysis tell us about the structure and function 
of DE genes expressed in refractory flies? 
Conserved protein residues are often seen in protein families where they play 
important functional roles as well involvement in critical stabilizing interactions 
since evolutionary pressure for stability or function could lead to clustering of 
conserved residues (Schueler-Furman and Baker, 2003). Also residues 
important for stability are often clustered together in the hydrophobic core and 
functional residues may be close together in sites involved in enzymatic 
reactions, protein-protein interaction or ligand binding sites (Schueler-Furman 
and Baker, 2003). Analysis of residue conservation is therefore a sensible 
approach to identify functionally important sites in a sequence.  
GMOY000153 contains the conserved consensus sequences of family 18 
chitinases consisting of the conserved active motif (DxDxE) of the catalytic 
domain. Structure prediction showed GMOY000153 has a triosephosphate 
isomerise fold or TIM barrel. This is typical of the catalytic domain of family 18 
chitinases (Suzuki et al., 2002). Also the catalytic domain contains a chitinase 
insertion domain (CID) which incorporates the conserved amino acid residues 
YxR that is known to interact with the substrate (Li and Greene, 2010). This 
small domain which is inserted into the TIM barrel catalytic domain is present in 
chitinases of subfamily A, but not in subfamily B (Suzuki et al., 2002). The CID 
has a large percentage of aromatic residues most of which exist in the 
hydrophobic core except those residues which interact with sugar and this may 
play an important role in the folding and stability of the protein (Li and Greene, 
2010). It is known that aromatic residues play an important role in the structural 
stability of proteins and peptides (Palermo et al., 2008, Subramaniam et al., 
2001). Therefore the presence of the CID and the TIM barrel may contribute to 
the thermal stability of the whole enzyme (Li and Greene, 2010). 
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Sequence analysis revealed that GMOY002400 contains a tetratricopeptide 
repeat (TPR)-containing N-terminal domain which consists of a variant 
consensus sequence typical of TPRs (Figure 3.5B). Although the consensus 
sequence defines the TPR, and consists of a mixture of small and large 
hydrophobic amino acid residues, no positions are fully invariant (Zeytuni and 
Zarivach, 2012). However, certain residues were found to be conserved 
including positions 4, 7, 8, 11, 20, 24, 27, and 32, but only positions 8 (Alanine or 
Glycine), 20 (Alanine), and 27 (Alanine) were highly conserved and consensus 
position 32 which is located in the turn between two TPR motifs is occupied by 
proline, (Figure 3.5B). This bears the hallmark of a TPR domain which consists 
of highly conserved residues at positions 8, 20, and 27, whereas positions 4, 7, 
11, and 24 show stronger preference for large hydrophobic amino acids with 
position 32 being usually occupied by a helix-breaking residue such as proline 
(D'Andrea and Regan, 2003).  
TPR is a versatile structural motif present in a wide range of proteins from 
bacteria to humans and are involved in diverse cellular processes such as 
transcriptional control, protein folding, transport and degradation, host defence 
against invading pathogen and viral replication (Lamb et al., 1995, Goebl and 
Yanagida, 1991, Callahan et al., 1998, Cziepluch et al., 1998, Mamane et al., 
2000). It is made up of 3-16 tandem-repeats of 34 amino acid residues which 
mediates protein-protein interactions with the formation of multi-protein 
complexes which elicits varying biological roles (D'Andrea and Regan, 2003). As 
a result of the numerous interactions that TPR-proteins are involved in and the 
diversity of the TPR domain, they hold a great promise for protein engineering, 
therapeutics and biotechnology since their binding specificity and affinity towards 
ligands of interest can be modulated by redesigning the basic TPR scaffold. 
Ligands with higher affinity can be designed to inhibit or isolate the TPR domains 
from the proteins to which they are usually attached and this can be employed to 
disrupt protein-protein interactions within the cell. 
Sequence analysis of GMOY009713, a protein of 236 amino acids, revealed the 
presence of several conserved features of group XII PLA2s. When 
phylogenetically compared to other PLA2s from other species, GMOY009713 
shared homology with GXIIA PLA2s from other arthropods. PLA2s are commonly 
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found throughout the animal kingdom where they are involved in various 
processes such as phospholipid digestion, rearrangement of cellular membrane 
phospholipid structures, inflammatory response, defence and predation 
mechanisms and signal transduction (Bowman et al., 1997). GMOY009713 has 
a signal peptide suggesting that the mature enzyme could be involved in the 
digestion of phospholipids in the extracellular space. Also its presence in the 
midgut of G. m. morsitans, an important site for the development and 
proliferation of trypanosomes, suggests that it could be involved in the defence 
of tsetse against trypanosome invasion, particularly during the early stage of the 
infection process. 
Based on the possession of the features of kunitz-type serine proteinase 
inhibitors, which includes the presence of a low molecular weight kunitz domain 
consisting of conserved cysteine residues that form disulphide bonds and a P1 
inhibitory site (Zupunski et al., 2003, Yuan et al., 2008), GMOY006016 is 
considered to belong to kunitz-type serine proteinase inhibitors. Kunitz-type 
serine proteinase inhibitors may be made up of a single domain, or a bis-
domainal molecule containing two kunitz inhibitor-relaed domains or the domain 
may be repeated many times as in Ancylostoma caninum (hookworm) with 12 
domains to form a multi-domain, single-chain inhibitor that can interact with 
several proteinase molecules (Ranasinghe and McManus, 2013). GMOY006016 
contains a potential signal peptide as predicted by SignalP 4.1 and two kunitz 
domains with twelve cysteine residues forming six disulphide bonds and a 
putative P1 (Lys) inhibitory reactive site. The P1 residue in the inhibitory loop is 
the main determinant of the specificity of a particular kunitz protein and is 
occupied by lysine or arginine in most cases (MacLean et al., 2004).  
Kunitz serine proteinase inhibitors in the saliva of blood feeding arthropods act 
as antihaemostatic factors preventing blood coagulation during feeding. The tick 
anticoagulant peptide (TAP) from the soft tick, Ornithodoros moubata, inhibits 
the formation of factor Xa (Waxman et al., 1990), the hard tick and Lyme disease 
vector, Ixodes scapularis has kunitz serine proteinase inhibitor which inhibits 
factor VIIa-tissue factor complex (Francischetti et al., 2002) and the black fly 
(Simulium vittatum) kunitz inhibitor which inhibits factor Xa, elastase and 
cathepsin G indicating its involvement in the regulation of both blood clotting and 
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inflammatory responses of the host (Tsujimoto et al., 2012). In blood feeding 
arthropods, kunitz-type serine proteinase inhibitors act as defence against 
microbial challenge in addition to their anticoagulant function. It has been shown 
that the stimulation of Drosophila melanogaster with bacteria or fungi leads to an 
up-regulation of two Kunitz proteins (De Gregorio et al., 2001). Also infection of 
Rhipicephalus (Boophilus) microplus with Babesia bovis led to an increase in the 
expression of a Kunitz proteinase inhibitor (Rachinsky et al., 2007) and a Kunitz-
type molecule isolated from the tick Dermacentor variabilis has been shown to 
exhibit both bacteriostatic and anticoagulant properties (Ceraul et al., 2008). 
 
3.4.2 Phylogenetic relationships 
Eukaryotic cells possess the innate ability to detect and react to perturbations 
arising from abnormal development of cells and pathogen challenge (Nappi et 
al., 2004). Innate immunity as a mechanism of defence involves several 
elements such as cell signalling pathways, transcriptional elements and cytotoxic 
effector responses which are known to be conserved (Beutler, 2004). 
Comparative genetic and molecular studies have shown that processes that are 
involved in innate immune signalling pathways that culminate in the production of 
pathogen-specific cytotoxic responses by the innate immune systems are 
evolutionarily conserved (Nappi et al., 2004). A phylogenetic approach was 
therefore used to compare four candidate genes expressed in the midgut of self -
cleared flies with counterparts from various other species.  
For OGT, the greatest degree of homology was between tsetse and Drosophila 
while there was distant relationship between tsetse and other Dipterans. Tsetse 
CHT protein sequence showed high degree of similarity to other insects CHT as 
well mammals (H. sapiens). This could be as a result of the fact that chitinases 
are widely distributed in nature as they are found in species from all kingdoms 
performing different functions such as digestion, arthropod moulting, 
defence/immunity and pathogenicity (Arakane and Muthukrishnan, 2010). 
Phylogenetic analysis shows a high level of similarity between tsetse SPI and 
other invertebrate SPI especially Drosophila. SPI protein sequences from 
various species form three main phylogenetic groups.  The tsetse (a blood 
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feeder) SPI showed significant homology with that of Drosophila (a non-blood 
feeder) as well as Echinococcus granulosus and Ancylostoma ceylanicum 
suggesting that serine proteinase inhibitors may not have evolved as a 
consequence of haematophagy and clustering may be by protein function. 
 
3.4.3 Homology modelling 
Homology modeling was used to develop 3D models for GMOY000153, 
GMOY002400, GMOY009713 and GMOY006016 (Figure 3.15). The biochemical 
functions of proteins can be deduced by their structures (Kleywegt and Jones, 
1998). Proteins in their native surroundings adopt a unique 3D structure which in 
turn determines their biochemical functions (Floudas et al., 2006). The three-
dimensional (3D) structure of a particular protein provides important information 
about its functions and interaction with other proteins and other compounds such 
as ligands (Tramontano, 1998). Homology or comparative modelling which is 
based on the observation that sequence similarity is equivalent to structural 
similarity remains the most accurate method to predict the three-dimensional 
structure of proteins (Lambert et al., 2002). It must be said however, that the 
quality of the predictions is dependent on the level of sequence similarity. More 
than 50% similarity between target and template represents a high quality 
prediction while significant errors would occur if the sequences share less than 
30% identity (Floudas et al., 2006). In this study the lowest level of similarity 
obtained between a target protein and its template sequence was 36.9% for the 
CPHmodels server that was used in the prediction of the 3D models (Table 3.7). 
ModRefiner was used to improve the resolution of the predicted models, since 
most structural prediction algorithms aim to assemble structures as reduced 
models that represent amino acids by a reduced number of atoms in order to 
speed up the conformational search (Xu and Zhang, 2011). A refinement 
simulation step is therefore necessary if high-resolution models are to be 
obtained (Bradley et al., 2005). ModRefiner aim to draw the initial starting 
models closer to their native states in terms of hydrogen bonds, global topology 
and side-chain positioning (Xu and Zhang, 2011) and its use led to an 
improvement in the qualities of the models (Figure 3.15). Using COFACTOR, 
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putative binding sites and ligands were predicted for the candidate genes. 
Chitinase was predicted to contain multiple ligands and 15 putative binding sites 
while OGT contains 8 putative binding sites and a uridine-5′-diphosphate (UDP) 
ligand which is an important factor in glycogenesis. PLA2 contains 9 putative 
binding site residues while SPI contains peptide ligand and 9 putative binding 
site residues. Prediction of protein-ligand binding sites is very important in 
determining the functions of proteins since in most cellular processes, proteins 
interact with other molecules to perform their biological functions (Dai et al., 
2011). 
 
3.4.4 Summary 
In this chapter it has been shown that phylogenetically, the genes that are 
differentially expressed in the midgut of refractory flies share sequence 
homology with genes involved in immune response in other insects. Also tsetse 
flies react to infection by trypanosomes by differentially expressing some set of 
genes as revealed by the analysis of the transcriptome data from the midgut of 
uninfected flies versus self-cleared flies. Additionally, we also used sequence 
analysis to reveal certain conserved motifs that are present in the genes that are 
essential for their functions. Finally we also used homology modeling to 
determine the 3D structures of the genes. 
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                                              CHAPTER 4  
            Validating the role of immune related genes CHT, OGT and SPI 
in the midgut of trypanosome-refractory flies  
                                           using RNAi silencing 
 
 
4.1 Introduction 
Insects are very often exposed to different types of parasites, but because they 
possess a complex and very effective immune system, they succeed in 
eliminating the invading parasites in most cases resulting in very few of the 
insects developing infection (Barribeau and Schmid-Hempel, 2013, Gillespie et 
al., 1997).  
In this chapter, RNAi knockdown of three immune related genes (chitinase, 
GMOY000153, O-GlcNAc transferase, GMOY002400 and serine proteinase 
inhibitor, GMOY006016) that were differentially regulated in the midgut of flies 
that cleared the parasites after being challenged with T. brucei was carried out. 
This was done to find out what effect the loss of the functions of these genes will 
have on the susceptibility of tsetse to trypanosome infection. These genes were 
chosen based on the important roles they play in the immunity of arthropods. 
The tsetse refractory phenotype observed in the field can be reproduced in the 
lab by feeding flies with normal blood prior to receiving an infected blood meal. 
These conditions were used to produce refractory flies and the genes of interest  
were down-regulated using RNAi before supplying the infective blood meal. Flies 
were dissected and scored for infection 7 days post-infection. 
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4.2 Materials and methods 
The materials and methods are as outlined in chapter 2 
 
4.3 Results 
 
4.3.1 Effect of RNAi knockdown of genes by injection of dsRNA 
RNA interference (RNAi) was used to knockdown the expression of tsetse 
chitinase (GMOY000153), OGT (GMOY002400) and SPI (GMOY006016) by 
injection of dsRNA. Flies were injected with 5 µg, 7 µg and 10 µg of dsRNA to 
determine the optimal concentration of dsRNA needed to achieve maximum 
knockdown without causing much mortality. The injection of 10 µg of dsRNA 
achieved significant knockdown of 68%, 62% and 69% respectively for 
GMOY000153, GMOY002400 and GMOY006016 respectively (Figure 4.1) and 
minimal mortality rates of 8%, 7% and 10% respectively (Table 4.1). The 
injection of dsRNA-GFP was used as control and produced no significant 
knockdown effect over the same period (Figure 4.1). This demonstrates that the 
knockdown effect observed was not as a result of injecting, but rather the effect 
of the injected dsRNA on the target genes.  
 
Table 4.1 Mortality rates observed in flies after injection with different 
concentrations of dsRNA of genes of interest. Flies (n=45) were injected with 5 µg, 7 
µg and 10 µg of dsRNA. Three replicates were used and data are presented as mean 
value ± SE. 
                                   
                                CHIT                 OGT                     SPI 
              5 µg/fly                  5%                 6%                      5% 
             7 µg/fly                  7%                10%                     8% 
            10 µg/fly                  8%                7%                      10% 
 
Mortality rate 
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Table 4.2 Transcript knockdown in midgut following injection with different 
concentrations of dsRNA of genes of interest. Flies (n= 45) were injected with 5 µg, 7 
µg and 10 µg of dsRNA. Three replicates were used and data are presented as mean 
value ± SE. 
                                           
         CHIT           OGT           SPI 
              5 µg/fly         38%           43%            35% 
              7 µg/fly         35%           47%            44% 
             10 µg/fly        68%           62%            69% 
 
Transcript knockdown 
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Figure 4.1 Transcript knockdown of Cht, OGT, PLA2 and SPI following 
dsRNA injections. QPCR analysis of midgut tissues of flies injected with 10µg 
of dsRNA-SPI, dsRNA-OGT, and dsRNACHIT and infected with trypanosomes. 
Midgut tissues were analyzed for transcript expression 7 days after infection. 
Transcript levels of SPI, OGT and CHT were decreased approximately 68%, 
62% and 69% respectively compared to controls (uninjected and dsRNA-GFP-
injected). p-values- (**) = 0.001; (***) = 0.0001. Data are presented as mean 
value of three replicates (45 flies per replicate) ± SE. 
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4.3.2 Survival rate of flies following injection of dsRNA. 
To monitor the effect of the injection of dsRNA on the longevity of the flies af ter 
the injection of dsRNA, flies were monitored every 5 days to see if the wound 
sustained as a result of dsRNA injection led to unusual death of the flies. The 
flies were fed normal defibrinated horse blood on the day of emergence. They 
were injected with dsRNA of the genes of interest the following day, fed a normal 
blood meal the next day, left to rest for a day, and then infected with T. b. brucei 
TSW196 bloodstream form parasites and then observed for occurrence of death 
during the course of the experiment and beyond. The observation was extended 
beyond the duration of the experiment to see if there was any latent effect that 
may have affected the health of the flies but was not manifest during the time the 
experiment lasted. The results show that there were no significant differences 
between flies injected with dsRNA compared with uninjected control during the 
course of the experiment (Figure 4.2). This demonstrates that the injection of 
dsRNA did not weaken the flies as to affect their immune response.  
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Figure 4.2 Survival rates of flies challenged with trypanosomes after 
dsRNA injection. Flies (n=45) were fed normal defibrinated horse blood on the 
day of emergence and then injected with 10 µg dsRNA of genes of interest 24 
hours later. The survival rates of flies were then monitored during the course of 
the experiment to check the effect of injecting dsRNA on the longevity and 
fitness of the flies. The observation was extended beyond the duration of the 
experiment to see if there were latent effects that may have affected the 
health of the flies but was not manifest during the time the experiment 
lasted. There were no significant differences between flies injected with dsRNA 
compared with uninjected controls during the course of the experiment. Data are 
presented as mean value for three replicates ± SE. 
 
 
A 
B C 
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4.3.3 Trypanosome infection prevalence after dsRNA injection 
In order to determine the function of the genes of interest in relation to 
trypanosome infection, the expression of each gene was suppressed using RNAi 
and subsequently infected with trypanosomes. Then flies were dissected to 
check for midgut infection. Flies were fed normal blood meal on the day of 
emergence and were injected with 10 µg of dsRNA the following day. Flies were 
infected at the third blood meal and dissected 7 days post-infection to check for 
midgut infection. Trypanosome infection prevalence in flies injected with dsRNA 
increased significantly compared with the two controls (uninjected and dsRNA-
GFP treated flies) (Figure 4.3). In flies injected with dsSPI there was a 41% 
increase in trypanosome infection prevalence compared to uninjected and 
dsRNA-GFP-injected controls (Figure 4.3A); flies injected with dsOGT had 38% 
increase in trypanosome infection rate compared to uninjected and dsRNA-GFP-
injected controls (Figure 4.3B); while in flies injected with dsCHIT there was a 
31% increase in trypanosome infection rate compared to uninjected and dsRNA-
GFP-injected controls (Figure 4.3C). Investigating the effect of injecting dsRNA 
on the mortality of the flies showed no significant increase in mortality rate 
compared to uninjected control.  
When tsetse flies are infected after having a couple of normal blood meals, 
trypanosome infection prevalence is usually less than 10% (Haines et al., 2010). 
In this experiment, flies were fed normal blood meal after emergence before 
being injected with dsRNA, followed by another blood meal and the third blood 
meal was contained T. b. brucei TSW196. Dissecting the flies after 7 days to 
check for midgut infection revealed significant increase in infection rate in flies 
injected with dsRNA of genes of interest while infection prevalence in the control  
groups were consistent with the normal rates of infection observed in flies that 
had a couple of normal blood meals prior to the infectious blood meal (less than 
10%). 
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Figure 4.3 Trypanosome infection prevalence following RNAi 
knockdown. Trypanosome infection prevalence following RNAi knockdown of 
SPI, OGT and CHT. Flies (n=45) were fed normal bloodmeal on the day of 
emergence, injected with dsRNA the following day (10 µg/fly) and then fed 
infectious bloodmeal (3rd bloodmeal) and dissected 7 days later. The infection 
prevalence values are presented for the controls (uninjected and dsRNA-
GFP-injected) and dsRNA-SPI, dsRNA-OGT and dsRNA-CHT-treated groups. 
RNAi knockdown of candidate genes resulted in significant increase (p = 
0.0001) in infection prevalence for dsRNA-SPI, dsRNA-OGT, and dsRNA-
CHT-treated flies respectively compared with controls (uninjected and dsRNA-
GFP). There was no significant difference in infection prevalence between the 
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controls (uninjected and dsRNA-GFP-injected flies). Data are presented as 
mean value for three replicates ± SE. 
 
4.4 Discussion 
RNA-mediated interference or RNAi for short is a valuable tool for the 
investigation of the functions of a gene in vivo. With RNAi one can knockdown 
the expression of a gene and then observe the loss-of-function phenotypes 
afterwards. Using RNAi,  any gene whose sequence is known can be targeted 
using the dsRNA of a sequence that is identical to the target gene. By 
introducing the dsRNA of the homologous sequence into the organism or cell, 
the dsRNA is cut by Dicer into short interfering RNAs (siRNA) of approximately 
21-23 bp which is involved in the silencing mechanism (Carthew and 
Sontheimer, 2009), after associating with an RNA-induced silencing complex 
(RISC) leading to the degradation of the target gene mRNA by cleaving the 
target mRNA in the middle of the complimentary region (Meister and Tuschl 
2004).  
In this chapter the involvement of three immune related candidate genes (CHT, 
OGT and SPI) that were differentially expressed in the midgut of refractory flies 
in the control of infection were investigated by using RNAi. The midgut of the fly 
is an important site for the establishment of trypanosome infection. For the 
parasites to have a chance of completing their life cycle in the fly, they must first 
of all establish infection in the midgut. It is aslo a very hostile environment for the 
development of the parasites because the fly mounts a robust immune reaction 
in its bid to get rid of the parasites. For the fact that these genes were 
differentially expressed in the midgut of flies that were resistant to trypanosome 
infection compared to flies that were not challenged by trypanosomes suggests 
that they could be involved in the process of elimination of infection. Also since 
the differential expression of these genes were observed to occur during the 
period when the fly tries to eliminate the invading parasites (the first 3 days after 
trypanosome challenge), a period characterised by a process of attrition that 
leads to the complete elimination of infection in some flies (Gibson and Bailey, 
2003).  
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Chitin and chitin-likeproteins are among the main features of the invertebrate 
and vertebrate immune systems (Beckerman et al., 2013). The regulation of 
chitin synthesis and degradation is thought to be central to arthropod defences 
(Beckerman et al., 2015). The pritrophic matrix of arthropod guts which forms a 
barrier and a major line of defence against pathogens and parasites is rich in 
chitin (Dinglasan et al., 2009). Also, some features such as the phenoloxidase 
(PO) cascade, melanization and antimicrobial peptides which are heavily 
involved in the arthropod innate immune system have been linked to chitin 
metabolism (Beckerman et al., 2013). Many antimicrobial peptides are chitin-
binding and are therefore thightly linked with chitinases (Tran et al., 2011). Even 
the PO cascade is thought to be triggered by chitin-binding antimicrobial 
peptides (Nagai et al., 2001). Also melanin, a major feature of invertebrate 
immune system is thought to be regulated by chitin metabolism (Marmaras et al., 
1996, Walker et al., 2010). Therefore, in arthropods, the immune system can be 
said to be highly dependent on the regulation of chitin synthesis and 
degradation. In arthropods, the midgut is of strategic importance because it is 
the point of entry for many arthropod parasites and it is not surprising therefore 
that it acts as a barrier to parasites both structurally and immunologically forming 
a first line of defence in the fight against parasite invasion.  
Since chitinase plays an important role in arthropod immunity, it therefore follows 
that its inhibition could impair immune reactions against invading parasites. In 
order to check if the inhibition of chitinase in tsetse will result in increase in 
infection rate, we carried out RNAi knockdown of chitinase and subsequently 
challenged the flies with trypanosomes. There was a significant increase in 
midgut infection in flies injedted with dsRNA-CHT compared to unjected and 
dsRNA-GFP-injected controls. This suggests that the knockdown of chitinase in 
tseste paves the way for trypanosome midgut establishment. The inhibition of 
chitinase could have a negative impact on the defensive roles of the peritrophic 
matrix since chitinase is involved the regulation of chitin (a major component of 
the peritrophic membrane) synthesis and degradation. It is therefore possible 
that the inhibition of chitinase could perturb the peritrophic matrix function in 
infected tsetse, thereby leading to increased susceptibility to trypanosome 
infection. The role of chitinase in the formation of the PM and involvement in the 
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modulation of immune response in tsetse can be investigated by supplementing 
the bloodmeal with a known chitinase inhibitor such as allosaminidin and 
measuring the susceptibility of the flies to trypanosome infection compared to 
trypanosome challenged flies that did not receive allosaminidin.  
Invertebrates rely solely on their innate immune system for defence against 
invading pathogens (Engelmann and Pujol, 2010). The use of O-GlcNAc 
transferase (OGT) as an immune modulator is evolutionarily conserved in both 
vertebrates and invertebrates (Bond et al., 2014). In Caenorhabditis elegans, 
OGT acts through the β-catenin (BAR-1) pathway together with p38 MAPK 
(PMK-1) to modulate immune response to Staphylococcus aureus, and mutant 
animals displayed a deregulation of stress-and immune-responsive genes in 
addition to being hypersensitive to S. aureus (Bond et al., 2014). OGT catalyses 
the addition of O-linked N-acetylglucosamine (O-GlcNAc) to serine and threonine 
residues (Hanover et al., 2010). This post-translational modification (PTM) of 
proteins plays a vital role in  numerous cellular signalling pathways involving 
growth, metabolism, cellular stress and host-pathogen interactions (Hanover et 
al., 2010). The presence or absence of PTM can have a profound effect on 
protein properties such as enzyme activity or regulation (Du et al., 2001, Federici 
et al., 2002, Parker et al., 2003), localisation and acivity (Juang et al., 2002). 
There is the notion that inappropriate O-GlcNAcylation of specific, key OGT 
targets brought about by the absence of OGT will lead to immunodeficiency 
(Bond et al., 2014).  
To check if this notion holds true for tsetse, OGT expression was suppressed 
using RNAi and flies were subsequently challenged with T. b. brucei to 
determine whether this will lead to increased midgut infection. A significant 
increase in midgut infection was observed in flies injected with dsRNA-OGT 
compared with uninjected control and dsRNA-GFP-injected cotrols. This 
suggests that the inhibition of OGT expression resulted in increased 
susceptibility of flies to trypanosome infection. From this result it can be 
concluded that OGT is essential for immune response in tsetse. It is possible 
that in the absence of OGT, which means no O-GlcNAcylation, proteins lacking 
O-GlcNAc may be inappropriately expressed, localised, or activated leading to a 
poorly cordinated immune response. I therefore suggest that OGT is essential 
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for tsetse immune response and plays a vital role in the tsetse innate immune 
response to trypanosome infection and may be a key component of its immune 
regulation systemsince its suppression using RNAi led to a significant increase in 
trypanosome infection rate.  
Insects possess an innate immune system that is made up of both humoral and 
cellular responses which operate in a coordinated way when reacting to infection 
by pathogens or parasites (Franssens et al., 2008). The serine proteinase 
inhibitors in arthropods are thought to protect their hosts from infection by 
inhibiting proteinases from pathogens or parasites in addition to regulating 
endogenous proteinases that are involved in coagulation, prophenol oxidase 
(PPO) activation or cytokine activation (Kanost, 1999). Pathogens possess 
proteinases that help them to penetrate the cuticle of arthropod hosts and can 
aslo contribute to the virulence of bacterial pathogens (Kanost, 1999). However, 
some proteinase inhibitors in arthropods may play a role in defending the host 
against such microbial proteinases as has been demonstrated in Bombyx mori in 
which a fungal proteinase inhibitor (FPI) is known to be active against 
proteinases from fungal pathogens (Eguchi et al., 1993). Also several variants of 
the Manduca sexta serpin-1 gene are known to inhibit bacterial or fungal serine 
proteinases (Jiang and Kanost, 1997).  
To obtain more information about the role of SPI (GMOY006016) in tsetse, RNAi 
targeting GMOY006016 was induced in tsetse followed by infection with T. b. 
brucei. The significant increase in trypanosome infection rate following the 
knockdown of GMOY006016, coupled with the fact that it is secreted in the 
midgut where it is in contact with invading trypanosomes suggests that it is 
involved in immune defences against trypanosome infection. An important 
component of the humoral immune response in arthropods is the 
prophenoloxidase-activating system (proPO-AS) (Cerenius and Soderhall, 2004, 
Kanost et al., 2004). When pathogens succeed in penetrating the cuticular 
barrier, a second line of immune defense reactions is induced leading to the 
limited activation of the prophenoloxidase (proPO) precursor into the active 
phenoloxidase (PO), culminating in the production of melanin and associated 
toxic intermediary compounds which kill invading pathogens (Franssens et al., 
2008). However, the activation of the proPO must be tightly controlled to avoid 
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premature activaion and to prevent it from acting beyond the inteded target. This 
is partly achieved by the presence of serine proteinase inhibitors (SPI) which 
prevent unwanted activation of this complex which  have the potential to cause 
undesirable destructive action if allowed to act beyond their intended target. We 
observed a significant increase in trypanosome infection in the midgut of dsRNA-
SPI knockdown flies compared to uninjected and dsRNA-GFP-injected flies 
(Figure 4.3 A) suggesting that SPI is involved in tsetse immune response during 
trypanosome infection. In the event of the inhibition of the fly‟s SPI, uncontrolled 
activation of the proPO might occur which will have deleterious effect on the fly 
thereby affecting its ability to fight trypanosome infection because the quinones 
and reactive oxygen species generated by uncontrolled spread of PPO activation 
would be harmful to the fly (Zhu et al., 2003). The effect of uncontrolled 
activation of PPO on the fitness of the fly can be tested by inhibiting the genes 
that regulate the production such serine proteinase inhibitor and then observe 
the survival rate of the flies compared controls. It is also possible that the 
inhibition of GMOY006016 affected the proper coordination of the activation of 
the proPO-AS which may lead to untimely activation of the proPO and which 
may impart negatively on the fly‟s immune response to trypanosome infection, 
hence the increased susceptibility of the flies to trypanosome infection. 
To further validate the roles of these genes in tsetse immune rseponse, it will be 
good to examine potential interactions between the candidate genes to uncover 
potential pathways involved in tsetse refractoriness. Also it will be interesting to 
knock down two or more candidate genes simultaneously and observe its effect 
on tsetse in relation to susceptibility to trypanosome infection.  
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                                                Chapter 5  
Role of sPLA2 (GMOY009713) in the establishment  
of midgut infection in Glossina morsitans morsitans  
 
 
5.1 Introduction 
Phospholipases A2 (PLA2s) are a family of enzymes that catalyze the hydrolysis 
of the second carbon group of the glycerol moiety of glycerophospholipids to 
release (mostly unsaturated) fatty acids and lysophospholipids (Murakami et al., 
2011b). They are present in viruses, bacteria, plants and animals (Farr et al., 
2005, Sato and Frank, 2004, Fujikawa et al., 2005, Six and Dennis, 2000, 
Valentin and Lambeau, 2000). Secreted  PLA2s are the most abundant in the 
PLA2 family making up about one third of all PLA2s and are characterised by low 
molecular weight, require Ca2+, are secreted and possess a His/Asp catalytic 
dyad (Murakami et al., 2011b). They  are synthesized by many different cell 
types, and are secreted in various body fluids where they are involved in a 
variety of pathophysiological processes such as the breakdown of dietary 
phospholipids, remodelling of cellular membrane, signal transduction, production 
of lipid mediators, inflammatory reaction, host immune defences and venom 
toxicity (Stanley, 2006a, Nevalainen et al., 2000, Nevalainen et al., 2008, Fry et 
al., 2009, Murakami et al., 2010, Murakami et al., 2011a). They can also act as 
ligands in many biological processes that mediate several pathological and 
biological interactions among organisms (Lambeau and Lazdunski, 1999, 
Hanasaki and Arita, 1999, Rouault et al., 2003, Triggiani et al., 2005). 
In insects, sPLA2s activities are important for the digestion of dietary 
phospholipids (PLs) helping them to meet the essential dietary requirements for 
polyunsaturated fatty acids by hydrolysing the sn-2 fatty acids, which are then 
absorbed via the midgut epithelium (Stanley, 2006a). Also since insects, unlike 
vertebrates do not produce bile salts whose function is to solubilise lipids and 
make them available for digestion and subsequent absorption, the 
lysophospholipids liberated from phospholipids by the catalytic activity of PLA2 
perform the function of bile salts by acting as solubilisers thereby facilitating lipid 
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digestion (Stanley, 2006a). It has been suggested that sPLA2s are a common 
and important feature of the digestive physiology of insects (Uscian et al., 1995).  
It has been suggested that prostaglandins (PGs) and other eicosanoids play 
important role in insect cellular immunity (Jurenka et al., 1999). Also, it has been 
established that in the event of microbial challenge, PLA2 activity increases in 
insects (Yajima et al., 2003, Tunaz et al., 2003, Shrestha and Kim, 2007, 
Shrestha and Kim, 2010). The biosynthesis of eicosanoids begins with the 
hydrolysis of arachidonic acid (AA) leading to the release of lipid mediators such 
as prostaglandins, thromboxanes and leukotrienes (Dennis et al., 2011). The 
enzymatic action of PLA2 on phospholipids with the release of AA is therefore 
the first and rate-limiting step for the biosynthesis of eicosanoids (Dennis et al., 
2011). It has been hypothesised that eicosanoids play an important role in insect 
immune responses when challenged by bacteria (Stanley-Samuelson et al., 
1991, Miller et al., 1994). Eicosanoids-mediated actions in insects include 
microaggregation and nodulation reactions to bacterial infections, 
prophenoloxidase (PPO) activation, phagocytosis and cell spreading (Miller et 
al., 1994, Downer et al., 1997, Miller, 2005). Inhibition of PLA2 led to significant 
reduction of phagocytosis of protozoan parasites (Figueiredo et al., 2008b) and 
prevented encapsulation of parasitoid eggs (Carton et al., 2002). 
It has been proposed that the eicosanoid signaling system is involved in a cross-
talk with plasmatocyte-spreading peptide (PSP) (Srikanth et al., 2011), an insect 
cytokine that mediates plasmatocytes spreading (Clark et al., 1998). Its 
precursor protein, the proPSP is expressed by granular haemocytes which 
subsequently release the PSP which rapidly adhere and spread at the target 
following the subjection an insect to immune challenge (Eleftherianos et al., 
2009). The initiation of infection by pathogens provokes the production of 
activated PSP which in turn activates PLA2 leading to the biosynthesis of 
prostaglandins with the ultimate effect of plasmatocytes spreading (Srikanth et 
al., 2011). This again establishes eicosanoids, and invariably PLA2 as an 
important element of the immune signaling system in insects. Perhaps, the most 
important indication that PLA2 plays an important role in insect immune 
responses is the fact that certain microbial pathogens produce and secrete 
137 
 
compounds that disable insect immune responses by specifically inhibiting PLA2 
(Stanley, 2006a). These pathogens exert their influence on host insects by 
blocking the immune-mediating eicosanoid pathway by their inhibitory action on 
the first step in eicosanoid biosynthesis catalysed by PLA2 (Park and Kim, 2000). 
For example, the entomopathogenic nematode, Steinernema carpocapsae, a 
mutualistic symbiont with the bacterium, Xenorhabdus nematophila, after 
invading an insect host is known to release X. nematophila (a member of the 
Enterobacteriaceae family) into the haemolymph. The bacterium is thought to 
inhibit the insect‟s immune reactions to the invading nematode by secreting 
substances that directly inhibit sPLA2 and also proliferates rapidly after being 
released and kills the insect host with the insect cadaver serving as a conducive 
microhabitat suitable for the nematode to complete its development providing 
nutrients and protection from other microbes (Park and Kim, 2000). Bacterial 
factors are known to be potent inhibitors of sPLA2 from different sources (Park et 
al., 2004). Another bacterium in the Enterobacteriaceae family, Photorhabdus 
temperate, is known to similarly inhibit PLA2 in insects (Kim et al., 2005). It may 
therefore be possible that other bacterial species in this family may also exhibit 
the same property of impairing insect immune responses by inhibiting sPLA2. In 
mammals, Gram-positive bacteria are thought to protect themselves from the 
bactericidal action of sPLA2 by secreting toxins which reduce the amount of PLA2 
rather than inhibiting the activity of PLA2 as seen in insects (Gimenez et al., 
2004).    
Apart from bacteria, protozoan parasites are also known to impair host immunity 
through the inhibition of eicosanoid biosynthesis. Experiments with Rhodnius 
prolixus shows that oral infection with Trypanosoma rangeli leads to suppression 
of eicosanoid biosynthesis just as the addition of dexamethasone, an indirect 
inhibitor of PLA2 to the blood meal of R. prolixus inhibited phagocytosis (Garcia 
et al., 2004). This inhibitory effect of dexamethasone was reversed when the 
larvae are treated with AA or with platelet activating factor (Figueiredo et al., 
2008b). The fact that some microbial pathogen aim to suppress host immune 
responses by inhibiting PLA2, a key enzyme in eicosanoid biosynthesis, points to 
the fact that PLA2s play important roles in insect immune responses. 
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G. morsitants expresses a sPLA2 activity in both the midgut and the salivary 
glands (see characteristics of this protein in Chapter 3), which is slightly down-
regulated in self-cured flies that have previously received a trypanosome-
infected blood meal. In this Chapter I describe the pattern of secretion of this 
sPLA2 during a trypanosome infection and show evidence that this activity may 
have a role in controlling the levels of parasite infection in the tsetse midgut. 
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5.2 Materials and methods 
Materials and methods are as outlined in section 2. 
 
       5.3 Results 
5.3.1 Tsetse PLA2 mRNA and protein levels were significantly reduced 
following gene knockdown by RNA interference 
RNAi-mediated knockdown was used to validate the role of Gmm sPLA2 in 
controlling the establishment of a trypanosome infection in the tsetse midgut. 
Injection of dsRNA (as described in section 2.5) resulted in a significant (~72%) 
reduction in transcript level of sPLA2 compared to controls (Figure 5.1). Similar 
results were obtained by western blotting, which revealed elimination of the 
endogenous protein in midguts of flies following the injection of 10 µg of dsRNA-
sPLA2 (Figure 5.2). Corroboration of the protein expression after RNAi silencing 
is important as using only transcript levels can sometimes be misleading for 
some genes (Gygi et al., 1999), particularly in haematophagous insects where 
post-transcriptional regulation is a common feature (Hamilton et al., 2002). The 
injection of dsRNA-sPLA2 therefore resulted in a significant reduction of both 
transcript expression and protein expression.  
                                 
Figure 5.1 Levels of sPLA2 expression after RNAi knockdown. dsRNA-
sPLA2 (10 µg per fly) was injected into adult flies. The knockdown level of PLA2 
transcripts was analysed by qPCR using cDNAs prepared from total RNA isolated 
from pools of five day 7 flies. Expression levels of sPLA2 were presented relative to 
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the level in dsRNA-GFP-injected and uninjected control flies. The transcript levels of 
G. m. morsitans α tubulin and β tubulin were measured to normalize for differences in 
the concentration of cDNA templates between samples. Transcript levels of sPLA2 
were decreased approximately 72%. An asterisk indicates a significant difference in 
transcript levels between control and test flies (** = 0.001; *** = 0.0001). Data are 
shown as mean value ± SE (n= 3). 
 
 
              
Figure 5.2 Tsetse PLA2 protein level after dsRNA injection. Flies were 
injected with 10 µg of dsRNA-sPLA2 24 hours after receiving a normal blood 
meal and dissected after seven days. Five midguts were pooled for each 
sample for protein isolation which was used for western blot analysis. Lane 1: 
dsRNA-PLA2 knockdown midguts; lane 2: dsRNA-GFP injected midguts; lane 
3: unfed salivary glands (SG) lysate (positive control for sPLA2 recognition); 
lane 4: Uninfected midguts; lane 5: SG (from fed flies). There was a decline in 
tsetse sPLA2 protein levels following dsRNA-PLA2 injection. The nigrosine-
stained PVDF (6-10) is placed adjacent the immunoblot film. 
 
 
5.3.2 Trypanosome infection prevalence is increased by RNAi-mediated 
knockdown of tsetse sPLA2 
To determine if sPLA2 influences trypanosome establishment in the midgut of 
tsetse, flies were injected with dsRNA-sPLA2 and subsequently offered an 
infectious blood meal. Typically, flies were allowed to recover for 24-48 hours 
after injecting dsRNA. They were then offered an infectious blood meal 
containing  T. b. brucei (TSW196). Seven days after the infectious blood meal 
the flies were dissected and examined microscopically to check for midgut 
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infection. A statistically significant increase in susceptibility to trypanosome 
infection was observed in flies injected with dsRNA compared to the controls 
(Figure 5.3).  
 
            
Figure 5.3 Trypanosome infection prevalence after dsRNA-PLA2 injection. 
Trypanosome infection in the midgut of flies injected with dsRNA-PLA2.  Flies 
(n=48) were injected with 10 µg dsRNA-sPLA2 and infected with BSF T. b. 
brucei. At 7 days post-infection, flies were dissected and the midguts analyzed 
microscopically to score for infection.  RNAi knockdown of candidate genes 
resulted in significant increase (p = 0.0001) in infection prevalence for dsRNA-
PLA2-treated flies compared with controls (uninjected and dsRNA-GFP-injected 
flies). There was no significant difference in infection prevalence between the 
controls (uninjected and dsRNA-GFP-treated flies). Data are presented as 
mean value of three biological replicates ± SE. 
 
  
5.3.3 Tsetse sPLA2 expression decreased following infection with T. b. 
brucei bloodstream form (BSF) 
Some bacteria and protozoans in a bid to suppress the insect host‟s immune 
response produce and secrete compounds specifically aimed at PLA2 (Stanley 
and Kim, 2011). The microbes try to suppress the eicosanoid-mediated immune 
response through the inhibition of sPLA2. To investigate if this is also true for 
tsetse, flies were infected with T. b. brucei BSF and the pattern of midgut 
expression of PLA2 was monitored over 14 day period. Typically, flies were 
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infected in their first blood meal and maintained on normal blood meal every 48 
hours for a period of 14 days. Dissections were carried out 24 hours after 
infection and at 3, 7 and 14 days post infection to extract midgut tissue from 
infected flies which were analysed for sPLA2 transcript expression using qPCR. 
Initially, there was a suppression of sPLA2 expression following trypanosome 
infection until day 14 post infection when a sharp increase in PLA2 was observed 
compared to uninfected control over the same period (Figure 5.4 A). Similar 
results were obtained when the protein fractions from the same samples were 
analysed by western blotting using a commercial anti-PLA2 antibody (Figure 5.4 
B).  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
143 
 
                                              
       
 
 
Figure 5.4 Timecourse of sPLA2 expression after infection with T. b. 
brucei BSFs. (A) Analysis of sPLA2 transcript expression using qPCR. Teneral 
flies (n=50) were infected with T. b. brucei and dissected 24 hours after 
infection and subsequently on days 3, 7 and 14 post-infection. Midguts were 
collected and analysed for sPLA2 transcript expression using qPCR. 
Expression levels of PLA2 were presented relative to the level in uninfected 
controls. The transcript levels of G. m. morsitans α tubulin and β-tubulin were 
measured to normalize for differences in the concentration of cDNA templates 
between samples. Level of significance between test samples and control is 
indicated by asterisks, *p < 0.05, **p < 0.01, ***p < 0.001. Data are shown as 
mean value ± SE (n = 3). (B) Left panel shows western blot analysis showing 
significant reduction in sPLA2 protein levels between days 1 and 7 and an 
increase in PLA2 protein level on day 14. Lane 1: day 0; lane 2: 24 hours: lane 
3: day 3: lane 4: day 7: lane 5: day 14: lane 6: tsetse SG extract (positive 
A 
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control). The nigrosine-stained PVDF membrane (7-12) is placed adjacent to 
the immunoblot film (right panel). 
 
5.3.4 Infecting flies with procyclic forms (PCF) of T. b. brucei does not alter 
the sPLA2 expression profile 
Since there was an increase in the expression of sPLA2 on day 14 following the 
infection of tsetse with blood stream forms of T. b. brucei, we thought the suden 
increase in the expression of PLA2 on day 14 after trypanosome infection could 
be related to an increase in the number of procyclic forms. We also wanted to 
know if there will be a drop in the exporession of sPLA2 beyond day 14. We 
therefore decided to infect flies directly with procyclic forms of T. b. brucei and 
also extended the time of infection up to 15 days. Teneral flies were fed 
infectious blood meal containing 1 x 105 cells/mL and 1 x 106 cells/mL of 
procyclic forms. Flies were dissected at the same time points used for blood 
stream form  experiment to extract midgut tissues which were subsequently 
analysed for PLA2 expression.  
The infection of flies with procyclic trypanosomes resulted in an initial 
suppression of PLA2 expression following trypanosome infection until day 15 
post infection when a notable increase in sPLA2 was observed compared to 
uninfected control over the same period. Furthermore, feeding flies different 
parasite loads (1 x 105 cells/mL and 1 x 106 cells/mL) did not alter the expression 
pattern of PLA2 showing no significant increase in sPLA2 expression as the 
parasitic load increases (Figure 5.5). This is similar to sPLA2 expression pattern 
when flies were infected with blood stream form trypanosomes (see section 
5.3.3). Thus the expression of sPLA2 following trypanosome infection appears  
not to be dependent on the stage of  the parasite.  
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Figure 5.5 Timecourse of sPLA2 expression after infection with T. b. 
brucei PCFs. Analysis of sPLA2 transcript expression using qPCR. Teneral 
flies (n=50) were infected with T. b. brucei and dissected 5, 10 and 15 days 
post-infection. Midguts were collected and analysed for sPLA2 transcript 
expression using qPCR. Expression levels of sPLA2 were presented relative 
to the level in uninfected controls. The transcript levels of G. m. morsitans α 
tubulin and β tubulin were measured to normalize for differences in the 
concentration of cDNA templates between samples. Level of significance 
between test samples and control is indicated by asterisks, *p < 0.05, **p < 
0.01, ***p < 0.001. Data are shown as mean value ± SE (n = 3). 
                       
 
5.3.5 Immune stimulation of flies with Gram-positive bacteria results in a 
significant change in sPLA2 expression 
It has been demonstrated that when tsetse flies are immune challenged with 
bacteria before receiving a trypanosome-infected blood meal they become less 
susceptible to trypanosome infection (Hao et al., 2001). In as much as this 
phenomenon has been linked to the induction of antimicrobial peptides, there 
might be other factors involved (Hao et al., 2001, Hao et al., 2003). In order to 
check if the expression of sPLA2 is specific for trypanosome infection or is it 
influenced by the presence of any pathogen, flies were fed with Gram-negative 
(E. coli) and Gram-positive (S. aureus) bacteria. Flies were fed live Escherichia. 
146 
 
coli and live Staphyloccocus aureus. Flies were dissected at 5, 10 and 15 days 
after immune challenge to extract midgut tissues which was analysed for sPLA2 
transcript expression using qPCR. 
The result indicates that there was a significant induction (~9-fold) of sPLA2 
expression in flies challenged with live S. aureus compared to those receiving E. 
coli or uninfected controls (Figure 5.6). The induction in sPLA2 occurs as early as 
5 dpi and remains high up to 15 dpi, where it expression was at least 2-fold 
higher than that detected in flies infected with T. brucei.  
 
                     
 
Figure 5.6 Timecourse of sPLA2 expression after immune challenge with 
bacteria. Analysis of sPLA2 transcript expression using qPCR. Teneral flies 
(n=50) were fed blood meal spiked with live S. aureus and E. coli and dissected 
at 5, 10 and 15 days after the infectious blood meal to extract midgut tissues 
which were analysed to check for sPLA2 transcript expression using qPCR. 
Challenging flies with live S. aureus resulted in a sharp increase in PLA2 
expression from day 5 while live E. coli did not result in any significant alteration 
in the expression of sPLA2 compared to controls. Expression levels of sPLA2 
were presented relative to the level in uninfected controls. The transcript levels 
of G. m. morsitans α-tubulin and β-tubulin were measured to normalize for 
differences in the concentration of cDNA templates between samples. Level of 
significance between test samples and control is indicated by asterisks, *p < 
0.05, ***p < 0.001. Data are shown as mean value ± SE (n = 3). 
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5.3.6 Immune stimulation of flies with dead bacteria or dead PCFs does not 
affect sPLA2 expression 
To investigate if the rise in PLA2 expression can be triggered only by the 
pathogen molecules, a timecourse experiment in which flies were challenged 
with dead procyclic trypanosomes and dead bacteria was performed. Teneral 
flies were fed blood meals containing dead procyclic trypanosomes (1x105 
cells/ml and 1x106 cells/ml) and dead S. aureus and dead E. coli. Flies were 
dissected at 5, 10 and 15 days after immune challenge to extract midgut tissues 
for sPLA2 transcript expression analysis using qPCR. If the rise in sPLA2 
expression is as result of presence of any foreign body, then we would expect a 
rise in sPLA2 expression after flies were challenged with dead PCFs and dead 
bacteria. Figure 5.7, panel A shows that feeding flies with dead procyclic 
trypanosomes (both 1x105 cells/ml and 1x106 cells/ml) did not result in any 
significant change in sPLA2 expression in the midgut compared to uninfected 
controls. Likewise, immune challenge of flies with dead bacteria (dead S. aureus 
and dead E. coli) did not produce any significant change in the expression of 
sPLA2 in the midgut compared to uninfected control (Figure 5.7, panel B). This 
suggests that expression of midgut sPLA2 is probably dependent on the density 
of live pathogens, but does not respond to the presence of dead cells or 
molecules derived from, although it remains to be determined whether it can be 
triggered by increasing the amount of surface molecules from either 
trypanosomes or bacteria. 
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Figure 5.7 Timecourse of sPLA2 expression after immune challenge with 
dead trypanosomes and dead bacteria. Teneral flies were fed blood meal 
containing dead T. b. brucei (A) and dead S. aureus and E. coli (B). Flies (n = 
35) were dissected at 5, 10, and 15 days post-infection to collect midgut 
tissues for sPLA2 transcript analysis. Feeding flies with dead T. b. brucei 
PCFs did not cause any significant change in sPLA2 expression compared to 
controls. Likewise challenging S. aureus or dead E. coli did not result in any 
significant change in the expression of sPLA2 compared to controls. 
Expression levels of PLA2 were presented relative to the level in uninfected 
controls. The transcript levels of G. m. morsitans α tubulin and β tubulin were 
measured to normalize for differences in the concentration of cDNA templates 
between samples. Level of significance between test samples and control is 
indicated by asterisks, *p < 0.05, **p < 0.01, ***p < 0.001. Data are shown as 
mean value ± SE (n = 3). 
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5.3.7 Effect of G. m. morsitans s PLA2 on trypanosome viability 
To determine if sPLA2 protein has trypanocidal activity, a Minimum Inhibitory 
Concentration (MIC) assay was performed on trypanosomes. PCF forms of T. b. 
brucei parasites were cultured with varying concentrations of recombinant G. m. 
morsitans sPLA2 (rec-sPLA2). Following incubations for 66-72 hours, parasite 
number was counted while the viability of the parasites were measured by 
determining their metabolic activity using alamarBlue substrate. The results are 
shown in Figure 5.8. The parasites were inhibited at high concentrations (50 
µg/mL) of rec-sPLA2 because there was a significant reduction in the number of 
parasites but lower concentrations of G. m. morsitans PLA2 seem to discretely 
aid parasite growth (Figure 5.8 A). A similar result was obtained when 
proliferation of the parasites was measured using alamarBlue substrate. The 
lowest intensity of fluorescence was recorded at 50 µg/mL while at lower 
concentrations (0.1 – 5.0 µg/mL) the intensity of fluorescence was similar to or 
slightly higher than the control (0 µg/mL) (Figure 5.8 B). This shows that parasite 
growth is comparable to or slightly higher than the control while there was 
inhibition of growth at 50 µg/mL. The results indicate that G. m. morsitans sPLA2 
is trypanocidal at higher concentrations while parasite growth seem to be slightly 
aided at lower concentrations of G. m. morsitans sPLA2.     
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Figure 5.8 Inhibition of parasite growth by recombinant G. m. morsitans 
sPLA2. MIC assay was performed on PCF of T. b. brucei. Panel A: 
Measurement of parasite growth after incubation at varying concentrations of 
recombinant G. m. morsitans PLA2. Parasite numbers were counted at 0, 24, 
48 and 72 hours after incubation. At 0 hours there was no increase in the 
number of parasites, at 24 and 48 hours there was no significant difference in 
the number of parasites between the various protein concentrations. After 72 
hours incubation, lower concentrations of G. m. morsitansPLA2 seem to aid 
parasite growth with the highest number of parasite recorded at 2.5 µg/mL 
while there was an inhibition of parasite growth at 50 µg/mL. Panel B: 
Detection of cell growth using alamarBlue. The alamarBlue assay was used to 
measure cell proliferation and the intensity of fluorescence is proportional to 
number of cells. The parasites were inhibited by G. m. morsitans sPLA2 at high 
concentrations (50 µg/mL), while parasite growth seem to be aided at lower 
concentrations of G. m. morsitans rec-sPLA2. 
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5.4 Discussion 
Although insects lack adaptive immunity, they rely mainly on innate immunity 
(cellular and humoral) for defense against invading pathogens. Although the 
chitinous exoskeleton and the peritrophic matrix lining the midgut epithelia are 
formidable physical barriers to infection, many organisms succeed in breaching 
these barriers, but once inside the insect body, the invaders are confronted with 
cellular and humoral defense mechanisms. In insects humoral immunity involves 
the induced biosynthesis of a wide range of anti-microbial proteins, the action of 
lysozymes and the release of prophenoloxidase (PPO) (Stanley and Kim, 2011). 
Humoral immunity is linked to Toll and Immune Deficiency (Imd) pathways, 
which are signal transduction systems that enable the host to differentiate 
different classes of infecting microbes and express specific genes encoding anti-
microbial peptides appropriate to the infecting microbe (Leulier et al., 2003, 
Hoffmann, 2003). The onset of humoral immunity is relatively slow (6-12 hours 
after infection) compared to cellular immune reactions (Stanley, 2006a).   
It has been suggested that eicosanoids mediate cellular, as opposed to humoral, 
immune reactions because inhibiting eicosanoid biosynthesis in the tobacco 
hornworms (Manduca sexta) impaired the ability of the insect to clear injected 
bacteria within 2 – 4 hours after immune challenge (Stanley-Samuelson et al., 
1991). Bacterial infection of the true armyworm, Pseudaletia unipuncta resulted 
in an increase in PLA2 activity as well as increased biosynthesis of  PG2α  30 
minutes post-infection (PI) (Jurenka et al., 1999). Also several other experiments 
have revealed that immune challenge of insects stimulated increased PLA2 
activity (Tunaz et al., 2003, Yajima et al., 2003, Shrestha and Kim, 2010). These 
experiments support the idea that PLA2 is involved in both cellular and humoral 
immune reactions to infection in insects. However, since trypanosomes do not 
enter the haemocoel, PLA2 may be involved in humoral immune response in 
tsetse. Compared to the work on Toll and other intracellular pathways, there is 
relatively very little knowledge on signaling mechanisms involved in mediating or 
coordinating cellular immune responses. Prostaglandins and other eicosanoids 
are involved in variuos aspects of cellular immune reactions to microbial 
infections (Stanley, 2000, Stanley, 2006b).  
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Although the role of secreted PLA2 proteins in some insects have been 
investigated, there is no information about the role of sPLA2 in tsetse immune 
response. Since sPLA2 was one of the genes that were differentially expressed 
in the midgut of refractory flies, and based on the fact that sPLA2 plays an 
important role in insect cellular immunity, we decided to investigate the role of 
this protein in the establishment of infection in tsetse following trypanosome 
challenge. In this chapter I investigated the functions of sPLA2 in the 
establishment of trypanosome infection in the midgut of tsetse. RNAi ablation of 
of  sPLA2 resulted in a significant increase in the susceptibility of the fies to 
trypanosome infection, indicating that sPLA2 is involved in the fight against 
infection by trypanosomes. This could be as a result of the direct action of sPLA2 
on the parasites since sPLA2 class XIIA are known to possess antimicrobial 
properties. However, it cannot be ruled out if sPLA2 is involved in some signaling 
pathways, such as the eicosanoid biosynthesis pathway leading to the 
production of prostaglandins and other eicosanoids (which are involved in 
cellular immune reactions to microbial infection) (Stanley, 2000, Stanley, 2006b), 
although this activity appears not to be intracellular or cell-bound.  
It has been demonstrated previously that PLA2 from snake venom can prevent 
P. falciparum oocyst formation by preventing midgut attachment of ookinete 
thereby inhibiting the full development of malaria parasite in mosquitoes (Zieler 
et al., 2001). The mechanism of action of sPLA2 on the parasite killing is not well 
understood, but it is known that sPLA2 proteins have a direct (porin-like) effect 
on the parasite and that enzymatic activity is not a prerequisite for antiparasitic 
activity. It was therefore suggested that sPLA2 associates with the midgut of 
surface of of mosquitoes thereby preventing ookinete attachment and thus 
preventing further development of the parasite in the midgut of the mosquito 
vector (Zieler et al., 2001).   
To investigate if the presence of trypanosomes in the midgut of tsetse leads to a 
suppression of sPLA2 expression, teneral  flies were infected with BSFs of T. b. 
brucei and the profile of sPLA2 transcript expression was analysed over a period 
of 14 days using qPCR. There was a significant reduction in the expression of 
sPLA2 compared to uninfected control suggesting that trypanosomes suppress 
sPLA2 expression upon invading tsetse. However, there was a sudden increase 
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in sPLA2 expression on day 14 after trypanosome infection. This is an intriguing 
and unprecedented phenomenon. Two questions come to mind as to why the 
sudden increase in sPLA2 expression: Firstly, does the increase in expression 
coincide with the transformation of the BSFs to procyclics, secondly, is the fly 
responding to an increase in cell density as a way of keeping the parasites at 
bay to prevent being overwhelmed. To address the first question I infected 
teneral flies with procyclics to investigate if the increase in sPLA2 expression is 
triggered by the onset of the procyclic forms of the parasite, in which case we 
expect to see an increase in sPLA2 expression right from the onset. This, 
however was not the case as the sPLA2 expression profile followed a similar 
pattern to that obtained when flies were infected with BSFs.  
To address the second question I infected flies with two different parasite loads 
(1 x 105 cells/ml and 1 x 106 cells/ml) to see if there will be a difference in sPLA2 
expression between the two treatment groups. Again the expression profile for 
sPLA2 was similar to that obtained when flies were infected with either BSFs of  
PCFs, however, sPLA2 expression was higher on day 14 in flies infected with 1 x 
106 parasites/ml compared to flies receiving 1x105 parasites/ml in their blood 
meal. This suggests that more sPLA2 is expressed as the level parasite infection 
increases, which is in aggrement with the lack of induction when challenged with 
dead trypanosomes and bacteria. In order words, the flies expressed more 
sPLA2 as the parasites proliferate and actively increase in number in the midgut. 
This could be a way of limiting the number of parasites in the midgut and 
preventing them from overwhelming the flies, although the expression may not 
be enough to fully erradicate the infection.  
It has been shown that some bacteria belonging to the Enterobacteriaceae 
family (Park et al., 2004, Park and Stanley, 2006, Kim et al., 2005, Park et al., 
2003, Park and Kim, 2000) and some protozoan parasites (Garcia et al., 2004) 
suppress the immune defences of their insect hosts by inhibiting eicosanoid 
biosynthesis. Bee venom PLA2 has been shown to have antimicrobial activity on 
some Gram-negative bacteria (Tatu, 1989). sPLA2 from mouse has been 
reported to exhibit a bactricidal action on both E. coli and Salmonella spp. 
(Koduri et al., 2002, Harwig et al., 1995). Also human sPLA2 and group III PLA2 
possessed antibacterial activity against Gram-positive and Gram-negative 
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bacteria respectively (Qu and Lehrer, 1998, Koduri et al., 2002). However, there 
are relatively few reports describing the effects of PLA2 on parasites. It has been 
shown that Trypanosoma rangeli, a protozoan parasite of Rhodnius prolixus 
inhibits the release of arachidonic acid for eicosanoid biosynthesis(Garcia et al., 
2004). 
The activity of the recombinant sPLA2 was measured fluorimetrically to 
determine if it is enzymatically active or not. The rec-sPLA2 was found to be 
enzymatically active and the enzyme activity increased with substrate 
concentration (Appendix 2). To determine if sPLA2 is trypanocidal, we used rec-
sPLA2 to perform a Minimum Inhibitory Concentration (MIC) assay on 
trypanosomes to ascertain the effects sPLA2 on the survival of T. b. brucei. 
PLA2s are known to possess antimicrobial acitivity. From our data, it appears 
that the presence of sPLA2 at low concentration does not seem to inhibit the 
growth of trypanosomes, while at higher concentration there was an inhibition of 
trypanosome growth suggesting that sPLA2 is trypanocidal at high 
concentrations. In as much as in vitro assays are important to investigate and 
identify cellular/molecular working mechanisms, they are performed with cells or 
biological molecules outside their normal biological environment and therefore 
cannot easily mimic in vivo exposures. The concentration of PLA2 needed to 
inhibit trypanosome growth in vivo might not be the same with the concentration 
of PLA2 in vivo. 
This is in line with what has been observed using bee venom PLA2 (bvPLA2) 
which has been demonstrated to kill trypanosomes at high concentrations 
(Boutrin et al., 2008). At lower concentrations of bvPLA2, the parasites are not 
completely killed, in fact, growth comparable to or higher than the controls was  
observed (Boutrin et al., 2008). It is thought that the PLA2 acts by disrupting the 
membranes of the parasites (Boutrin et al., 2008). Trypanosomes expresses a 
membrane bound PLA2 activity, which is known to be involved in the regulation 
of calcium metabolism (Eintracht et al., 1998, Catisti et al., 2000). The activity of 
PLA2 in trypanosomes produces arachidonic acid (AA) which in turn activates 
calcium influx, thereby serving as a positive feedback regulator to PLA2 
(Eintracht et al., 1998). If membrane disruption occurs, calcium regulation in 
trypanosomes could be lost because there will be uncontrolled efflux of calcium 
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brought about by holes in the membrane caused by PLA2 digestion (Boutrin et 
al., 2008). Also, higher levels of intracellular AA may be produced as a result of 
the PLA2 reaching the cytoplasm and this may lead to accumulation of higher 
concentrations of intracellular Ca2+ which in combination with reactive oxygen 
species could trigger calcium-dependent fragmentation of nuclear DNA, loss of 
motility and ultimate death of trypanosome cell death (Parsons and Ruben, 
2000, Ridgley et al., 1999). It means therefore that with or without significant 
membrane damage, sPLA2 may still be able to disrupt the regulation of calcium 
leading to death. This is in contrast with what has been observed in mosquitoes 
in which snake venom PLA2 prevented oocyst formation but does not have a 
direct effect on the plasmodium parasite (Zieler et al., 2001). It remains to be 
determined how the G. morsitans sPLA2 kill trypanosomes, but the protein may 
act either on the parasite surface forming pores or intracellularly (e.g. lysosome), 
in which case it may altere parasite homeostasis.   
The downregulation of sPLA2 early on during the infection process was not 
surprising since the parasites will try to suppress the expression of sPLA2 (and 
other immune-related molecules) to establish an infection. The fly on its part 
starts to express more sPLA2 as the infection progresses to eliminate the 
proliferating parasites. Although the expression of sPLA2 was found to be down-
regulated in refractory flies, this could have been influenced by the timing of 
midgut dissection following the infectious blood meal (3 dpi). This was done to 
maximise the opportunity of finding the genes involved in the elimination of the 
invading parasites, since this period is characterised by a process of attrition that 
leads to complete elimination of parasites in some flies (Gibson and Bailey, 
2003).  
Based on our findings we propose the following: (i) tsetse sPLA2 is involved in 
immune response during trypanosome infection since its downregulation partially 
reverses the refractory phenotype; (ii) following trypanosome infection, the 
expression of sPLA2 is suppressed by the parasites in order to create a 
conducive environment in which to proliferate and (iii) expression of sPLA2 may 
be linked to the tsetse Toll pathway as a challenge with S. aureus, but not E. coli 
induces a massive expression of this protein. In response to the increase in the 
number of parasites, the fly tries to fight back and starts to express more sPLA2 
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in a bid to possibly eliminate the parasites or reduce the number of parasites to a 
level that will not overwhelm the fly and result in a fitness cost (Figure 5.8).  
Attention is turning towards blocking the transmission cycle in the tsetse fly host, 
but before this will become a reality the it is absolutely important to understand 
the molecular mechanisms underlying the complex interactions between 
trypanosomes and their tsetse fly vector. Interestingly tsetse flies are naturally 
refractory (resistant) to trypanosome infection and the genes involved in 
refractoriness can be used to fight the parasite in the fly by constitutively 
expressing these genes in the midgut of the fly in close proximity to the invading 
parasites. Therefore, it is necessary to better understand how tsetse sPLA2 
works as it can be used as a paratrangenesis control tool. Since tsetse flies 
reproduce by adenotrophic viviparity this can only be done paratransgenetically 
by using one of the endosymbionts found in the midgut (e.g. Sodalis glossinidus) 
to express the genes in the midgut. The midgut of tsetse, however, is not a 
particulary friendly environment, being filled with degradative enzymes that are 
also employed in the fight against invading parasites.  
Candidate genes must therefore be able to withstand the harsh midgut 
environment. One gene that fits this bill is the PLA2. PLA2 possesses some 
unique properties that make them very suitable for expression in the degradative 
environment of tsetse and one of these properties is that it is exceptionally stable 
and can withstand the degradative environment of the tsetse midgut lumen 
(Zieler et al., 2001). Furthemore, sPLA2 is also expressed in tsetse saliva, which 
raises the fascinating question as to whether this enzyme helps to control 
colonisation of the fly salivary glands by the parasite epimastigotes. In summary, 
I have demonstrated that a reduction in the expression of PLA2 in tsetse made 
the flies more susceptible to trypanosome infection suggesting that sPLA2 is 
actively involved in immune response to trypanosome infection. Furthermore, I 
have shown that the invading parasites suppress the expression of PLA2 early 
on during the infection process to create a favourable environment for their 
proliferation. The data presented here will be helpful in understanding the 
mechanisms involved in tsetse-trypanosome interaction.  
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Figure 5.9 Schematic representation of sPLA2 expression during the 
cross-talk between tsetse and trypanosomes. Trypanosomes invade tsetse 
midgut and secrete or express substances aimed at suppressing sPLA2 
expression thereby crippling tsetse immune response. This creates a 
favourable environment for the parasites to flourish. In response to the increase 
in parasitaemia, the flies fight back by increasing the expression of sPLA2 to 
possibly eliminate or at least prevent the parasites from overwhelming the flies. 
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                                              Chapter 6  
                       General discussions and conclusions 
 
 
The main objective of the work presented in this thesis was the identification and 
characterisation of some genes that are differentially expressed in the midgut of 
tsetse flies that are refractory to trypanosome infection. By doing this I intended 
to shed more light on the molecular mechanisms underlying the interaction 
between trypanosomes and tsetse which is not fully understood. RNAi was used 
to knockdown the genes of interest (i.e. Chit, SPI, OGT and sPLA2) and then 
observed their effects on the susceptibility of the flies to trypanosome infection. 
In this chapter, a summary of the main findings with regards to the research 
questions are presented together with general conclusions arising from the 
findings outlined in this study.  
African trypanosomes undergo an obligatory and complex developmental cycle 
in tsetse flies before maturing into mammalian infective forms and therefore rely 
on them for transmission and dissemination. To better understand the 
transmission dynamics of these parasites therefore, it is imperative that the 
complex interaction between the parasite and the tsetse fly is understood. 
Against this backdrop, coupled with the difficulty in developing a vaccine for the 
disease because of the phenomenon of antigenic variation exhibited by the 
parasites, there has been a shift in paradigm towards blocking the transmission 
of the parasite by disrupting its developmental cycle in the vector using 
paratransgenetic approach.  
The identification and characterisation of genes that have the potential of 
disrupting the life cycle of the parasites when expressed in the vector is an 
important step in paratransgenetic technology. To this end, there have been 
reports of the development of transmission-blocking antibodies that have the 
ability to block the development of trypanosomes in the fly (Nantulya et al., 1987, 
Nantulya and Moloo, 1988). An alternative approach is the use of genes that are 
employed by the insects naturally to fight infection as potential effectors. Insects 
generally are known to mount robust innate immune responses in reaction to the 
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presence of pathogens and in fact, can clear these pathogens. These immunity 
genes are therefore potential candidates that can be identified and characterised 
to be used as effector molecules. Tsetse flies are known to be naturally 
refractory (resistant) to trypanosome infection because of their innate ability to 
mount robust immune responses to invading trypanosomes clearing the 
parasites in most cases resulting in a few flies being able to nurture and transmit 
the parasites to mammalian hosts (Gibson and Bailey, 2003). As a result of this, 
it has been speculated that either the immune responses are belated or are not 
expressed close enough to the parasites, or both, and as a result are not able to 
combat the parasites. Constitutive expression of these antitrypanosomal 
molecules in the midgut of tsetse using one of its endosymbionts therefore looks 
promising as a means of enhancing the immune responses of the fly. This 
method has been successfully used to reduce the development of Trypanosoma 
cruzi infections in the hindgut of triatomine vectors of Chagas disease 
(Durvasula et al., 1997, Beard et al., 1998). Also the use of paratransgenetic 
approach to control parasite transmission has been applied to other vector-borne 
diseases such as sand fly-transmitted leishmaniasis (Hillesland et al., 2008). To 
use this approach for African trypanosomiasis we must first of all understand the 
molecular mechanisms involved in the crosstalk between tsetse and 
trypanosome. Major findings in this thesis are summarised below. 
 
 We identified a set of differentially expressed genes in the midgut of self-
cleared trypanosome infected flies. Bioinformatic analysis revealed a total 
of 17 genes that were up-regulated and 38 genes that were down-
regulated in the midguts of flies that had self-cleared trypanosome 
infections compared to non-trypanosome-challenged tsetses. It has been 
observed that only a small proportion of genes are upregulated in tsetse 
in response to trypanosome or bacterial challenge while the majority of 
genes (including immune related genes) are downregulated (Lehane et 
al., 2003a). 
 
 In this study, I have shown that Chit, OGT, SPI and sPLA2 are involved in 
the immune responses of the tsetse fly during trypanosome infection, 
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although only OGT gene was found to be up-regulated in refractory flies. 
It has been shown that trypanosome or bacterial challenge of flies leads 
to a significant increase in the number of down-regulated genes (Lehane 
et al., 2003a). The knockdown of each of the candidate genes led to a 
significant increase in midgut infections. In arthropods the immune system 
can be said to be highly dependent on the regulation of chitin synthesis 
and degradation since most of the features of the immune system such as 
the phenoloxidase (PO) cascade, melanization and antimicrobial peptides 
are linked to chitin metabolism (Beckerman et al., 2013). Also PO 
cascade is thought to be triggered by chitin-binding antimicrobial peptides 
(Nagai et al., 2001) and melanin a major feature of invertebrate immune 
system is thought to be regulated by chitin metabolism (Marmaras et al., 
1996, Walker et al., 2010).  
Chitinase which is directly involved in chitin degradation and modification 
(Muthukrishnan et al., 2012), can be said to play an important role in 
insect immune response. The inhibition of chitinase can also have a 
negative impact on the defensive roles of the peritrophic matrix since 
chitinase is involved the regulation of chitin (a major component of the 
peritrophic matrix) synthesis and degradation thereby compromising the 
defensive role of the peritrophic membrane. It is therefore expected that 
RNAi-mediated knockdown of chitinase will make the flies more 
susceptible to trypanosome infection. Accordingly, there was a significant 
increase in midgut trypanosome infection prevalence in dsRNA-CHT 
knockdown flies compared to controls. 
 
 I was also able to demonstrate that OGT is involved in immune response 
when flies are challenged with trypanosomes. The use of OGT as an 
immune modulator is thought to be evolutionarily conserved in both 
vertebrates and invertebrates (Bond et al., 2014). OGT catalyses the 
transfer of O-linked GlcNAc residues to both nuclear and cytosolic 
proteins, a post-translational modification (PTM) that plays a vital role in 
numerous cellular signalling pathways involving growth, metabolism, 
cellular stress and host-pathogen interactions (Hanover et al., 2010). 
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There is the notion that inappropriate O-GlcNAcylation of specific, key 
OGT targets brought about by the absence of OGT will lead to 
immunodeficiency (Bond et al., 2014). Consistent with this notion, a 
significant increase in midgut infection was observed in flies injected with 
dsRNA-OGT compared with uninjected and dsRNA-GFP-injected 
controls. It has been shown that the prevention of O-GlcNAcylation of 
proteins leads to significant loss of nitric oxide (NO) and cytokine 
production (Ryu and Do, 2011) which are known to play important roles in 
early host defence against invading pathogens (Janeway and Medzhitov, 
2002, Beutler and Rietschel, 2003).  
This thesis provides strong evidence that OGT is deployed during 
trypanosome infection to increase O-GlcNAcylation of proteins. It is our 
view that the knockdown of OGT led to a reduction in O-GlcNAcylation of 
proteins which results in significant reduction in NO production thereby 
inhibiting the ability of the flies to fight the invading parasites. This 
therefore results in increased susceptibility of the flies to trypanosome 
infection. It has been suggested that a complex interaction exists between 
NO signaling and  O-GlcNAcylation pathway (Baudoin and Issad, 2014). 
Innate immune signaling is known to be initiated by specific interaction of 
pathogen ligands with Toll-like receptors (TLRs), which induces iNOS 
expression, and, subsequently, the production of NO, which acts as both 
bactericidal agent as well as an intracellular mediator (Baudoin and Issad, 
2014). The knockdown of OGT is known to abolish NO-induced effects in 
mice (Liu et al., 2014). Therefore, it is possible that tsetse OGT controls 
immune-related pathways like production of NO, which is known to be 
deleterious for trypanosomes in the fly. 
 
 An important component of the humoral immune response in arthropods 
is the prophenoloxidase-activating system (proPO-AS) (Cerenius and 
Soderhall, 2004, Kanost et al., 2004). It is induced in response to 
pathogen invasion with limited activation of the prophenoloxidase (proPO) 
precursor into the active phenoloxidase (PO), culminating in the 
production of melanin and associated toxic intermediary compounds 
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which kill invading pathogens (Franssens et al., 2008). If the active 
proteases involved in proPO activation are not inhibited, they can cause 
damage by cleaving other host proteins or trigger premature or excessive 
activation of proPO which may act beyond the intended target.  
Serine proteinase inhibitors are an important part of controlling the 
responses that rely on serine proteases (such as melanisation and 
activation of the Toll pathway) to generate an effector response (Ragan, 
2008). They are known to inhibit serine proteases involved in the Toll 
pathway (Levashina et al., 1999) as well as the melanisation pathway in a 
host of insects such as D. melanogaster (De Gregorio et al., 2002), M. 
sexta (Jiang and Kanost, 1997, Tong et al., 2005, Tong and Kanost, 2005, 
Wang and Jiang, 2004, Zhu et al., 2003) and A. gambiae (Michel et al., 
2006).  
Serine proteinase inhibitors therefore can be said to form an integral part 
of the immune response in insects and its inhibition could lead to 
uncontrolled action of serine proteases which apart from causing damage 
as a result of the cleavage of host proteins, can also result in uncontrolled 
or untimely activation of the proPO leading to the accumulation of toxins. 
The above factors could have contributed to the increased susceptibility of 
dsRNA-SPI knockdown flies to trypanosome infection and with this result, 
we have demonstrated that SPI plays an active role in tsetse immune 
response. This SPI is different to the series of serine protease inhibitors 
secreted in the tsetse midgut and with proven anti-complement activity 
(Ooi et al., 2015). 
 
 As part of the investigation to understand the interaction between 
trypanosomes and tsetse fly, the role of PLA2 in the establishment of 
infection in the midgut of G. m. morsitans was carried out. Chapter 5 
discusses most aspects of the potential role if this enzyme in the innate 
immune pathway of tsetse flies. 
One aspect that remains unresolved is whether sPLA2 exhibit trypanocidal 
activity in the fly or does it act through the eicosanoid biosynthetic 
pathway to release prostaglandins and other eicosanoids that are involved 
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in immune response? The role of PLA2 on eicosanoid biosynthesis can be 
tested by inhibiting the activity of PLA2 using a specific PLA2 inhibitor such 
as dexamethasone and observing the effect on the immune response of 
tsetse. The addition of arachidonic acid will restore the production of 
eicosanoids and boosting of immune reactions (Figure 6.1). In addition, 
the mode of action of tsetse sPLA2 on trypanosomes is not known 
although it may be acting by disrupting the trypanosome membrane 
leading to an uncontrolled efflux of calcium resulting in cell death (Boutrin 
et al., 2008). Collectively, my data shows that PLA2 plays an important 
role in the immune response of tsetse to trypanosome infection and we 
propose a model that trypanosomes inhibit sPLA2 expression on invading 
the flies but the fly fights back as the parasites proliferate in the midgut by 
expressing more PLA2 to get rid of the parasites. This is depicted in 
Figure 5.9. 
 
           
            Figure 6.1 Role of PLA2 on eicosanoid biosynthesis. Phospholipids are hydrolyzed 
by PLA2 with the production arachidonic acid and the subsequent production of 
prostaglandins and other eicosanoids using arachidonic as substrate. In the presence 
of dexamethasone, a specific PLA2 inhibitor, the immune responses are suppressed as 
a result of the inhibition of PLA2 activity leading to the suppression of eicosanoid 
production, while the exogenous addition of arachidonic acid restores the production of 
eicosanoids and enhancement of immune responses 
 
Last, there were some constrains and limitations that were encountered during 
the course of this study.  
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 The transcriptome data consists of reads from control (uninfected) and 
flies fed an infective bloodmeal (containing a mixture of self-cured 
(refractory) and infected (susceptible) flies). Comparison of gene 
expression was therefore between uninfected flies and flies challenged 
with trypanosomes. The group of flies challenged with trypanosomes will 
therefore consist of refractory and susceptible flies. There was no 
opportunity to compare gene expression between refractory (self cured) 
and susceptible flies.  
 
 Although qPCR was used to check for knockdown and transcript 
expression, western blot analysis was only used to corroborate 
expression of sPLA2 due to non availability of suitable antibodies for the 
other proteins and time constraints.  
 Also, it would have been interesting to knockdown O-GlcNAcase (OGA; 
the enzyme that removes OGT from proteins) and see what effect it will 
have on the expression of OGT and trypanosome infection prevalence.  
 Although dsRNA was delivered by injection, it will be nice to feed the 
dsRNA to see if the same level of knockdown and effect on trypanosome 
establishment will be achieved. Moreover this will avoid pre-stimulating 
the immne system of the fly by injection.  
 For sPLA2, because of time constraints, we could not proceed with the 
knockdown of some genes involved in the Toll/Imd pathways to observe 
what effect it will have on the expression of sPLA2 since it has been 
observed that the activation of sPLA2 is functionally linked to Toll/Imd 
signal pathways (Shrestha and Kim, 2010).  
 
Future work  
 It will also be interesting to feed tsetse with Sodalis glossinidius and then 
measure sPLA2 expression. This will be an interesting experiment since 
S. glossinidius has been linked with increased susceptibility to 
trypanosome infection in tsetse (Welburn and Maudlin, 1999) based on its 
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chitinolytic activity which produces lectin (Welburn et al., 1993). However 
its effect on sPLA2 expression has never been investigated.  
 Also since S. glossinidius belongs to the Enterobacteriaceae family some 
of which have been implicated in the impairment of insect host immunity 
by inhibition of sPLA2s (Park and Kim, 2000, Park et al., 2003, Park et al., 
2004, Park and Stanley, 2006, Kim et al., 2005), it will be interesting to 
see if it does inhibit sPLA2 in tsetse also.  
 It will be good to determine the potential link between Toll/Imd pathways 
and PLA2 expression by knocking down genes (one in each pathway) and 
then analyse the expression of PLA2 following challenge with T. b. brucei. 
 Extend timecourse experiments beyond day 15 to see if PLA2 expression 
is sustained beyond that time point. 
 To ascertain if systemic knockdown of PLA2 was achieved following after 
injection dsRNA by examining PLA2 expression in the salivary glands 
using western blot. 
 Analysis of the SG and PV to look at the parasite 
population/developmental stages and possible link between the 
negotiating the PV or colonization of the SG and PLA2 expression. 
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Figure A.1. Ramachandran plots of initial and final models of (A) GmmCHT, 
(B) GmmOGT, (C) GmmPLA2  and (D) GmmSPI. Number of residues in 
favoured region: (A) initial, 319 (91.1%), final, 327 (93.4%); (B) initial, 319 
(91.1%), final, 327 (93.4%); (C) initial, 90 (92.8%), final, 96 (99.0%); (D) initial, 82 
(82.8%), final, 94(94.9%). Number of residues in allowed region: (A) initial, 24 
(6.9%), final, 16 (4.6%); (B) initial, 24 (6.9%), final 15 (4.3%); (C) initial, 7 (7.2%), 
final 1 (1.0%); (D) initial, 13 (13.1%), final, 4 (4.0%). Number of residues in 
outlier region: (A) initial, 7 (2.0%), final 7 (2.0%); (B) initial, 7 (2.0%), final, 8 
(2.3%); (C) initial, 0 (0.0%), final, 0 (0.0%); (D) initial, 4 (4.0%), final, 1 (1.0%) 
A 
B 
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Figure A2 sPLA2 activity assay. Recombinant sPLA2 is enzymatically active and 
activity increases with protein concentration. 
